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ABSTRACT 
This thesis outlines the results of occupational respiratory health surveillance at 
Minara Resources, Murrin Murrin mine site. The research was conducted as part of a 
collaborative agreement between Edith Cowan University and Minara Resources, the 
overarching title of which was ‘Establishing best practice protocols in the management 
of occupational and environmental health in a high-risk mining and ore-processing 
environment’. 
To form the basis of this research it was hypothesised that although the chemical 
hazards had been adequately identified, and the occupational exposures in each work 
area at Murrin Murrin were generally well below their respective occupational exposure 
levels, it was still possible that additive, or even synergistic biological effects could 
cause adverse respiratory health effects due to the exposure to a combination of these 
atmospheric contaminants. This was the perception and a concern voiced by the Murrin 
Murrin workforce. 
Therefore, in working through the hypothesis, a literature review concentrating on 
the gaps in current knowledge and research for the early detection of occupational 
respiratory diseases was conducted, and the research tool and experiment design 
determined. The case for using pulmonary function tests in conjunction with a 
respiratory questionnaire in assessing early respiratory changes due to occupational 
exposures was established.  
Over a period between 17 February 2004 and 21 June 2006, a longitudinal study was 
conducted to ascertain the prevalence of respiratory symptoms and lung function of 
employees at the Murrin Murrin Operation, and compared with a local control group 
consisting of catering staff who resided at the accommodation camp approximately 
eight kilometres from the mine site. Lung function data were also compared to 
established predicted normal values from a reference population with normal lung 
function. Lung function data were analysed to determine whether there was an effect 
due to the area worked, and the employee’s length of service. The lung function 
parameters of the study group, corrected for age and height were compared using linear 
regression analysis with both the control group and the predicted normal values. Repeat 
lung function tests were conducted on a sample of the original study group 
approximately two years after the initial study and statistically analysed to determine 
iv 
whether there was an effect on lung function over this time period. In addition, lung 
function tests were conducted for a cohort of refinery workers at the start and end of 
their two-week work period to determine whether there was a before-and-after effect 
due to their working conditions. 
The prevalence of respiratory symptoms was less in the study group compared to the 
controls; and these respiratory symptoms were determined to be non-work-related. On 
statistical analysis, for the ‘presumed healthy’ workers (minus the smokers and those 
with known non-work-related respiratory symptoms) there was no overall decrement in 
lung function. Similarly, there was no overall statistically significant decrement in lung 
function for the ‘presumed healthy’ workers in the repeat study conducted 
approximately two years after the initial study. There was no decrement in lung function 
associated with area work; nor was there a decrement in lung function for the cohort of 
refinery workers from the start to completion of their two-week work period. However, 
there were decrements in lung function for the smokers in the study and control groups. 
There was a significant difference in FEV1 between non-smokers and smokers with 
length of service (p <0.05); and a significant difference (p <0.05) in FEV1 from first 
spirometry test compared with the repeat spirometry test for the smokers/asthmatics 
sub-group in the repeat study. This in effect acted as ‘internal validity’ indicating that 
spirometry was sensitive enough to detect a decrease in lung function due to smoking in 
the initial and repeat studies; and that if there were adverse respiratory health effects due 
to the exposure of atmospheric contaminants at the Murrin Murrin Operation, that this 
would have been detected.  
Hence the concern shown by the employees at the Murrin Murrin Operation, that 
workplace emissions may be harming their respiratory health, appears to be dispelled by 
this study. 
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1. INTRODUCTION 
The extent to which occupational respiratory disease contributes to work-related 
illness in Australia remains unknown although estimates have been made. Two main 
reasons for this are that the aetiology of occupational respiratory disease is difficult to 
establish largely due to the long latency period, and the effect confounding such as 
environmental exposures and lifestyle factors such as smoking (Morrell, Kerr, Driscoll, 
Taylor, Salkeld, & Corbett, 1998). The magnitude of occupational injury is far easier to 
establish than for occupational diseases as there is a clear cause and effect for an injury. 
Worldwide it has been estimated that approximately two million people die every year 
as a result of work-related injury and/or illness (CCH, 2009). The National 
Occupational Health and Safety Commission (NOHSC, 2003) estimated there are more 
than 2,000 workplace-related fatalities every year in Australia. This figure is thought to 
be only an estimate, because the long latency period of some diseases and the difficulty 
in relating some conditions to periods of work make it difficult to quantify the precise 
number of deaths. Nevertheless, it has been estimated that 85% of workplace deaths 
worldwide are due to occupational diseases and, apart from cancer, the most common 
job-related health problems are respiratory diseases, musculoskeletal disorders, hearing 
loss, circulatory diseases and communicable diseases (CCH, 2009). 
To add to the complexity of this issue, available statistics (such as workers’ 
compensation data) suggest that musculoskeletal injury and dysfunction are the main 
cause of occupational abnormalities in Australia. However, these data sources have 
been reported to be misleading, because the more recognisable problems (such as 
musculoskeletal disorders) are more likely to be reported and recorded. By contrast, 
health problems related to substances (for example, toxic dust exposure) are often hard 
to identify because the early effects can be subtle and the time between exposure and 
the development of symptoms can be substantial (Morrell, Kerr, Driscoll, Taylor, 
Salkeld, & Corbett, 1998).   
Although it is well known that exposure to irritant gases, aerosols and particulates in 
ambient air can cause adverse effects in the respiratory system (Balmes, 2002) the 
Parliament of Australia (2004) reported a paucity of data in Australia on morbidity and 
mortality associated with workplace toxic dust exposure. It also highlighted the need for 
robust surveillance systems and early accurate diagnosis of loss of lung function.   
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On inhalation of toxic agents there is a continuum of effects which may range from 
acute reversible effects through to chronic respiratory disease (Meldrum, 2001; 
McCance & Huether, 1999) and even fatality at concentrations immediately dangerous 
to life (National Institute for Occupational Safety and Health [NIOSH], 2005). This 
embodies the ‘threshold concept’ where a small amount of a toxic agent produces little 
or no effect, but as the dose increases the incidence of a health effect in an exposed 
population exceeds that of a control population not exposed to the toxic agent (Cohen, 
2002, p. 126). At the cellular level, injured cells affected by inhaled toxic agents may 
recover (i.e., a reversible effect) or die (i.e., an irreversible effect) (McCance & Huether, 
1999). Such effects have been reported to be dependent on the chemical and physical 
properties of the toxic agent (or mixture of agents); the concentration in the air; the 
duration and frequency of exposure; the respiratory rate; and the susceptibility of each 
individual (Witschi, Pinkerton, Van Winkle, & Last, 2008; Cohen, 2002).  
Inhalation of irritant gases or particulates can result in inflammation of the airways 
and lung parenchyma and can therefore affect lung function and initiate respiratory 
disease (Mitchell, 1997; Schwartz, 2002). The Australian Safety and Compensation 
Council (2006, p. 2) defined occupational respiratory disease (in contrast to non-work-
related respiratory disease) as “caused or exacerbated by work factors”. Moreover, the 
Australian and New Zealand Society of Respiratory Science (ANZSRS) considered it 
feasible to provide early detection of occupational respiratory disease (Parliament of 
Australia, 2004). 
It is not, however, always clear whether respiratory disease is in fact occupational as 
there are normally confounding non-occupational factors that contribute to the disease 
burden in the individual. Cigarette smoking has been regarded as the classic example of 
this phenomenon in that regular smoking is widely regarded as the major risk factor for 
respiratory disease (Wewers et al., 2010).  Likewise, asthma may be initiated and/or 
exacerbated by occupational exposures. In combination, mixed exposures to such non-
occupational and occupational factors have been suggested to be additive or even 
synergistic (Tranter, 2004; Burge, 2002) 
This research examined the respiratory health of workers at the Murrin Murrin 
lateritic nickel and cobalt extraction and processing operation in Western Australia. This 
chapter provides the rationale and background to the study including information on the 
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occupational setting, an overview of the respiratory health hazards associated with this 
occupational setting, and a summary of the possible pathophysiological effects of 
exposure to airborne contaminants. This is followed by the justification, significance, 
and purpose of the study. 
1.1 Problem Statement 
The respiratory health effects of concurrent and repeat exposures to complex 
mixtures of low-level airborne hazardous substances at the Murrin Murrin Operation 
remain unknown. Traditionally, health risk assessments are based on measurement of 
the airborne concentrations of hazardous substances independently. Such monitoring 
was conducted as a precursor to this study to determine the occupational exposures in 
each work area at Murrin Murrin (Oosthuizen & Cross, 2004). Although they were 
generally well below their respective occupational exposure levels, it is possible 
however, that additive, antagonistic, potentiated or even synergistic biological effects 
could occur due to exposure to a combination of these atmospheric contaminants 
(Zeliger, 2008). Moreover, it was the perception of the Murrin Murrin workforce that 
such exposures may result in adverse health effects not predicted by atmospheric 
monitoring (Oosthuizen & Cross, 2004).  
1.2 Background 
The Minara Resources’ Murrin Murrin mine site is located approximately 60 km east 
of Leonora and 60 km west of Laverton in the north eastern Goldfields region of 
Western Australia. The primary business at Murrin Murrin is to produce nickel and 
cobalt from laterite ore. The operation exists to extract lateritic ore through open cast 
mining and then to process the ore using the Sherritt International Pressure Acid Leach 
(PAL) technology to recover nickel and cobalt (Mining-Technology.Com, 2010) whilst 
at the same time preventing or minimising unwanted releases of hazardous materials 
that could expose employees. This biological monitoring study was commissioned by 
Minara Resources to monitor the process safety and control measures at the Murrin 
Murrin Operation. 
Atmospheric exposure measurements (also known as occupational hygiene 
monitoring) have been conducted since the Murrin Murrin mine operation commenced 
in 1999, in order to evaluate the adequacy of the primary preventive measures. As a 
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precursor to this study, in 2004 a systematic approach to occupational health and 
hygiene was adopted in order to develop best practice protocols for the management of 
occupational hygiene hazards at the Murrin Murrin mine site (Oosthuizen & Cross 
2004; Wing, 2005; Wing & Oosthuizen, 2007). During the systematic identification and 
evaluation of all occupational health and hygiene hazards associated with the complex 
chemical extraction process of nickel and cobalt from ore at the Murrin Murrin mine 
site, a number of potentially irritant gases, aerosols and dusts were identified, the most 
notable being hydrogen sulphide, ammonia, sulphur dioxide/trioxide, oxides of 
nitrogen, sulphur dust, nickel dust, cobalt dust, calcrete dust and red dirt dust (dust from 
the ground in this area). Occupational hygiene monitoring has demonstrated that the 
mean occupational exposures were generally well below their respective occupational 
exposure levels (Wing, 2005; Wing & Oosthuizen, 2007). Despite this, there was 
concern expressed by the staff that, in combination, the various contaminants may 
present an additive or even a synergistic deleterious health effect (Interdepartmental 
Group on Health Risks from Chemicals, 2008). 
1.3 Justification and Significance 
1.3.1 Justification 
Toxicological reviews of the potentially irritant gases, aerosols and dusts identified 
via the occupational hygiene surveys at the Murrin Murrin mine site, determined that 
the predominant route of exposure would be via inhalation, with the lung being the main 
target organ, possibly resulting in respiratory disease (Witschi, Pinkerton, Van Winkle, 
& Last, 2008; Nemery, 2002; Cowie, 2002). If this were the case, this would potentially 
cause a significant, short-term and long-term, health and economic impact. The aim of 
this biological monitoring was therefore to detect possible adverse effects at an early 
stage in order to prevent potential long-term occupational respiratory disease (Hendrick, 
Burge, Beckett, & Churg, 2002; Parliament of Australia, 2004). 
As stated by Morgan and Seaton “All occupational lung disease represents a failure 
of preventive measures” (1995, p. 9). Atmospheric exposure measurements and 
biological monitoring are therefore used to determine whether existing preventive 
measures are adequate, and if not, that additional controls are implemented (Plog, 2002; 
Hendrick et al., 2002). Prevention of disease is a fundamental principle of occupational 
epidemiology (Checkoway, Pearce, & Kriebel, 2004). Hence an occupational 
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epidemiological study of the workforce at the Murrin Murrin Operation was conducted. 
The prevalence of respiratory symptoms and lung function for each worker and each 
independent workgroup – that is, mining, ore leach, refinery, utilities, calcrete, pastoral 
and administration – were investigated.  
1.3.2 Significance 
An epidemiological study of complex mixtures of low-level respiratory irritants in an 
Australian lateritic ore mining and processing plant did not appear to have been 
conducted previously. Each work area/department at the Murrin Murrin Operation has 
its own unique profile of potential respiratory irritants, with limited periods of low-level 
exposure not experienced in any other industry. Thus this epidemiological study 
enabled the measurement of low-level exposures of these complex mixtures in each 
work area as well as for the whole site. The findings therefore have the potential to 
identify any additive or synergistic effects which may occur through interaction of a 
combination of the potential respiratory irritants.  
Although the outcome of this study is specific to the Murrin Murrin Operation, it 
may also have some relevance to other lateritic mining operations using the high 
pressure acid leach (HPAL) method of extraction such as those in Indonesia, Brazil, 
Cuba, Colombia and New Caledonia (Intec, n.d.; Barnes, 1998; Mining-
Technology.Com, 2010).  
1.4 Purpose of the Study 
This study was a longitudinal study of the Murrin Murrin workforce, looking for 
possible early respiratory health effects due to potential exposure to various hazardous 
substances associated with the mining and processing of ore for production of nickel 
and cobalt. The purpose of the study was to conduct respiratory health surveillance of 
the Murrin Murrin workforce to:  
 detect possible adverse respiratory health effects at an early stage, in order to 
 prevent potential long-term occupational respiratory disease, and then, if 
necessary,  
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 to recommend interventions to prevent untoward health effects, and to enable 
management to have a proactive approach for the protection of the workforce 
(Hendrick et al., 2002). 
1.5 Organisation of Thesis 
Chapter 2 provides a critical review of existing literature regarding how air quality 
can affect lung function and cause respiratory disease. The impact of respiratory disease 
is discussed and the literature review then focuses specifically on occupational 
respiratory disease, its aetiology, the health surveillance methodology to determine 
occupational respiratory disease, and the potential confounding factors. It identifies the 
gaps in current knowledge and research for the early detection of occupational 
respiratory diseases, and states the case for pulmonary function tests in conjunction with 
a respiratory questionnaire in assessing early respiratory changes due to occupational 
exposures, which was the main aim of this study. 
Chapter 3 provides an overview of the Murrin Murrin Operation process, from 
mining of the ore, through its processing to produce the final nickel and cobalt products. 
In doing so, the chemical hazards that workers may face on a daily basis are identified.  
Chapter 4 focuses on the respiratory health issues presented by each hazardous 
substance associated with the mining, the process plant, and specific work areas, and 
relates this to the personal exposure assessments that were determined through the 
occupational hygiene component of this study. It also discusses the effects of mixed 
exposures on the respiratory system.  
Described in Chapter 5 are the methods and procedures used to collect the data for 
this biological effects monitoring study. This includes the study design, administration 
of the respiratory questionnaire, the measurement technique, the equipment and quality 
control, and statistical analysis. 
Presented in Chapter 6 are the results of this study. The prevalence of respiratory 
symptoms of the study group of workers at the Murrin Murrin Operation is compared 
with those of a control group of caterers located close to the operation. The lung 
function of the study group is compared both with their predicted values, and the control 
group, and analysed with the sequential removal of the confounding factors known to 
affect lung function. Also presented in Chapter 6 are the results of the initial and repeat 
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lung function study, as well as the lung function for a cohort of refinery workers before 
and after a work period. The results chapter also presents an analysis of the effect of 
length of service, and the effect of smoking on lung function. 
Chapter 7 provides a discussion of the results and the limitations of this research and, 
finally, Chapter 8 provides the conclusions and recommendations that emerged from 
this research. 
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2. LITERATURE REVIEW 
2.1 Introduction 
It is known that occupational respiratory disease is a major contributor to the burden 
of lung disease in Australia but the exact causes and statistics remain unknown 
(Morrell, Kerr, Driscoll, Taylor, Salkeld, & Corbett, 1998). The extent to which the 
occupational air quality at the Murrin Murrin Operation affects lung function remains 
unknown. This study investigates this. This chapter provides the background for this 
research and contains a critical examination of published epidemiological, experimental 
and theoretical evidence relevant to this research. 
The main literature review was conducted prior to the start of the study to shape the 
experimental design and, therefore, the methodology is based on references current at 
the start of the study in 2004.  
2.2 Air Quality and Respiratory Impairment 
It has been widely reported in the literature that air quality affects lung function and 
thus morbidity and ultimately mortality (Ostrowski & Barud, 2006; Samet et al., 2000). 
According to the European Lung Foundation (n.d.a) respiratory disease is the second 
biggest killer globally after cardiovascular diseases (British Lung Foundation, n.d.) and 
excessive exposure to hazardous substances at work via inhalation is known to cause 
occupational lung disease, morbidity and mortality. Perhaps the most classic case in 
history was documented by Ramazzini who uncovered the association of stonemasonry 
and the exposure of silica dust, to silicosis (Wright, 1964; Checkoway et al., 2004). 
Similarly, pneumoconiosis in miners was reported by Agricola in 1556 (Cantrell & 
Volkwein, n.d.). A more recent case where poor air quality caused a significant number 
of deaths was the London Smog Episode of 1952 where mortality in London was 
affected by air pollution (Amdur, 1980). This was largely attributed to the burning of 
coal by house owners wanting to keep warm during a cold winter, and industries such as 
coal-fired power stations, resulting in an atmosphere dense with smoke particles, soot 
and sulphur dioxide. This event influenced public perception of poor air quality 
ultimately leading to the introduction of air quality guidelines (Bell, Davis, & Fletcher, 
2004). 
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Subsequently, there have been many studies of air pollutants measured both in cities 
and other geographical areas throughout the world where air pollutants have been found 
to be associated with respiratory impairment and mortality (Souza, Saldiva, Pope, & 
Capelozzi, 1998; Wieringa et al., 1998; Samoli et al., 2008; Wong, Vichit-Vadakan, 
Kan, Qian, & the PAPA Project Teams, 2008). Urban air pollution remains a significant 
public health problem in many countries and is known to cause and aggravate existing 
respiratory disorders and cardiovascular disease (Anderson, Atkinson, Peacock, 
Marston, & Konstantinou, 2004). The main sources of air pollutants for the general 
Australian population are considered to be: 
 particulates; 
 ozone (O3); 
 nitrogen dioxide (NO2); 
 carbon monoxide (CO); 
 sulphur dioxide (SO2).  
(Australian Bureau of Statistics, 2009)  
2.3 Impact of Occupational Lung Disease 
2.3.1 Worldwide 
According to Driscoll et al. (2005) in the year 2000 chronic obstructive pulmonary 
disease (COPD) asthma and pneumoconioses caused by airborne particulates were 
estimated to have caused up to 386,000 deaths worldwide; and the sum of years of 
potential life lost due to premature mortality and the years of productive life lost due to 
disability (Disability Adjusted Life Years – DALY’s) was estimated to be 3.7 million 
and 1.6 million respectively. Nelson et al. (2005) estimated for the year 2000 13% of 
COPD, 11% of asthma, and 9% of lung cancer, was occupationally related and 
accounted for a sizable proportion of the global burden of disease, which could be 
substantially reduced through application of proven risk prevention strategies. The 
annual cost of occupational COPD in the U.S. population alone was estimated to be $5 
billion, based on an assumed attributable fraction for COPD deaths due to occupational 
exposure of 15% (Leigh et al., 2002). According to Blanc, et al., (2002) exposure to 
workplace contaminants such as dust, gases, vapours, or fumes was associated with a 
2.0-fold (95% CI [1.6–2.5]) increase in the risk of COPD.  
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The European Lung Foundation (n.d.a) predicts that in 2020, there will be 11.9 
million (community and occupational) deaths worldwide caused by lung diseases.  
2.3.2 Europe 
Sigsgaard et al., (2010) reported that in Europe in 2000, it was estimated that COPD, 
asthma and pneumoconioses caused 52,700 deaths (39,300, 6,200, and 7,200 
respectively). Therefore occupational respiratory disease was ranked third overall, with 
mining occupations having the highest prevalence of occupational lung disease. 
Furthermore, male manual workers have been reported to have twice the risk of 
mortality from occupational respiratory disease than non-manual workers (Sigsgaard et 
al., 2010). 
2.3.3 Finland 
The Finnish Institute of Occupational Health (2010) reported that in 2005 the number 
of notified asbestos-induced cases was 807 and the number of cases of allergic 
respiratory disease was 746. Karjalainen, Kurppa, Martikainen, Karjalainen, and 
Klaukka (2002) determined the attributable fraction of work-related asthma to be 29% 
for men and 17% for women. The overall incidence of pneumonia in Finland was 
estimated to be 10.8 per 1,000 adults per year (European Lung Foundation, n.d.a). 
2.3.4 Norway 
Eagan, Gulsvik, Eide, and Bakke (2002) conducted an 11-year cohort study of a 
population of 2,819 Norwegian subjects to evaluate the influence of occupational 
exposure on the incidence of respiratory symptoms and asthma. They determined that 
occupational exposure accounted for 14% of asthma cases and 6-19% of respiratory 
symptoms. 
2.3.5 USA 
The most recent report from the NIOSH Work-Related Lung Disease (WoRLD) 
Surveillance System (2009b) presents detailed data on occupationally-related 
respiratory disease in the USA. Selected extracts quoted from the highlights are 
provided below. 
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2.3.5.1 Hypersensitivity pneumonitis 
The annual number of hypersensitivity pneumonitis deaths in the USA has been 
generally increasing, from less than 20 per year in 1979 to over 60 in 2004.  
2.3.5.2 Work-related asthma 
There were 4,132 cases of work-related asthma in the USA during 1993–2002. 
About 68% of which represented asthma caused by occupational exposure, while 20% 
represented pre-existing asthma aggravated by occupational exposure. 
Nearly 20% of asthma cases were associated with miscellaneous chemicals, 13% 
with mineral and inorganic dust, twelve percent with cleaning materials, 11% with 
indoor air pollutants, and 4% with exposures to polymers, among others. 
2.3.5.3 COPD 
Mining industries were in the top five USA industries for COPD mortality, as were 
trucking service and automotive repair and related services. 
2.3.5.4 Respiratory conditions due to toxic agents 
The estimated number of cases of respiratory conditions due to toxic agents in 2000 
in the USA was 14,700. 
The estimated rate of respiratory conditions due to toxic agents in the primary metals 
industry (CIC 33) was 3.8 per 10,000 full-time workers in 2000. 
2.3.5.5 Asbestos 
Data from the Occupational Safety and Health Administration (OSHA) and the Mine 
Safety and Health Administration (MSHA) indicate a trend towards lower asbestos 
exposure levels from 1979 to 1999, concomitant with mandated reductions in the OSHA 
permissible exposure limit (PEL). However, data indicate a steady increase in asbestos 
exposure levels in the mining industry for the years 2000 through 2003 and a slight rise 
in all other industries in the 2 years previous to 2003. Olsen et al (2011, p. 273) state 
that “in [Western Australia] WA, 1631 people (1408 men, 223 women) were diagnosed 
with malignant mesothelioma between 1960 and 2008”. Asbestos may be intersected 
during exploration drilling and unearthed during mining operations as it is widely 
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distributed in WA particularly in the “greenstone belts” (Department of Mines and 
Petroleum, 2010c)  
2.3.5.6 Silica 
Over the past several decades in the USA, silicosis mortality has declined, from well 
over 1,000 deaths annually in the late 1960s to fewer than 200 per year in the mid 
2000s. The construction and mining industries accounted for at least one third of deaths 
attributable to silicosis from 1990 through 1999 (Centers for Disease Control & 
Prevention, 2008). 
2.3.6 Germany 
According to Loddenkemper (2006) 37% of all compensated occupational diseases 
are attributable to occupational lung disease in Germany. Baur and Latza (2005, p. 597) 
reported that the confirmed cases of non-malignant occupational respiratory diseases in 
Germany were: 
 benign asbestos-associated diseases (1,975 cases); 
 silicosis/coal-worker's pneumoconiosis (1,158 cases);  
 obstructive airway diseases due to allergens (935 cases);  
 chronic obstructive bronchitis and/or emphysema in hard-coal miners 
(414 cases); 
 obstructive airway diseases due to irritants and toxic agents (181 
cases); 
 diseases caused by ionising radiation (171 cases); 
 diseases due to isocyanates (55 cases); and  
 22 cases of other rare occupational lung and airway diseases. 
Baur and Latza (2005, p. 597) also reported that miners, bakers, chemical workers, 
hairdressers and health care workers were affected the most. 
2.3.7 United Kingdom 
In the 1999 SWORD surveillance of work-related and occupational respiratory 
disease report an increase was seen in most respiratory diseases in the United Kingdom. 
There were 4,393 incident cases. Benign pleural disease was the single most frequently 
reported condition (28% of all diagnoses reported) there were 1,168 (26%) occupational 
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asthma cases and 1,032 (23%) cases of mesothelioma (Meyer, Holt, Chen, Cherry, & 
McDonald, 2001). 
The British Thoracic Society (2006) determined that mortality and morbidity due to 
occupational lung disease was increasing, with a 70% rise in mortality due to 
mesothelioma since 1992. It was estimated that 4,000 COPD deaths every year may be 
associated with work exposures. Also, in 2006 the Health and Safety Executive, UK, 
estimated that the true total lifetime cost of occupational asthma for male workers was 
between £53.6 and £78.0 million (British Lung Foundation (n.d.a). Ayres, Boyd, Cowie, 
and Hurley (2010) estimated the cost of occupational asthma to be as large as £70—
£100 million however, and, due to underreporting, may be as large as £95—£135 
million.  
The Health and Safety Executive (n.d.) determined that in the UK in 2009-2010 there 
were 38,000 workers who had breathing or lung problems caused or exacerbated by 
work. 
2.3.8 South Africa 
In South Africa, despite incomplete reporting, diseases with long latency periods 
made up 76.2% of the cases of work-related respiratory disease. This is reflected in the 
study by Girdler-Brown, White, Ehrlich, and Churchyard (2008) who determined that in 
a cohort of former gold miners, 18 months after cessation of work, 50% had either 
silicosis, tuberculosis or COPD. Moreover, Esterhuizen et al. (2001) reported that 
pneumoconiosis was the most frequently reported disease, followed by inhalation 
accidents; and that occupational asthma was the fourth most reported disease.  
Overall it can be seen that the profile of occupational lung disease varies with each 
country, geographical region, and type of industry, and is in constant flux due to 
changes in industrialisation. According to Hendrick et al. (2002) occupational asthma 
and chronic bronchitis are currently more prevalent than alveolar and interstitial 
diseases. To this end, the World Health Organization (2010) has developed a strategy 
for the prevention and control of chronic respiratory disease; and many workplace 
regulatory authorities throughout the world have developed preventative strategies 
(WorkSafe WA, 2004; Department of Mines and Petroleum [DMP], 2010a; Safe Work 
Australia, 2010d; Health and Safety Executive, UK, n.d.; NIOSH, 2009a). 
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2.3.9 The background general respiratory health of Australians 
According to the Australian Bureau of Statistics (2009) lung disease is a significant 
and growing health issue in Australia with 2.6 million cases of lung disease reported in 
2007–2008. The Australian Bureau of Statistics also stated that more than 2 million 
Australians reported having asthma during 2007–2008; and that each year lung disease 
causes 19,200 deaths in Australia. According to the Australian Lung Foundation (2009) 
one in five Australians over 40 is affected by COPD. 
However, the degree to which occupational exposure to respiratory hazards affects 
these statistics appears at present to be unknown. Although Safe Work Australia (2010c, 
p. 3) states that “occupational respiratory diseases did not display a clear overall trend 
of increase or decrease”, and it is difficult to separate work-related from non-work-
related respiratory disease (NIOSH, 2007). 
Australia ranked fourth highest out of 16 high-income countries in the prevalence of 
moderate to severe COPD (de Marco et al., 2004) and according to the Australian 
Institute of Health and Welfare (2008) about 9–15% of asthma in adults may be caused 
by occupational exposures, which can result in a significant time off work for those 
suffering from the disease. 
2.4 Occupational Respiratory Disease 
The Australian Safety and Compensation Council (2006, p. 2) defined occupational 
respiratory disease as “respiratory disease that is caused or exacerbated by work 
factors”, and asserted that the causative agents are airborne contaminants “such as dust, 
mist, fibres, fume, vapour or gas” which if inhaled and are “small enough in size to gain 
access to the deeper, pulmonary areas of the lung” are likely to cause occupational 
respiratory disease. 
Except for inhalational accidents where excessive exposures results in obvious acute 
lung injury (Sallie & McDonald, 1996; Shakeri, Dick, & Ayres, 2008) occupational 
respiratory disease is often hard to distinguish from respiratory disease observed in the 
general population (Hendrick et al., 2002) as respiratory disease may be caused by 
environmental or occupational exposures and the contribution that each plays is often 
not determined. These combined effects may be additive or even synergistic, as in the 
case of smoking and asbestos exposure (Selikoff, Hammond, & Churg, 1968). Even in 
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one discrete industry it is not easy to determine the causative agents of respiratory 
disease. For example; Ross and Murray (2004) pointed out there are different airborne 
exposures in the mining industry even for the extraction of one type of mineral due to 
the different tasks and equipment used. In 1997, Mitchell called for an Australian 
register of all occupational lung diseases, and again in 2006 Sim, Abramson and Radi 
commented on the lack of data regarding occupational respiratory disease in Australia. 
More recently, to address this Safe Work Australia (2010d) conducted a National 
Hazard Exposure Worker Surveillance: Exposures to dust, gases, vapours, smoke and 
fumes and the provision of controls for these airborne hazards in Australian 
workplaces. Hence it is work in progress. The extent to which occupational factors 
contribute to respiratory disease does not appear to have been determined and is 
difficult to ascertain. 
2.5 Epidemiology – Cause and Effect 
All diseases have causes and consequences. The aetiology of workplace exposures to 
airborne contaminants may be obvious if an apparent disease cluster or rare disease is 
observed. For example, vinyl chloride was found to cause angiosarcoma, a rare cancer 
of the liver (Creech & Johnson, 1974). Determining the aetiology of lung disease may 
be obvious, for example, in the case where excessive exposure to silica dust causes 
silicosis. Similarly the smog and its constituent smoke particles, soot and sulphur 
dioxide that caused the London Smog Episode, caused and aggravated existing 
respiratory disorders and cardiovascular diseases (Amdur, 1980). Likewise the cause 
and effect of a single massive chemical exposure resulting in reactive airways 
dysfunction syndrome (RADS) (Shakeri et al., 2008) is obvious. These are case series 
reports where an apparent increase in a specific disease is reported and clear a cause and 
consequence determined in each case. However, for more complex cases more complete 
epidemiological studies are required with comparison groups and exposure assessments 
(Checkoway et al., 2004).  
2.6 Aetiology of Lung Disease 
Epidemiological studies aim to determine the aetiology of disease and can be utilised 
to determine the aetiology of occupational respiratory disease. Respiratory irritants via 
inhalation may cause airways inflammation and subsequent damage of the upper and 
lower respiratory tract, or chemical pneumonitis which is acute inflammation of the 
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pulmonary parenchyma. Asthmagens can cause diseases of allergic and immunological 
origin and provoke respiratory symptoms in sensitised individuals at very low 
concentrations (Ryon & Rom, 1998). 
The aetiology of lung disease is due to the inhalation of hazardous substances such as 
dust, fibre, gas, vapour, mist, aerosol, fumes and smoke (Campbell, 2009) above a 
threshold level (United States Environmental Protection Agency, 2009). The toxic 
effect is reversible if the exposure (or dose) to the hazardous substance remains below 
the threshold (the no-observed-adverse-effect level [NOAEL]) level and irreversible if it 
exceeds this level. The American Thoracic Society (2003, p 787) states, “There are 
convincing data to show that the level of exposure is a critical risk factor for sensitizer-
induced occupational asthma”. Similarly Oudijk, Lammers and Koenderman (2003, p. 
9) state that COPD: 
appears to start as a reversible self limiting inflammatory reaction … 
mediated by both monocytes and neutrophils .… After prolonged exposure 
… a switch to chronicity takes place and an irreversible inflammatory 
reaction is initiated which is clearly associated with neutrophils in the lung 
tissue. 
According to Barnes, Shapiro, and Pauwels (2003) the switch to chronicity, or 
chronic inflammation, in the case of COPD results in fixed narrowing of small airways 
and emphysema. There are histopathological differences between COPD and asthma in 
that COPD mostly affects the bronchioles as well as the parenchyma, whilst there is an 
inflammatory response in all airways with asthma, however, this is usually without 
involvement of the lung parenchyma (Fabbri et al., 2003). 
The pathophysiological effects of airborne contaminants on the respiratory system 
are dependent on the physicochemical properties, the toxicity, and the dose of the 
airborne contaminant or mixture of airborne contaminants (Tranter, 2004; Plog, 2002). 
Normally, as the dose of the airborne contaminant increases so does the response on the 
respiratory system that is, the dose-response relationship (Tranter, 2004). For gases, the 
water solubility of an inhaled gas will determine the site of deposition, whilst the 
duration of exposure and rate of breathing of an individual, and their susceptibility, will 
influence the severity of the toxic effect  (Sullivan & Krieger, 2001). For particulates 
the aerodynamic diameter is of importance. Aerodynamic diameters in the 0.3-0.5 μm 
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range may be deposited in the lower airways and alveoli, often resulting in diffuse 
bronchiolar inflammation and obstruction as well as pulmonary oedema (Rosenstock, 
Cullen, Brodkin, & Redlich, 2004). Acute or subacute exposure to toxic chemicals, as 
described by Nemery (2002), results in inflammation of lung tissue. A vast number of 
substances can therefore cause inhalation injury. 
The immunological aspects of COPD are described by Cosio, Seatta and Agusti 
(2009) as a cascade of inflammatory processes. The histopathological picture of a 
typical respiratory insult is loss of ciliated epithelial cells of the airway and of type I 
alveolar epithelial cells. Following this there is damage to the tight junction interface 
between epithelial cells, sequentially leading to subepithelial and submucosal damage, 
with effects on the smooth muscle and afferent parasympathetic sensory nerve endings 
causing bronchoconstriction. This in turn initiates an inflammatory response where 
neutrophils and eosinophils release mediators that cause further injury. According to 
Ryon and Rom (1998) the repair mechanism is initiated by type II pneumocytes and 
cuboidal cells.  
2.7 Continuum of Respiratory Health Effects 
As with most pathophysiological effects there may be a continuum of effects on the 
respiratory system. These may be an acute and reversible effect due to a single or a 
small number of sub-threshold exposures, or irreversible effects due to a single high-
level acute exposure, or repeated chronic exposure (Plog, 2002). Delayed onset from 
acute exposure to toxic agents may occur days to weeks after initial insult (Schwartz, 
2002). The consequences of such respiratory exposures may range from irritation, 
allergy, cell damage, fibrosis, oedema, emphysema, cancer or systemic effects (Winder 
& Stacey, 2004). 
A continuum of effects on the pulmonary system begins with acute lung injury due to 
damage to the epithelial-endothelial barrier of the lung, which may be due to a variety 
of agents. This begins with an early inflammatory response with the release of humoral 
mediators, which, if left unchecked, may progress with the development of chronic lung 
injury (Jacono et al., 2006).  
Meldrum (2001) and Banks (2001) both state that responses to irritants may be 
viewed as occurring along a continuum. At one end of the continuum no effects would 
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be observed, followed by reversible irritation, and ultimately irreversible effects would 
be observed. The aim of respiratory health surveillance is to detect possible adverse 
effects at an early stage in order to prevent potential long-term occupational respiratory 
disease. Ammonia, hydrogen sulphide, nitrogen oxides and sulphur dioxide have been 
shown to be associated with inflammatory changes in small airways. These respiratory 
irritants at low-level repeated exposure and acute high-dose exposure are capable of 
causing decrements in lung functions measured by spirometry (Boswell & McCunney, 
1995).  
Menzel and McClelland (1980, p. 264) categorise pulmonary responses to an array of 
toxicants into five categories as follows: 
1. Irritation of the air passages which results in constriction of the 
airways. Oedema often occurs and secondary infection frequently 
compounds the damage. 
2. Damage to the cells lining the airways, which results in necrosis, 
increased permeability, and oedema. This oedema is, in general, 
intraluminal (within the airways) rather than interstitial (within the 
cells of the airway). 
3. Production of fibrosis, which may become massive and cause 
obliteration of the respiratory capacity of the lung. Local fibrosis of 
the pleura also occurs, restricting the movement of the lung and 
producing pain through the irritation of the pleural surfaces. 
4. Constriction of the airways through allergic responses. Allergic 
alveolitis is a widespread response to the inhalation of some simple 
compounds, as well as of complex organic materials capable of 
producing specific antigenic responses. 
5. Oncogenesis leading to primary lung tumours. 
Gee and Mossman (1995, p. 197) focused on the cellular and molecular mechanisms 
of occupational lung disease and describe the pathophysiology of acute lung injury as: 
1. Direct toxic effects on type I cells and endothelial cells (ECs); 
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2. Compliment activation; 
3. Coagulation factors activation; and  
4. EC biochemical response and polymorphonuclear neutrophil 
recruitment and activation that release protease and oxidants. 
Gee and Mossman (1995, p. 197) also emphasise that “patients with the first group of 
disorders, even when severe, frequently make a complete recovery, and lung fibrosis is 
not the rule”. 
There is a threshold level, which, if exceeded ultimately leads to irreversible lung 
disease, and at sub-threshold levels the effects are reversible, as in the continuum 
postulated by Meldrum (2001) and Banks (2001). The aim of occupational respiratory 
health surveillance is to detect respiratory effects (should they exist) prior to the 
development of chronic irreversible pulmonary disease. 
The susceptibility of the target organ or tissue and its repair mechanisms also has an 
impact on the reversibility/irreversibility of a pathophysiological effect (Eaton & 
Gilbert, 2008). Higenbottam, Siddon and Demoncheaux (2001) recognise that 
environmental pollution in its various forms, such as dust, fibre, gas, vapour, mist, 
aerosol, fumes and smoke, may produce a variety of effects on the lungs, both localised 
and general. Whilst Checkoway et al. (2004) point out that normally the risk is 
proportional to the dose (exposure) for most pathophysiological mechanisms. However, 
there are occasions where this is not so and toxicity follows a “non-linear or dynamic” 
pattern, such as with occupational asthma where there is “development of specific 
sensitivity”, and “in-migration of inflammatory cells following irritant exposure to the 
airways” where there is a “positive feedback” (Checkoway et al., 2004, p. 309). 
Notwithstanding, Crapo, Harmsen, Sherman and Musson (2000) emphasise that the 
lung’s defence mechanism maintains lung homeostasis and keeps the inflammatory 
response to foreign substances and antigens in check. Lafferty, Qureshi and Schnare 
(2010, p. 1) capture this in their statement: 
Selective induction of inflammatory responses to harmful environmental 
exposures and tolerance to innocuous antigens are required to maintain 
tissue homeostasis and integrity. Conversely, dysregulated innate immune 
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responses manifest as sustained and self-perpetuating tissue damage rather 
than controlled tissue repair. 
Once this defence mechanism is breached, “disordered inflammation and immune 
responses” occur, which ultimately leads to “progressive and chronic lung diseases” 
(Crapo et al., 2000, p. 1983) most notably COPD or chronic asthma. COPD is usually a 
combination of emphysema and chronic bronchitis, where the alveolar walls are 
gradually destroyed (emphysema) and excessive mucus is produced as a consequence of 
chronic bronchitis (Australian Lung Foundation, 2010). Asthma, known to be caused by 
a variety of chemical and biological substances, is an inflammatory response 
(hypersensitivity) that causes narrowing of the upper respiratory tract which results in 
difficulty in breathing and wheezing (Chang-Yeung & Malo, 1994). 
2.8 Mixed Exposures 
As already discussed, exposure to low levels of airborne contaminants in the 
workplace may cause acute inhalation injury and occupational asthma, although an 
acute excessive exposure may result in substantial lung injury (Banks, 2001; Hudson & 
Steinberg, 1999). Balmes (2002, p. 727) reports, however, that such acute excessive 
exposures do not frequently occur and that “chronic recurrent exposures to lower levels 
of irritants are much more common”. Furthermore, Balmes et al. (2003, p.787) state that 
“the lungs of workers at risk are subjected to the total exposure burden of all airborne 
contaminants in any workplace”. It therefore seems that many occupational diseases 
have multiple causes (Muir, 1995). 
Lung injury often results from interactions between two or more toxic agents 
(Witschi & Hakkinen, 1984). Petsonk (2002) asserts that work-related asthma may be 
caused by mixed exposures. On reviewing the disease suberosis, Alegre, Morell, and 
Cobo (1990) believe that three different distinct diseases with three different 
aetiological factors occur simultaneously due to mixed exposure to cork dust, toluene 
diisocyanate and conidia. 
It is now well established that certain occupational exposures are strongly associated 
with an increased risk of COPD, and that, in combination, smoking and occupational 
exposure may significantly magnify the risk of COPD. Blanc et al. (2009, p. 12) state, 
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“On a population level, prevention of both smoking and occupational exposure, and 
especially both together, is needed to prevent the global burden of disease”. 
2.8.1 Low-level mixtures of respiratory irritants 
Occupational exposure to low levels of mixtures of respiratory irritants (i.e., each 
below its respective occupational exposure standard) is capable of causing respiratory 
symptoms and a decrement in lung function (Barnhart, 1994; Kortenkamp, Faust, 
Scholze, & Backhaus, 2007). Kremer, Pal, Boleij, Schouten, and Rijcken (1994) 
identified a decrement in lung function for employees working greater than 10 years 
exposed to a mixture of low-level lung irritants (i.e., polyester vapour and oil mist and 
vapour workgroups). Similarly, Mustajbegovic et al. (2000. p. 439) detected decrements 
in lung function associated with mixed exposures, in two chemical factories in Croatia, 
even when the atmospheric levels of chemicals were “for the most part within 
acceptable limits”. The effect on the lung by interaction between respiratory irritants 
may be additive, synergistic or antagonistic (Witschi & Hakkinem, 1984). It is possible 
to predict the respiratory response of a respiratory irritant if the physical and chemical 
properties are known. It becomes more difficult, however, when there is a mixed 
exposure. Historic examples of ‘cocktails’ of respiratory irritants include London smog, 
characterised by sulphur dioxide and smoke from incomplete combustion of coal 
combined with temperature inversion. Equally, the Los Angeles 
oxidising/photochemical air pollution, was characterised by hydrocarbons, nitrogen 
oxides, and photochemical oxidants catalysed by intense sunlight and a meteorological 
inversion (Amdur, 1980). More recently, environmental air pollution studies have been 
conducted using spirometry and questionnaires. For example, the study by Yu et al. 
(2001, p. 310) addressed the Adverse Effects of Low-Level Air Pollution on the 
Respiratory Health of Schoolchildren in Hong Kong, determined that “children living in 
a more polluted district” had increased respiratory symptoms and “significantly poorer 
lung function”. Balmes (2002, p. 727) states that “although the contribution of low-level 
irritant exposures to the overall burden of work-related asthma cannot be precisely 
estimated the available data indicate that it is not likely to be inconsequential”. Further 
research into the toxicology of low-level mixed exposures affecting the respiratory 
system is warranted, particularly in the mining industry, in order to identify such 
hazards and prevent occupational lung disease. 
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2.9 Prevention of Lung Diseases 
Both the World Health Organization and the International Labour Organization 
(ILO) have targeted occupational lung disease for their preventive strategies due to its 
high prevalence, the fact that it is severely disabling, and workplace exposures can be 
avoided. Key to such preventive strategies is health surveillance (Takahashi et al., 
1998). 
Occupational exposure to respiratory hazards still remains a significant worldwide 
problem (Blanc et al., 2009). Different patterns of respiratory disease are seen 
throughout the world, being more prevalent in newly industrialised regions (Hendrick et 
al., 2002). There are a number of occupational lung disease surveillance databases 
which highlight the impact of occupational lung disease, although direct comparison is 
made difficult due to differences in reporting, classification, and medical diagnosis 
(Hendrick et al., 2002).  
Various countries throughout the world, including Finland, the UK, the USA, France 
and South Africa have developed occupational respiratory disease surveillance systems. 
For example, NIOSH (2009b) manage an occupational respiratory disease surveillance 
system in the USA. However, as Elder et al., (2004, p 395) state “there are few such 
comprehensive and systematic data collection systems in place to monitor the extent of 
occupational respiratory disease in Australia”. Similarly, the Australian Safety and 
Compensation Council (2006, p. iv) states “there is limited information on the extent of 
work-related respiratory disease in Australia”. Therefore, the true incidence of 
occupational respiratory diseases in Australia remains largely unknown. One such 
surveillance scheme, SABRE, has been introduced in Victoria and Tasmania and is 
currently being extended to New South Wales. This system will provide data on 
occupational respiratory disease in those states (Monash University, 2004). The 
feasibility of a national environmental health surveillance system for Australia was 
considered in January 2008 by the Western Australian Environmental Health 
Directorate, under guidance from the Australian Government Office of Health 
Protection (Mullan, Ferguson, & Paech, 2008). Such surveillance schemes are an 
important component in the development of comprehensive occupational respiratory 
disease prevention strategies. 
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Health surveillance programs in the workplace will help pinpoint potential causative 
agents and adverse health effects at an early stage, in order to prevent potential long-
term occupational respiratory disease. Health surveillance is a secondary preventative 
strategy. However, when used in combination with primary preventive strategies that 
focus on the control of workplace exposures using the traditional hierarchy of controls 
including education and training programs (Tranter, 2004) then prevention of 
occupational respiratory disease is feasible. According to Hnizdo, Glindmeyer, and 
Petsonk (2010, p. 797) “there are documented examples of spirometry monitoring 
coupled with intervention successes”. They cite Musk, Peters, Bernstein, Rubin and 
Monroe (1982) and Pahwa, Senthilselvan, McDuffie and Dosman (2003) where a 
decline in forced expiratory volume in one second (FEV1) and forced vital capacity 
(FVC) was reduced after introduction of a hierarchy of controls for fire-fighters and 
granary workers respectively. 
2.10 Distinguishing Occupational Respiratory Disease from 
Background Environmental Respiratory Disease and Lifestyle 
Factors 
Several authors have determined that workplace exposure contributes to overall 
mortality and morbidity of COPD (Hnizdo et al., 2002; American Thoracic Society, 
2003; Trupin et al., 2003). 
In 1965, Sir Austin Bradford-Hill (1897—1991) established nine criteria to 
determine the strength of potential links between a causative agent and a disease 
(causality). These include: 
 temporal relationship; 
 strength; 
 dose-response relationship; 
 consistency; 
 plausibility; 
 consideration of alternate explanations; 
 experiment; 
 specificity; 
 coherence. 
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Checkoway et al. (2004, p, 12) state that “determining the potentially harmful effects 
of occupational exposures typically involves estimating relative risks or changes in 
physiological function in relation to exposure types and levels”. The assessment of 
respiratory health risk requires recognition and evaluation of hazards by reviewing the 
process, raw materials used, work practices and controls in place, followed by an 
assessment of exposures through the determination of airborne contaminants using air 
sampling techniques (Plog 2002; Safe Work Australia, 2010a). Following such a formal 
process provides reliable information that can be used to determine the causes of 
occupational respiratory disease and pave the way for prevention strategies and controls. 
Using a formal epidemiological approach, the impact of work-related respiratory 
disease can be established, by comparing incidences of respiratory disease in an 
exposed (study) and a non-exposed (control) population. Excess incidence in an 
exposed population (after correcting for confounding factors, such as smoking) allows 
for the calculation of the population attributable risk (PAR %) – assuming the 
proportion of exposed persons in the population is known (Health and Safety Executive, 
UK, 2004). 
2.10.1 Confounding 
To distinguish occupational respiratory disease from background environmental 
respiratory disease and lifestyle factors, such as the prevalence of smoking, it is 
necessary to identify and eliminate these confounding factors where possible. 
According to Checkoway et al. (2004, p. 89) “Confounding can be thought of as a 
mixing of the effects of the exposure being studied with effects of other factors on risk 
of the health outcome of interest”.  
Conversely there may be a healthy worker effect which can occur when comparing 
health outcomes between the study and control group. A potential exists for the health 
impacts in this study to have been underestimated among the study group (Checkoway 
et al., 2004). Age, gender and body mass index are all confounding factors that need to 
be adequately controlled in the study design or analysis (Checkoway et al., 2004).  
2.11 Occupational Health Surveillance 
There is an international directive, ILO C176 Article11 (International Labour 
Organization, 1998) for the provision of health surveillance in mining. The primary aim 
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of occupational health surveillance is to maintain and protect worker health (Cooper & 
Zavon, 1994). Health surveillance is the systematic collection, analysis, and 
interpretation of health data to enable detection of early disease in individuals, followed 
by interventions aimed at preventing further exacerbation (Centers for Disease Control 
and Prevention, n.d.).  
Such a health surveillance program should:  
 identify workers or work groups who are exposed to health hazards at 
work;  
 assess their risk of suffering an adverse health effect from exposure to 
these hazards;  
 evaluate their health to detect early signs and symptoms of adverse 
health effects;  
 verify the effectiveness of workplace controls (National Offshore 
Petroleum Safety Authority , n.d.); or 
 implement further workplace controls if the risk remains intolerable. 
(Tranter, 2004). 
It is necessary to recognise when respiratory disease is work related, to manage the 
consequences and prevent its reoccurrence (Hendrick et al., 2002). The UK Health and 
Safety Executive assert that the key to the formulation of effective treatment and 
preventative strategies relies on the accurate diagnosis of occupational respiratory 
disease (Health and Safety Executive, UK, n.d.). Fortunately, in the workplace, levels of 
hazardous substances can be measured through air monitoring, and their respiratory 
effects can be monitored by lung function tests (Hendrick et al., 2002) and diagnosis 
can be made through a respiratory questionnaire and spirometry that complies with the 
ATS/ERS criteria (American Thoracic Society, 1995; Miller et al., 2005; DMP, 2010a). 
2.11.1 Workplace health surveillance in Australia 
A senate inquiry (Parliament of Australia Senate Committee, 2006) into workplace 
harm related to toxic dust and emerging technologies highlighted the need for robust 
surveillance systems and early accurate diagnosis of loss of lung function. The 
surveillance system in Australia is based primarily on workers’ compensation claims 
(Safe Work Australia, 2011c). Safe Work Australia (2011c) has targeted occupational 
respiratory diseases as one of eight identified occupational diseases for priority action. 
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The current the Australian National Guidelines for Health Surveillance [NOSHC: 
7039], in NOSHC, 1995c, p. 1) state “these guidelines are intended for use by the 
appointed medical practitioner when planning and implementing a program of health 
surveillance”. Schedule 3 of these guidelines requires that a workplace risk assessment 
be conducted when one or more of 17 specified hazardous substances exist at a 
workplace. The related National Model Regulations for the Control of Workplace 
Hazardous Substances [NOHSC: 1005] 1994, Health Surveillance (Safe Work 
Australia 2011d) require that a risk assessment be conducted in each workplace where 
Schedule 3 hazardous substances exist, where other hazardous substances may cause 
health effects, or “there is a valid biological monitoring procedure available and a 
reasonable likelihood that accepted values might be exceeded”. The employer then is 
required to provide health surveillance (Safe Work Australia 2011d, Section 14 c). 
2.11.2 Department of Mines and Petroleum MineHealth Surveillance System 
Health surveillance is driven by the statutory requirement in Western Australia under 
the Mines Safety and Inspection Act 1994. The Department of Mineral and Petroleum 
Resources (DMPR) under the Health Surveillance Program for Mine Employees states 
“It is mandatory that all assessments required under the Act are completed in 
accordance with these approved procedures”. This program has been established 
according to DMPR “to promote the implementation of an effective health surveillance 
system for mining industry employees” (Department of Consumer and Employee 
Protection, 2010, p. 3).  
The objectives of the health surveillance system for mining employees are to:  
 Assess the health status of all mining industry employees on a regular 
basis;  
 Analyse collected data to detect adverse health effects at the earliest 
opportunity; 
 Enable appropriate and timely corrective action to be taken in order to 
safeguard the health and well-being of mining industry employees; 
 Provide data for future epidemiological studies. 
(DMP, 2010a, p 2) 
Mining industry employers in Western Australia are required under legislation to 
establish and maintain a health surveillance system for employees. This health 
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surveillance system requires a health assessment for mining employees which consists 
of: 
 a work history; 
 a respiratory questionnaire; 
 a lung function test; 
 an audiometric (hearing) test; and  
 in some cases, a chest x-ray. 
(DMP, 2010a, p. 2) 
Further health assessments are required at least every five years for all mine 
employees. One of the main objectives of this health surveillance is to determine the 
respiratory health of the mine and process workers to “enable appropriate and timely 
corrective action to be taken in order to safeguard the health and well-being of mining 
industry employees” (DMP, 2010a, p. 2). 
2.11.3 Spirometry and respiratory questionnaire: subjective instruments to 
measure respiratory health 
Beach (2002, p.1009) states that “lung function measurements provide an important 
tool in the diagnosis and management of occupational lung diseases”. Used in 
conjunction with a respiratory questionnaire, spirometry testing provides a powerful 
diagnostic tool with adequate sensitivity and specificity (Post et al., 1998). Bellia et al. 
(2003, p. 21) asserts that a validated respiratory questionnaire provides a “subjective 
instrument of measurement in respiratory epidemiology”. That is why respiratory health 
surveillance utilises a combination of a work history, a respiratory questionnaire and a 
lung function test. 
2.11.4 Health surveillance studies utilising the combined questionnaire and 
spirometry 
Various occupational respiratory health surveillance studies have been undertaken 
utilising the combined questionnaire and spirometry tool. Some selected examples are 
provided: 
 In a longitudinal follow-up study of manganese mine workers, Boojar 
and Goodarzi (2002) using a respiratory questionnaire and spirometry 
combination, observed a significant decrement in lung function in 145 
manganese mine workers compared to a control population at 
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approximately 4 years and 7 years after baseline measurements made 
at the time of employment. 
 Vogelzang, van der Gulden, Folgering, and van Schayck (1998) 
investigated lung function in swine-confinement workers. This 
longitudinal study utilised a combined questionnaire and spirometry 
approach and identified “a longitudinal decline in forced expiratory 
volume in one second (FEV1) which was significantly associated with 
the use of quaternary ammonia compounds as disinfectants and the 
automated dry feeding system” (Vogelzang, van der Gulden, 
Folgering, & van Schayck, 1998, p. 1048). The study also 
demonstrated the value of the combined use of spirometry and a 
respiratory questionnaire. In this study the questionnaire alone would 
not have distinguished respiratory symptoms because a significant 
number of pig farmers ceased to report their chronic symptoms. 
However, there was a definite decrement in FEV1 in the cohort of 171 
pig farmers over a 3-year period. 
 From referrals to family physicians, Mpofu, Lockinger, Bidwell, and 
McDuffie (2002) observed decrements in lung function in a study of 
farmers and their families. This research was predominantly about the 
evaluation of a respiratory health program for Saskatchewan farmers 
and their families in Canada. There are a myriad of exposures likely to 
affect the respiratory health of farmers and their families. This was 
addressed to a limited degree in this study through a qualitative 
analysis of exposure to dust or fumes/chemicals. The protocol for this 
program included spirometry and a respiratory questionnaire as well 
as a health promotional component. Thus the study analysed the 
association of pulmonary function and self reported respiratory 
symptoms. The main outcome of the study was that “Individuals with 
these symptoms or who smoked were more likely than individuals 
without these symptoms and non-smokers to have lower than 
predicted overall pulmonary function” (Mpofu, Lockinger, Bidwell, & 
McDuffie, 2002, p. 1069). 
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 In a case study pulmonary effects were evident in workers exposed to 
incinerator fly ash, when using the combined questionnaire and 
spirometry tool (Boswell & McCunney, 1995). 
 In a longitudinal study conducted by Motley, Smart, and Valero. 
(1956. p. 265) there was poor correlation with lung function testing 
compared with radiography for diatomaceous earth workers. In the 
initial study a decrement in lung function was detected in 
compensation claimants employed in the diatomaceous earth industry. 
In the repeat study combining radiography, spirometry and a 
questionnaire, the decrement in lung function was not convincing, 
although “the best lung function was present in those with no 
radiographic abnormality”. 
 In longitudinal studies of cannabis smokers, Taylor et al., (2002) 
found a relationship between cannabis smoking and a decline in lung 
function. Taylor et al., (2002, p. 1060) concluded “Longitudinal 
observations over 8 years in young adults revealed a dose-dependent 
relationship between cumulative cannabis consumption and decline in 
FEV1/VC”. “Dispelling the myth that cannabis smoking is relatively 
safe” Taylor followed this up in a Position Statement of the Thoracic 
Society of Australia and New Zealand stating that adverse respiratory 
effects of smoking cannabis are similar to those of smoking tobacco… 
(Taylor, & Hall, 2003, p. 310). 
 Case studies on the lung function of 30 fire-eaters prior to and after 
their daily activity showed a mild decrease of airflows, which partially 
correlated with number of years spent in this activity. After a 1-day 
fire-eating activity, further airflow limitation increased. Up to 63% of 
subjects tested improved some spirometric airflow value after 
salbutamol inhalation (Cabrera et al., 2003). 
 A cross-sectional and cohort of respiratory morbidity study of long-
term and former asbestos workers with substantial exposure in Brazil 
(Algranti et al., 2000) and a case control study of asbestos workers in 
China (Wang, Yano, Wang & Christiani, 2001) demonstrated 
decreased pulmonary function, pleura thickening due to asbestos 
exposure. 
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 In a cross-sectional study there were subtle decreases in pulmonary 
function detected for a sub-population of tea packers from the start to 
the end of a shift (Abramson et al., 2001). 
 In a cross sectional study Musk et al. (2000) concluded that no major 
adverse respiratory health effects were associated with work in the 
Australian alumina refineries studied. 
 In a cross-sectional cross-shift study Raulf-Heimsoth et al. (2007) 
found significant cross-shift declines in lung function due to the 
irritative effects of fumes and aerosols of bitumen. 
 Peters, Demers, Sehmer, Karlen, and Kennedy (2010) studied the lung 
function of a cohort of 281 trades’ apprentices and concluded that 
“early signs of respiratory trouble among young adults….are related 
to the development of asthma and other respiratory illness later in 
life” (Peters, Demers, Sehmer, Karlen, & Kennedy, 2010, p. 242). 
 The Queensland Mines Inspectorate determined that some Queensland 
quarries had problems with the control of silica dust exposure, did not 
have adequate exposure assessments, or health surveillance in place 
for their workers. Hedges, Reed, Mulley, Djukic and Tiernan (2010) 
therefore conducted a cross-sectional study of Respirable Crystalline 
Silica (RCS) exposure in quarries in Queensland and determined loss 
of lung function using an EasyOne® spirometer. They recommended 
that frequent lung function measurements be made to detect 
developing health problems due to cumulative exposures of RCS. 
2.11.5 Reliability and validity of spirometry 
In the past some authors have questioned the practical value of pulmonary function 
tests for early changes for disorders such as chronic obstructive lung disease (West, 
1987). The Health and Welfare Canada Task Force on Health Surveillance (Canadian 
Public Health Association, 1986, p. 106) went even further to infer that “Spirometry is 
indicated [only useful] to monitor established disease or for diagnostic purposes in 
symptomatic individuals”. Rossignol, Seguin, and DeGuire (1996, p. 1259) found in a 
Regional Public Health Program, “there were too many sources of variation for 
spirometry to fulfil the objective of early detection of pulmonary function decline 
related to exposure to welding fumes. Sobaszek et al. (1998, p. 223) reported for 
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stainless steel welders that “there was no influence of the specific welding process on 
the spirographic parameters, but a decrease in spirographic values after 25 years of 
welding activity was evident”. Ulvestad et al. (2001) did not detect a decrement in lung 
function, whereas they detected airways changes using acoustic rhinometry and detected 
increased levels of exhaled nitrous oxide, associated with underground construction 
workers exposed to dusts and gases. Nield and Burmas (n.d., Conclusion) representing 
DMP, Western Australia, Resources Safety, concluded that the “use of screening 
spirometry in healthy populations is questionable based on costs versus benefits to 
stakeholders, thus MineHealth methodology is currently under review”. In their 
presentation Nield and Burmas discussed the phenomenon of an improved lung function 
response for individuals at a repeat/second test, which is considered to be due to an 
individual’s ability to do better on a repeat spirometry test as they have mastered and 
improved their technique, hence adding a form of confounding although such 
intersession changes are likely to be considered measurement noise (Nield and Burmas, 
n.d.). 
For lung function tests to be valid they must be performed rigorously to the 
American Thoracic Society and European Respiratory Society (ATS/ERS) criteria 
(American Thoracic Society, 1995; Miller et al., 2005) and the Thoracic Society of 
Australia and New Zealand (in Pierce and Johns, 1996). If these protocols are followed 
rigorously, issues such as reproducibility, reliability, sensitivity, specificity and quality 
control are addressed (Doherty, 2008). In so doing, the American College of 
Occupational and Environmental Medicine (2010, p. 1) state that, “Spirometry, the most 
frequently performed pulmonary function test (PFT) is the cornerstone of occupational 
respiratory evaluation programs”. Spirometry has been recommended as an instrument 
for health surveillance to help determine and prevent occupational respiratory disease 
(Hankinson & Wagner, 1993; Harber & Lockey, 1993; American College of 
Occupational and Environmental Medicine, 2000; Townsend, 2005).  
Finkelstein et al. (1993, p. 532) determine that measurement in the home using 
portable spirometers was valid when compared with the ‘gold standard’ of the 
pulmonary function laboratory; and Johns and Pierce (2003, p.1) promote spirometry as 
“the single most broadly useful non-invasive test for ventilatory lung function”. With 
interpretation, spirometry is capable of detecting a range of decrements in pulmonary 
function such as: 
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 inflammation of the respiratory system; 
 airway narrowing; 
 obstruction; 
 bronchospasm; 
 COPD; 
 asthma; 
 emphysema. 
Johns and Pierce (2003) conclude that spirometry is particularly useful for 
differentiating between obstructive and restrictive lung function problems.  
2.11.6 Obstructive ventilatory defect 
Obstructive ventilatory defects disturb air flow in and out of the lungs as 
pathophysiological effects reduce the diameter of the airways causing airflow resistance 
(usually from an inflammatory response) bronchospasm, oedema and increased mucus 
secretions (NIOSH, 2003). Obstructive disorders include asthma, bronchitis, and 
emphysema although the pathophysiological mechanisms are considered to be different 
(Johns Hopkins School of Medicine's Interactive Respiratory Physiology, 1995). 
Obstructive ventilatory defects are associated with a reduction in FEV1 in relation to 
FVC and other measures. This results in a low FEV1/FVC%. The lower limit of normal 
is considered to be approximately 70—75% (Pierce & Johns, 1996). Beach (2002) 
asserts that FEV1/FVC% values < 50% imply severe obstruction. 
According to Pellegrino et al. (2005, p. 953): 
An obstructive ventilatory defect is described as a disproportionate 
reduction of maximal airflow from the lung in relation to the maximal 
volume (i.e., VC) that can be displaced from the lung. It implies airway 
narrowing during exhalation and is defined by a reduced FEV1/VC ratio 
below the 5th percentile of the predicted value. 
2.11.7 Restrictive ventilatory defect 
Johns Hopkins School of Medicine's Interactive Respiratory Physiology (1995, p. 1) 
describes restrictive disorders as a “pulmonary deficit, such as pulmonary fibrosis 
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(abnormally stiff, non-compliant lungs)”. However, it may also be caused by 
“respiratory muscle weakness, paralysis, and deformity or rigidity of the chest wall”. 
Such a restrictive pattern, according to Beach (2002, p. 1012) gives a “proportionate 
reduction in both FVC and FEV1 and by reduction of TLC, VC, and other static lung 
volumes. Whilst Pellegrino et al. (2005, p. 955) defines a restrictive ventilatory defect 
as:  
characterised by a reduction in total lung capacity (TLC) below the 5th 
percentile of the predicted value, and a normal FEV1/VC. The presence of a 
restrictive ventilatory defect may be suspected when VC is reduced, the 
FEV1/VC is increased (85–90%) and the flow-volume curve shows a 
convex pattern. 
Spirometry therefore is considered very useful as a screening test of general 
respiratory health, to establish as early as possible whether or not there is respiratory 
impairment. 
2.11.8 Assessing early respiratory changes due to occupational exposures 
Spirometry has been proven to be particularly useful in assessing early respiratory 
changes due to occupational exposures. Several researchers have demonstrated 
decrements in lung function, using spirometry, due to exposure to low-level irritants 
(Balmes, 2002; Dube, Puruckherr, Byrd, & Roy, 2002; El-Zein, Malo, Infante-Rivard, 
& Gautrin, 2003) and mixtures of low-level respiratory irritants (Barnhart, 1994; 
Kremer et al., 1994; Mustajbegovic et al., 2000; Ryon & Rom, 1998; Hendrick et al., 
1996; White, 1996; Harber et al., 2007). 
Pasker et al. (1997) demonstrated very subtle pulmonary function changes due to 
exposures to zinc oxide containing fumes. They demonstrated that it was possible to 
detect a subclinical response. This study, of 57 workers exposed to zinc oxide 
containing dust and 55 controls, not only used the questionnaire/spirometry approach 
but also compared the forced oscillation technique (FOT) with spirometry. The study 
investigated pre-shift and post-shift pulmonary function. The outcome was the 
observation of a subtle decrease in pulmonary function, observed during night shift with 
both spirometry and confirmed by FOT. Abramson et al. (2001) also detected an across-
shift decline in FEV1 among a cohort of tea packers. In a study of occupational asthma, 
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Anees, Moore and Burge (2010) conclude that sufferers of the condition demonstrated a 
rapid decline in FEV1 due to exposure; however, after removal from exposure, the effect 
reverses and there is an improvement (a step-up) after which it then continues to decline 
at a slower rate similar to individuals with normal lung function. 
Johns and Pierce (2003, p. 92) state that: 
Spirometry has the capacity to detect airway dysfunction long before 
symptoms develop, bringing the opportunity to remove harmful exposures 
before disability develops or becomes severe. These factors render 
spirometry a critically useful investigation in the detection, management and 
prevention of respiratory disease. 
It has therefore been demonstrated conclusively in multiple studies, among a range of 
populations and occupational exposure groups that, when used in conjunction with a 
respiratory questionnaire, spirometry testing provides a powerful diagnostic tool with 
adequate sensitivity and specificity (Post et al., 1998; Bellia et al., 2003,  Hankinson 
1986; Utell, Frampton, & Morrow, 1993; Hankinson, Kinsley, & Wagner, 1996; White, 
1996; Luo, Hsu, Hsieh, Wong, & Chang,  1998; Sobaszek et al., 1998; Baur & Latza, 
2005 Algranti et al., 2000; Musk et al., 2000; Abramson et al., 2001; Kern et al., 2001;  
Meijer, Grobbee, & Heederik, 2001; Yu et al., 2001; Boojar & Goodarzi , 2002; Mpofu 
et al., 2002; Murphy , Harrison, & Beach, 2002; Cabrera et al., 2003; Chénard et al., 
2007; Doherty, 2008; Forbes et al., 2009). 
2.11.9 Reliability, validity, accuracy and precision of the EasyOne spirometer 
After determining that spirometry in conjunction with a respiratory questionnaire 
provides a powerful diagnostic tool with adequate sensitivity and specificity, a review 
of spirometer’s, in particular the EasyOne spirometer, was conducted to ensure its 
reliability, validity, accuracy and precision. According to Blanc et al. (2009, p. 8) The 
EasyOne™ spirometer (ndd Medical Technologies, Zurich) “has been recognised for its 
reliability, accuracy, and durability and has been widely used in epidemiologic 
research”. Evaluations of the stability and accuracy of this specific spirometer have 
been conducted by Walters, Wood-Baker, Walls and Johns (2006), Coates (n.d.), 
Australian and New Zealand Horizon Scanning Network (2007), Skloot, Edwards, and 
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Enright (2010), Gallo, Crapo and Jensen (2009), and Barr et al. (2008), justifying its use 
in clinical, occupational and research settings. 
2.11.10 Alternatives to spirometry 
Alternative techniques to determine early effects of workplace exposures on the 
respiratory system were reviewed prior to the commencement of this study. In general it 
was found that such newer methods were yet unproven and access to most was 
restricted to specialised respiratory laboratories due to the need for using specialised 
equipment or invasive techniques such as lung biopsy, bronchoalveolar lavage, and 
induced sputum (Balbi et al., 2007). 
A new development in the area of respiratory screening is fractional exhaled nitric 
oxide (FeNO) which functions as a “noninvasive, simple, well-tolerated, and 
reproducible marker of airway inflammation” (del Giudice et al., 2004, p. 759). 
Measurement of exhaled nitric oxide (eNO) in a breath test can be conducted to 
determine airway inflammation particularly asthma (Taylor, Pijnenburg, Smith, & 
Jongste, 2006). Portable instruments are becoming available making it more practical 
under field conditions. However, the main limitation of this technique is the need for 
predicted normal FeNO reference values for normal populations which are yet to be 
established (Balbi et al., 2007; Taylor, Pijnenburg, Smith and Jongste, 2006).  
Biomarkers are potential candidates for further research, though few have been 
validated. Those showing most promise are sputum neutrophils, IL-8, serum tumour 
necrosis factor, and C-reactive protein (Tzortzaki, Lambiri, Valchaki & Siafakas, 2007; 
Kony et al., 2004).  
2.12 Summary 
This chapter has outlined that air quality can affect lung function and cause 
respiratory disease (Ostrowski & Barud, 2006). It presented a critical review of existing 
literature regarding the aetiology and impact of occupational lung disease, the possible 
effects of low levels of mixed exposures, the confounding factors, and the health 
surveillance techniques to enable detection of such effects. 
The impact of respiratory disease is a major problem worldwide, and the total 
lifetime cost considerable, but it can be avoided (Takahashi et al., 1998). Several 
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countries have respiratory disease surveillance systems and some specifically for 
occupational respiratory disease. The surveillance system in Australia is based primarily 
on workers compensation claims (Safe Work Australia, 2011c). Hence there is a long 
latency period and these data reflect historical workplace exposures and not emerging 
new issues. Safe Work Australia (2011c) has targeted occupational respiratory diseases 
as one of eight identified occupational diseases for priority action. Prior to this the 
senate inquiry (Parliament of Australia Senate Committee, 2006) into workplace harm 
related to toxic dust and emerging technologies highlighted the need for robust 
surveillance systems and early accurate diagnosis of loss of lung function. During the 
inquiry process the Australian and New Zealand Society of Respiratory Science 
recommended regular lung function testing to detect early signs of respiratory 
symptoms. Therefore, a top-down, bottom-up approach, employing an Australian 
occupational respiratory health surveillance system to define the problem of work-
related respiratory disease so that specific workplace hazards can be targeted, plus a 
risk-based approach at the local workplace level to identify, evaluate and control 
respiratory hazards, is advocated. 
This review determined that pulmonary function tests, providing they are performed 
rigorously to the ATS/ERS criteria (Miller et al., 2005) detect airway dysfunction long 
before symptoms develop (Johns & Pierce, 2003). Several researchers have been able to 
detect such early respiratory changes. These studies have shown that pulmonary 
function tests used in conjunction with respiratory questionnaires, conducted by 
competent practitioners using reliable and accurate equipment, provide valid data. Thus 
such an approach was adopted with the aim of determining whether exposure to a 
specific spectrum of gases, aerosols and particulates present in each work area at the 
Murrin Murrin Operation presented a respiratory health risk. 
The main gaps in this research area appear to be that the extent to which occupational 
respiratory disease contributes to work-related illness in Australia remains effectively 
unknown. The extent to which occupational factors such as dust, gases, vapours, smoke 
and fumes that contribute to respiratory disease also remains unknown. Very little is 
known about mixed exposures, particularly in the mining industry, and research is also 
needed into early detection of respiratory diseases in order to prevent them. 
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This literature review, along with an overview of the Murrin Murrin mine and 
processing plant processes (Chapter 3) plus the review of the respiratory health effects 
presented by the hazardous substances associated with these processes (Chapter 4) 
helped formulate the research methodology. This culminated in a longitudinal study of 
the Occupational Respiratory Health Surveillance at Minara Resources, Murrin Murrin 
Mine Site  
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3. OVERVIEW OF THE MURRIN MURRIN OPERATION 
PROCESS 
3.1 Introduction 
The Minara Resources’ Murrin Murrin Operation (Figure 3.1) is situated 
approximately 60 kilometres equidistant from Laverton and Leonora, on the edge of the 
Gibson Desert in Western Australia, in the north east Goldfields region (Figure 3.2). 
The Murrin Murrin Operation mines lateritic ore in the locality, which is refined in to 
nickel and cobalt at the processing plant. 
 
Figure 3.1 Murrin Murrin Operation 
(Source: Minara Resources, 2004a) 
The project, commissioned in May 1999 by Anaconda Nickel Ltd, is a joint venture 
between Murrin Murrin Holdings Pty Ltd, a wholly owned subsidiary of Minara 
Resources Ltd (60%) and Glenmurrin Pty Ltd, a wholly owned subsidiary of Glencore 
International AG (40%) (SPG Media Limited, 2007; Mining-Technology.Com., n.d.). 
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The source of the laterite mineralisation, with its concentration of nickel and cobalt 
in silicate minerals, was formed as a consequence of extensive weathering of olivine-
rich ultramafic rocks (Gaudin, Decarreau, Noack, & Grauby, 2005; Dalvi, Bacon, & 
Osborne, 2004). The laterite ore, with its soft clay-like nature, lies close to the ground 
surface and is therefore relatively easily mined using open cut mining techniques.  
The ore is processed at the Murrin Murrin processing plant based on the Sherritt 
International high pressure acid leach technology (Figure 3.3) (Taylor, 2000; Wellesley-
Wood, 2002). In brief, the Murrin Murrin process prepares the ore prior to subjecting it 
to sulphuric acid in high-temperature, high-pressure autoclave vessels to extract nickel 
and cobalt from lateritic ores (Ozberka, Jankolab, Vecchiarellic, & Krysad, 1995; 
Mining-Technology.Com., n.d.). Following this, the solid wastes are thickened and 
neutralised, and the liquid containing nickel and cobalt is separated by counter current 
decantation (CCD). The nickel and cobalt are precipitated out as mixed sulphides, and 
eventually refined using solvent extraction and a range of chemical reagents.  
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Figure 3.2 Location of the Murrin Murrin Operation 
(Source: Minara Resources, 2004a) 
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Figure 3.3 Murrin Murrin Process Flowsheet 
(Source: Taylor, 2000) 
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3.2 Murrin Murrin Technology 
3.2.1 Mining 
The soft lateritic ore is mined by the open pit method as they are near-surface 
deposits. The pits are shallow because there is usually only an overburden of 
approximately 10 metres overlying the ore body of about 20 metres in depth. The areas 
of the ore body which have nickel-cobalt mineralisation occur in horizontal zones, 
which allows for bulk mining methods to be employed. Excavators are used to extract 
the ore which is transported by haul trucks to the Run of Mine (ROM) ore stockpile, 
ready to be processed. The simplified geology showing the horizontal zones of the ore 
body are pictured below. 
 Ferruginous Zone (FZ): The top laterite unit contains mainly iron 
oxides as waste. A small amount of Ni/Co mineralisation appears at 
the bottom of this zone. 
 Smectite Zone (SM): The middle laterite unit contains mainly 
smectite clays and medium to high grade Ni/Co mineralisation 
throughout the zone. 
 Saprolite Zone (SAP): The deepest laterite unit contains mainly 
primary smectite clays and basic minerals referred to as serpentine 
minerals. The grade of Ni/Co mineralisation varies significantly in the 
saprolite zone. 
  
 
Figure 3.4 Simplified Geology  
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(Source: Minara Resources, 2004a) 
The three ore types, shown in Figure 3.4, are mined separately and blended to 
achieve the optimum nickel concentration as an ore feed from the ROM stockpiles.  
The activities required to mine the ore include: 
 overburden removal by excavators and trucks; 
 some blasting of occasional areas of cap rock; 
 ore extraction by excavators and trucks. 
The mining operations include the removal of ore from the ground and its 
transportation to the ROM pad. The ROM pad is the first point of contact with the 
processing plant. 
3.3 Processing Plant 
3.3.1 Ore leach 
The purpose of the ore preparation facility is to crush the ore to a specified size and 
add water to produce a slurry feed at the required density prior to feeding it into the acid 
leach circuit. To achieve this, ore is blended from finger piles on the ROM pad by front-
end loader. The ore is then loaded into a low-capacity ore bin which feeds a sizer 
(similar to a crusher). The MMD Group of Companies’ sizer is the first point of size 
reduction and breaks up any large lumps of ore, crushing the ore to less than 150mm. 
3.3.1.1 Slurrying mill 
The sizer product is conveyed to the slurrying or semi-autogenous grinding (SAG) 
mill (Figure 3.5). The ore is prepared in the slurrying mill where it is ground to produce 
a slurry feed of the correct particle size and density to feed the pressure acid leach 
circuit, with a final slurry density of between 39% and 42% solids by weight, adjusted 
by adding water.  
As the slurry flows from the mill onto a vibrating screen the larger particles are 
caught and then removed by conveyor to a low-grade stockpile. The slurry filtered 
through the screen (approximately 1.7% nickel and 0.07% cobalt) is pumped to a slurry 
storage tank which is eventually pumped into the acid leach section.  
 44 
 
Figure 3.5 Ore from Stockpile to the Slurry Mill 
(Source: Minara Resources, 2004a) 
3.3.1.2 High pressure acid leaching 
The high pressure acid leach circuit is shown in Figure 3.6. The high pressure 
leaching is carried out in titanium-lined autoclaves in which the ore slurry is mixed with 
concentrated sulphuric acid. There are four autoclaves which operate at 255°C and 42 
bar pressure (4200KPa) to dissolve out the nickel (Ni) and cobalt (Co) as soluble 
sulphate salts.  
The sulphuric acid for the leaching process is generated by the acid plant located 
close by on the site. The leaching reaction extracts nearly all of the nickel and cobalt 
into the solution (liquid) phase with the solids as residue. The nickel and cobalt is 
released from the ore leaving residual waste material, which is returned to the slurry ore 
preparation before ultimately being pumped out, after being neutralised, into the tailings 
dam. 
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Figure 3.6 High Pressure Acid Leach Circuit 
(Source: Minara Resources, 2004a) 
3.3.1.3 Counter current decantation (CCD) circuit 
The slurry from the pressure acid leach circuit is fed into the CCD circuit. The CCD 
circuit has seven 50-metre thickeners where the slurry is separated into two streams, the 
residue solids, and soluble nickel and cobalt solution. 
The CCD and solution neutralisation circuits are outlined in the simplified flow 
diagram, (Figure 3.7).  
Each CCD thickener mixes, washes and separates the solid residue waste from the 
sought-after nickel and cobalt solution. The residue solids from the last thickener are 
pumped to the tailings neutralisation circuit prior to disposal into a tailings dam, whilst 
the nickel and cobalt sulphate solution from the first wash thickener gravitates to the 
solution neutralisation circuit. 
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Figure 3.7 Counter Current Decantation (CCD) Circuit 
(Source: Minara Resources, 2004a) 
3.3.1.4 Solution neutralisation circuit 
The pressure leach solution (which contains dissolved nickel and cobalt sulphates) 
passes into the neutralisation circuit to neutralise the pH which is less than pH 1.0. The 
solution has to be neutralised prior to the recovery of nickel and cobalt in the refinery 
because of its highly corrosive nature. Calcrete (a limestone-like mineral mined locally) 
is added to neutralise the acid. The solution then enters the mixed sulphides 
precipitation circuit, where hydrogen sulphide gas is introduced which converts the 
solution into a mixed nickel/cobalt sulphide.  
Initially, hydrogen sulphide is mixed with the nickel/cobalt solution from the first 
wash thickener, to change the iron chemistry from ferric to ferrous iron which interferes 
with the process, in order to maximise the nickel and cobalt extraction in the following 
neutralisation stage.  
As it flows through a series of four agitated tanks, the free sulphuric acid is 
neutralised by the addition of calcrete slurry, which forms a gypsum precipitate. The 
leachate is separated from the gypsum precipitate, filtered, and directed to the sulphide 
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precipitation area for further treatment. The thickened solids underflow from the 
thickener is returned to the CCD circuit to extract the residual nickel and cobalt liquor. 
Eventually, the gypsum is removed, along with the solid residue, for disposal into the 
tailings dam. 
3.3.1.5 Mixed sulphide precipitation and slurry neutralisation circuits 
Figure 3.8 below represents diagrammatically the mixed sulphide precipitation and 
tailings slurry neutralisation circuits. 
 
Figure 3.8 Mixed Sulphide Precipitation and Slurry Neutralisation Circuits 
(Source: Minara Resources, 2004a) 
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3.3.1.6 Mixed sulphide precipitation 
The aim of the mixed sulphide precipitation circuit is to transform the nickel and 
cobalt sulphate solution into solid mixed sulphides. In order to precipitate out the mixed 
sulphides, hydrogen sulphide is introduced into the neutralised solution in four agitated 
tank stages. The hydrogen sulphide reacts with the nickel and cobalt sulphate in solution 
and forms a mixed (nickel and cobalt) sulphide solid precipitate. The precipitation 
reaction also removes unwanted manganese and iron.  
The solid precipitate is washed and then it thickens as it settles out of the solution. 
The washed precipitate, still a slurry, is next filtered and then stored before being 
refined on site or sold directly on the open market.  
The wash (barren solution) is pumped to either: 
 the last wash thickener in the CCD circuit (approximately 40% of 
flow); or 
 an evaporation pond (approximately 60% of flow). 
3.3.1.7 Slurry neutralisation circuit 
The pH of the waste solids in the underflow from the CCD circuit is neutralised 
using calcrete slurry introduced into agitated tanks in the slurry neutralisation circuit. 
The solids are disposed of in the tailings dam, and the liquid flows to the evaporation 
pond.  
3.3.2 Refinery 
In the refinery, the mixed sulphides are refined to produce high-grade nickel and 
cobalt powder which is then bonded into briquettes ready for purchase. This process is 
carried out in numerous steps which are briefly outlined below and outlined in the 
simplified flow diagram, Figure 3.9. 
3.3.2.1 Mixed sulphide leaching 
The mixed sulphide precipitate is taken from storage or directly from ore leach to the 
refinery. Here the mixed sulphides are firstly washed and slurried with water to undergo 
pressure oxygen leach in a stainless steel autoclave, to manufacture a 99.5% nickel and 
cobalt solution. 
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3.3.2.2 Iron/copper removal 
Unwanted iron is removed after leaching by adding ammonia to the nickel/cobalt. 
Zinc sulphide is also added to remove unwanted copper. Inevitably, during this process 
a small amount (+9%) of nickel is removed in the precipitate along with the iron. The 
solution is therefore thickened and filtered to remove the iron cake, and the residual 
nickel in solution is returned back into the process through the ore leach feed. 
3.3.2.3 Zinc/copper removal 
The nickel solution, now free of iron, is reacted with anhydrous ammonia and 
hydrogen sulphide which removes residual copper and zinc. Again the copper and zinc 
form a precipitate, which is thickened and filtered out of solution as copper/zinc cake 
waste. 
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Figure 3.9 Refinery: Simplified Flow Diagram 
(Source: Minara Resources, 2004a) 
3.3.2.4 Solvent extraction 
Cobalt is removed from the Ni/Co solution by using Cyanex 272, a solvent 
extractant. For this process, a large volume of solution is mixed with a smaller volume 
of organic extractant which separates out the cobalt in the organic phase and the solvent 
becomes loaded with cobalt. Cobalt is then removed from the solvent with sulphuric 
acid and the barren solvent is recycled through the cobalt hydrogen reduction circuit.  
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Once the cobalt has been removed from the Ni/Co solution and separated from the 
nickel, it is then concentrated into high-grade cobalt solution (raffinate) and pumped to 
the cobalt hydrogen reduction circuit. 
3.3.2.5 Hydrogen reduction of nickel and cobalt solutions 
The nickel raffinate and cobalt raffinate are now separated and processed separately 
by autoclave in two streams. Anhydrous ammonia and ammonium sulphate is added to 
both the high-strength pure cobalt and nickel solutions prior to hydrogen reduction. The 
nickel ammonium sulphate liquor is preheated prior to entering the nickel hydrogen 
reduction autoclaves. Hydrogen gas is introduced under pressure and the nickel is 
precipitated as a powder. The powder is recovered from the bulk liquor via a flash tank, 
pan filter and dryer. The cobalt raffinate is similarly processed and precipitated as a 
powder. 
3.3.2.6 Briquetting and sintering 
Next, the powdered nickel and cobalt from each reduction autoclave circuit is 
compressed into pillow-shaped lumps (briquettes) which are then sintered in a furnace 
at approximately 1120 degrees C prior to it being transported and sold to smelters 
around the world. There are separate briquetting and sintering furnaces for nickel and 
cobalt products. 
3.3.3 Utilities 
The Utilities Department or Utility Areas provide services such as electricity, gas, 
water, and chemicals used in ore leach and the refinery. These services are required to 
process and treat the crude ore and refine it into pure nickel and cobalt metal products. 
These consumable products, which assist the processing areas to extract the nickel and 
cobalt, are provided by a number of dedicated utility plants.  
The plant layout of all facilities at the Murrin Murrin Operation is illustrated in the 
diagram (Figure 3.10). It shows the relationship between the processing and utility 
areas. A brief description of each of the utility areas is provided below.  
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3.3.3.1 Sulphuric acid plant 
The Murrin Murrin sulphuric acid plant is one of the biggest in the world with 4400 
M tons per day acid production. The acid is used in the HPAL processing circuit to 
leach the nickel and cobalt out of the ore in the ore leach area. The acid plant also 
provides most of the heat required to drive the power and steam generation plant. 
3.3.3.2 Power and steam generation plant 
Power is essential for every area of the plant, and steam is used in the ore leach and 
refining processes. 
To meet the site’s energy requirements there are 3 x 55 tonnes per hour steam 
boilers. The steam is used to drive 2 x 28-megawatt steam turbines. Additional power 
may also be generated by the 20-megawatt gas turbine, and there are six standby diesel 
generators and associated mechanical and electrical equipment. Energy is also recycled 
from the ore leach autoclave flash system to preheat feed slurry into the HPAL circuit.  
3.3.3.3 Water supply and water treatment plant 
The water supply, critical to the Murrin Murrin processing plant, is sourced from the 
borefields some 50 km away. Approximately one third of the raw water is treated by 
reverse osmosis in the water treatment plant to produce high-quality demineralised and 
potable water for use in the sensitive processing stages and for human consumption 
respectively. The remaining two thirds are used directly as process water. 
3.3.3.4 Natural gas supply 
Natural gas supplied by the Goldfields Gas Transmission Pipeline is used in many 
areas of the plant for various burners and as a heating source in the hydrogen sulphide 
plant. Natural gas is also the source or primary feed for the hydrogen plant. 
3.3.3.5 Hydrogen plant 
Hydrogen is produced in the hydrogen plant on site by reacting natural gas with 
steam. Hydrogen is used in the nickel and cobalt autoclave circuits (furnaces) to reduce 
the powdered nickel and cobalt into briquettes and to sinter them, and for the production 
of hydrogen sulphide gas produced in the hydrogen sulphide plant. 
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3.3.3.6 Hydrogen sulphide plant 
Hydrogen sulphide (H2S) is used in the process prior to and in the refinery, to 
produce a mixed nickel and cobalt solid sulphide product. H2S is produced in the 
hydrogen sulphide plant by reacting hydrogen and sulphur together. The sulphur is 
pumped from the sulphur pit located in the sulphuric acid plant. 
3.3.3.7 Sulphur stockpile 
Sulphur is trucked in from external suppliers and stored as a large stockpile close to 
the acid plant and hydrogen sulphide plant. Approximately 500,000 tonnes/year of 
sulphur is used to produce sulphuric acid in the acid plant and hydrogen sulphide gas in 
the hydrogen sulphide plant.  
3.3.3.8 Oxygen/nitrogen (air separation) plant 
The air separation plant produces oxygen and nitrogen from the air of the local 
atmosphere. The plant uses a double column distillation/ pressure swing absorption 
system to produce oxygen and nitrogen which are used in various stages of the 
nickel/cobalt processing.  
Nitrogen is used predominantly for the pressure acid leach autoclaves and for 
purging in the hydrogen and hydrogen sulphide plants, whilst oxygen is used mainly in 
the refinery area for the mixed sulphide pressure leach.  
3.3.3.9 Air supply 
Instrument air supply for the entire plant is provided from the air separation plant. 
Air compressors are installed in most areas of the operation to provide high and low 
pressure plant and dried instrument air. 
3.3.3.10 Ammonia supply and storage 
Ammonia is primarily utilised in the refinery in the hydrogen reduction areas. 
Ammonia is transported to the site and stored in pressurised bullet storage tanks to be 
distributed to the processing plant. 
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3.3.3.11 Ammonium sulphate 
Ammonium sulphate is used as a catalyst for the refining of nickel and cobalt in the 
hydrogen reduction process. The excess of ammonium sulphate from the process is 
reclaimed in a three-stage evaporation process and sold predominantly for fertiliser. 
3.3.4 Calcrete plant 
Calcrete (similar to limestone) is a strong alkaline substance used in the solution 
neutralisation circuit to neutralise the acidic HPAL product prior to introducing it into 
the refinery.  
Calcrete is mined locally at the calcrete pit approximately 50 km from the processing 
plant. This is transported to the calcrete plant close to the processing plant where it is 
made into fine slurry for use in the neutralisation circuit. 
3.3.5 Final products 
The following products are produced by the Murrin Murrin processing plant: 
 nickel; 
 cobalt; 
 ammonium sulphate. 
3.3.6 Packaging and transport of products 
The final nickel product is packed in two tonne bulka bags or metal drums according 
to customer requirements, whilst cobalt is packaged in metal drums. These products are 
transported by road to the local port to be shipped to customers worldwide. Ammonium 
sulphate fertiliser is trucked to the close-by Malcolm Siding rail head for transportation 
to be sold locally. 
In 2003/04, the Murrin Murrin Operation mined and processed 2.8 million tonnes per 
annum of laterite ore to produce about 27,950 tonnes per annum of nickel and 1,982 
tonnes per annum of cobalt briquettes (Minara, 2004b). In 2005, 28,240 tonnes of nickel 
and 1,750 tonnes of cobalt were produced (Minara, 2005) and in 2006 approximately 
32,000 tonnes of nickel were produced (Johnson, 2007). 
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3.3.7 The Processing plant layout at the Murrin Murrin Operation 
 
Figure 3.10 Processing Plant Layout 
(Source: Minara Resources, 2004a) 
The area names for each of the above area numbers are outlined in Table 3.1. 
Table 3.1 Processing Plant Areas 
10/1 Earthworks Contractors Area (during 
construction phase) 
43 Power Plant 
10/2 Temporary Batch Plant (during 
construction phase) 
44/1 Raw Water Dam 
10/3 Construction Water Dam (during 
construction phase) 
44/2 Process Water Dam 
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31 Slurrying (SAG) Mill - Ore 
Preparation 
44/3 Water Treatment Plant 
32 High Pressure Acid Leaching 44/4 Caustic Storage 
33 CCD Containment 45 Natural Gas Supply 
33/2 CCD Containment Pond 46 Air Supply System 
34 Neutralisation and Thickening 47 Fuel Farm 
35 Ni/Co Precipitation and Barren Liquor 
Neutralisation 
48 Main Pipe Racks 
36 Sulphide Grinding, Dissolution and 
Impurity Removal 
51 Hydrogen Sulphide Plant 
37 Hydrogen Reduction 52 Ammonia Storage 
38 Cobalt Reduction 54  Hydrogen Plant 
39 Solvent Extraction 55 Oxygen Plant 
41/1 Acid Plant 59 Ammonium Sulphate Plant 
41/2 Acid Storage 71/1 Administration Office Area 
41/3 Sulphur Storage 71/2 Workshop/Warehouse Area 
42 Calcrete Plant 77 Tailings Dam 
(Source: Minara Resources, 2004a) 
Colloquially the areas are referred to by the area numbers above with a suffix of two 
further zeros. For example: 
 ore leach – 3100, 3200, 3300, 3400 (thirty-one hundred, thirty-two 
hundred, etc.); 
 refinery – 3500, 3600, 3700, 3800, 3900; 
 57 
 utilities – 4100, 4300, 4400; 
 BOC plant (air supply system) – 4600; 
 calcrete plant – 4200. 
3.4 Conclusion 
The overview of the Murrin Murrin Operation process provides an indication of the 
chemical hazards that workers potentially face on a daily basis. The area names and 
numbers provide an indication of the processes occurring in that area and the chemical 
hazards associated with the tasks conducted in those work areas. The overview of the 
Murrin Murrin Operation process formed part of the exposure assessment strategy from 
which the health effects presented by the hazardous substances associated with the 
mining and process plant were determined. This is the subject of the next chapter. 
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4. THE RESPIRATORY HEALTH EFFECTS PRESENTED BY 
THE HAZARDOUS SUBSTANCES ASSOCIATED WITH THE 
MINING AND PROCESS PLANT 
4.1 Introduction 
In the precursor occupational hygiene studies prior to this study at the Murrin Murrin 
Operation a number of respiratory hazards associated with the complex chemical 
extraction process of nickel and cobalt were identified and the following exposure 
groups were identified as areas of concern: 
 ore leach, area 3100, operators – inhalable dust, cleaning under the 
sizer; 
 refinery, area 3700, furnace operators – nickel dust; 
 refinery, area 3700, packaging operators – cobalt dust; 
 refinery, area 3800, operators – cobalt dust. 
(Oosthuizen & Cross, 2004; Wing, 2005; Wing & Oosthuizen, 2007). 
Workers in these areas were required to wear P2 respiratory protection that complied 
with AS 1716 and was used in accordance with AS1715 as the work areas had been 
previously demarcated as potentially hazardous. 
Wing (2005, p. 120) discussed the potential for exposure to sulphuric acid mist (from 
the acid plant in area 4100) “if operators were working near a leak in the process”. 
Similarly, there is the potential for exposure to sulphuric acid mist at start-up of the acid 
plant especially during a cold start-up. These exposure scenarios are avoidable as they 
are “visible to the naked eye, so the identification of leaks prior to an exposure is 
possible” (Wing, 2005). 
Wing (2005) also identified other possible exposures, mainly associated with 
problems with the process, including process failures or abnormal operating conditions. 
The areas highlighted included: 
 hydrogen sulphide in utilities, Areas 4100/5100; 
 ore leach, Areas 3400 and 3510; 
 inhalable dust, hosing out the sizer tunnel – in ore leach, area 3100; 
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 nickel and cobalt dust – “working with dry production materials” – in 
the refinery, area 3500; 
 “Exposure to high short term concentrations of Ammonia” – refinery, 
area 5900. 
Wing (2005) did not include the mining operations and calcrete pit in the scope of his 
work.  
Additional historical data from the Occupational Hygiene Database (Minara 
Resources, 2005b) was accessed to identify worker exposures that may have occurred 
prior to the study conducted by Wing. Most of these exposures were one-off incidents, 
usually under abnormal working conditions, and, as far as can be established, 
appropriate personal protective equipment was worn in each situation. These included: 
 calcrete dust exposure in the calcrete pit and plant; 
 intersection of chrysotile and anthophyllite asbestos in mining ore 
bodies and during exploration drilling; 
 respirable dust levels for the mining blast crew and drillers; 
 respirable dust levels during preparation of ore samples in the 
laboratory; 
 grinding and welding in confined space; 
 ammonia in the refinery sampling and analysis huts; 
 reclaiming nickel powder/waste when loading nickel bags into hopper 
of the screening unit in the refinery; 
 loading nickel powder into bins/hoppers in the refinery; 
 welding fume during maintenance activities. 
At the time when these data were collected it was noted that the majority of the dirty 
work was being done by contractors, particularly during scheduled shutdowns. These 
transient workers were not included in routine occupational hygiene monitoring and 
their exposure profiles could not be established, particularly since they worked at 
multiple mine sites. Regular contractors based on site were included in this study, these 
included calcrete workers, and maintenance workers employed in the central works and 
BIMS areas. 
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4.2 The Specific Exposures Present in Each Work Area at the 
Murrin Murrin Operation 
The specific exposures present in each work area at the Murrin Murrin Operation 
were determined to be as follows: 
4.2.1 Mining 
 mineral dust; 
 general (red dirt) dust; 
 fibrous material (chrysotile and anthophyllite); 
 silica (from blast and drilling); 
 diesel emissions. 
4.2.2 Ore leach 
 mineral dust;  
 sulphur dioxide/trioxide and sulphuric acid mist; 
 caustic soda; 
 hydrogen sulphide; 
 general (red dirt) dust. 
4.2.3 Refinery 
 hydrogen sulphide; 
 hydrogen peroxide mist; 
 ammonia; 
 nickel dust; 
 cobalt dust; 
 mixed sulphides (nickel/cobalt sulphides); 
 organic solvent;  
 ammonium sulphate; 
 general (red dirt) dust. 
4.2.4 Utilities 
 sulphur dioxide/trioxide and sulphuric acid mist; 
 sulphur dust; 
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 hydrogen sulphide; 
 diatomaceous earth; 
 lime dust; 
 caustic soda dust. 
4.2.5 Calcrete plant and pit 
 calcrete dust; 
 diesel emissions. 
(Oosthuizen & Cross, 2004). 
The predominant route of exposure across the mining and processing operation was 
considered to be inhalation, and the primary target organ the lung. This was determined 
from the toxicological profile of each health hazard. A summary of the respiratory 
health issues presented by each of these hazardous substances individually (a single 
chemical) and the issues surrounding the toxicity of a combination of chemical agents 
(chemical mixtures) is addressed below. 
4.3 Respiratory Health Issues Presented by Each Hazardous 
Substance 
4.3.1 The inflammatory response 
Insult due to any toxic agent will initiate an inflammatory response (Rote, 1998). The 
extent of this response is dependent on the concentration, duration and frequency of 
exposure of the toxic agent (Eaton & Gilbert, 2008). There is a continuum of effects: the 
inflammatory response may resolve if the insult ceases, repair may occur with minimal 
pathophysiological results (Teder et al., 2002) or it may result in permanent damage, 
chronic injury, and possibly death.  
4.3.2 Toxic effects of dusts and particulates 
4.3.2.1 Dusts and particulates 
Dust particle size is the major factor that dictates where particulates will be deposited 
within the respiratory tract, and the area of deposition is a factor that influences the 
eventual pathophysiological effect. The aerodynamic equivalent diameter (AED) is used 
to predict where the particle will be deposited in the respiratory system (Kelly, 2002). 
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Larger particles (greater than 10 μm) are generally deposited in the nares, particles in 
the region of 10-5 μm are deposited in the large conducting airways, whilst those 
between 0.5 and 5.0 μm are most likely to be deposited in the thoracic/bronchial region, 
and particles of between 0.5 and 2.0 μm are more likely to be deposited in the alveoli 
(World Health Organization, 1999; Witschi, Pinkerton, Van Winkle, & Last, 2008). The 
convention is that particulate matter of 10μm or below (named PM10) will reach the 
bronchi and lower regions of the respiratory tract, and that particulate matter of 2.5μm 
or less (PM2.5) can penetrate deep into the respirable part of the lung, the alveoli (World 
Health Organization, 1999). PM10 are the airborne particles with an aerodynamic 
diameter smaller than 10 microns, and PM2.5 are airborne particles with an aerodynamic 
diameter smaller than 2.5 microns. 
Fibres as long as 200 μm and with a diameter of 3 μm are able to penetrate deep into 
the lung (Winder & Stacey, 2004). The chemical nature of asbestos fibres renders them 
relatively insoluble and therefore difficult to remove from the lung via its natural 
defence mechanisms (Kelly, 2002). 
The chemical properties of inhaled particulate matter has a significant effect on 
pathophysiology which is dependent on the toxic nature of the particulate, its 
concentration (level of exposure) and the duration of exposure (which, in combination, 
equals the dose) (Kelly, 2002).  
Dust inhalation may initiate pulmonary fibrosis which is dependent on the 
physicochemical properties of the dust. Pneumoconiosis is the term used to describe 
interstitial disease of the lung due to prolonged exposure from inhalation of significant 
amounts of inorganic dust (Brichet, Desurmont, & Wallraet, 2002). A continuum of 
effects –  from reversible on termination of exposure, slight effects with little decrement 
in lung function, to progressive massive fibrosis and the possibility of lung cancer – is 
dependent on the physicochemical/toxic properties of the dust and the dose (Gee & 
Mossman, 1995; Haspeter, Witschi, Pinkerton, Van Winkle, & Last, 2008). 
There is strong evidence linking a significant decrease in lung function to long-term 
excessive dust exposure (Parliament of Australia Senate Committee, 2006). Despite the 
paucity of data in Australia on morbidity and mortality associated with toxic dust 
exposure, this association has been well established internationally (Downs et al., 2007).  
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Exposure to high levels of dust, irrespective of its physicochemical composition, will 
affect lung function. The degree of toxicity and the severity of the effects on lung 
function are dependent on the level of exposure and the physicochemical properties of 
the dust. For example, dust exposure in young coal miners (Carta, Aru, Barbieri, 
Avataneo, & Casula, 1996) and iron foundry workers (Gomes, Lloyd, Norman, & 
Pahwa, 2001) increases the incidence of respiratory symptoms and decline of lung 
function. Inhalable dust (PM10) exposure is a significant predictor of decreased lung 
function (Downs et al., 2007).  
4.3.2.2 Mineral dust and general (red dirt) dust 
NIOSH (2001, p. 1) states that, “miners at noncoal surface mining operations are 
often exposed to high levels of respirable dust”. The silica content of the respirable dust 
is of major concern hence DMP (2010b, p. 1) require dust suppression where dust is 
generated from operations that involve ground disturbance when using machinery, and 
“along each open pit road and vehicle operating area, during dumping operations, at all 
stockpile areas, stockpile stacking operations, stockpile tunnels and material reclaim 
operations, and at all crushing and screening plant”. 
Most of the dust from mining activities consists of coarse particles larger than 10 μm 
in diameter most of which will be trapped in the nasal region and expelled from the 
respiratory system (New South Wales Department of Health, 2007). However, 
operations such as drilling, blasting, loading, unloading, and transporting can generate 
sufficient respirable dust (Onder & Yigit, 2009) to warrant dust suppression controls, 
regular dust monitoring, and health surveillance.  
Dust storms are a seasonal event at the edge of the Gibson Desert where the Murrin 
Murrin Operation is located. The main health concern associated with the red dirt dust 
from the gravel roads and the surrounding bushland, is its potential to trigger respiratory 
symptoms and exacerbate asthma. The New South Wales Department of Health (2003) 
and the Health Department of Victoria (2010) both state that particles from dust storms 
tend to be coarse and do not pose a serious health risk; and that they may worsen pre-
existing conditions such as asthma and emphysema. 
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4.3.2.3 Fibrous material (chrysotile and anthophyllite) 
In Western Australia, asbestiform minerals are found throughout the “greenstone 
belts”, which host the state's major gold and nickel deposits (DMPR, n.d.). At the 
Murrin Murrin mine site, chrysotile and anthophyllite has been intersected during 
exploration drilling and identified in a few of the pits. Asbestos fibres are capable of 
causing asbestosis, lung cancer and mesothelioma (International Agency for Research 
on Cancer [IARC], 1998; Gibbons 2000; Winder & Stacey, 2004). 
The risk of asbestos-related disease is dependent upon: 
 the concentration of respirable fibres in the air; 
 the length of time exposed; 
 the type of fibre present (amphibole asbestos or serpentine); and 
 the morphology of the fibres (fibre size and shape). 
(DMPR, n.d., p. 5) 
Asbestosis is a diffuse interstitial fibrosis of the lung parenchyma resulting from the 
exposure and retention of a high concentration of asbestos fibres. The lung function 
measured by spirometry in such cases presents as a restrictive ventilatory disorder (De 
Vuyst & Gevenosis, 2002). 
It was considered that the potential for exposure to asbestiform material would be 
greatest during exploration drilling when asbestos is intersected. Asbestos has been 
observed in the pit areas and upon delivery of ore to the mill. Despite this, air 
monitoring has shown no significant risk to workers (Wing, 2005). 
4.3.2.4 Silica 
The mining industry has often been associated with silicosis (a pneumoconiosis) 
caused by the silica content of dust which may cause massive fibrosis and lung cancer 
(Haspeter et al., 2008; Winder & Stacey, 2004; IARC, 1986). Silicosis is considered to 
be associated with occupations that have very high exposures to respirable silica dust. 
On 1 January 2005 a revised national exposure standard of 0.1 mg/m3 (time-weighted 
average [TWA], 8 hours) for quartz, cristobalite and tridymite came into effect 
(Parliament of Australia Senate Committee, 2006).  
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In Western Australia, particularly in open cut mining, the silica exposures are now 
mostly well below the occupational exposure standard which is reflected by the Health 
Surveillance Program for Mine Employees, Department of Industry and Resources, 
WA, which has shown no significant decrement in lung function observed for this group 
of WA mine workers over the past 5 years (Nield & Burmas, n.d.). The blast crew and 
drillers are perhaps at the highest risk of dust and respirable silica exposure in the open 
pit areas (Brichet, Desurmont & Wallaert, 2002) and the laboratory staff during 
preparation of ore samples for laboratory analysis (Minara Resources, 2005b). The 
potential for exposure to elevated levels of inhalable dust during operation of heavy 
mining vehicles and during charging and blasting at the Murrin Murrin mine site was 
identified (Minara Resources, 2005). 
Exposure to silica dust has been associated with decreased lung function, and can be 
a cause of fixed obstructive airway disease at doses below that which lung fibrosis 
becomes clinically obvious (Parliament of Australia Senate Committee, 2006).  
4.3.2.5 Calcrete dust 
Calcrete, a limestone-like mineral mined in a local pit, is added to neutralise the acid 
in the neutralisation circuit. Calcrete consists of calcium carbonate, magnesium 
carbonate and silica. Although the silica content is often low, the exact proportion of 
these components in calcrete varies from location to location (Chen, Lintern, & Roach, 
2002).  
Dust monitoring at the calcrete plant and calcrete pit has shown that levels of silica 
were below the occupational exposure standard applicable at the time. However, the 
exposure standard for silica was reduced in 2004 (NOHSC, 2004) as the previous 
standards were not considered adequate for protecting workers from the risk of silicosis 
and lung cancer (Rice et al, 2001; Safe Work Australia, 2010b).  
There have been occasional excursions above the occupational exposure standard for 
the respirable dust level, which were associated with the calcrete crushing circuit; 
however, the crusher operators were required to wear respiratory protection (Minara 
Resources, 2005b; Wing, 2005). 
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4.3.2.6 Diatomaceous earth 
Diatomaceous earth is an amorphous silica, derived essentially from the remains of 
dead diatoms in marine sediments (Antonides, 1997; Harber, Dahlgren, Bunn, Lockey, 
& Chase, 1998). It was used as a filtering agent in the acid plant area (Wing, 2005; 
Minara Resources, 2001) but has since been substituted by perlite. Diatomaceous earth 
is known to cause silicosis and lung cancer (Rice et al., 2001). 
Regular dust monitoring in the acid plant area indicated that the levels of 
diatomaceous earth dust have been well below the exposure standard (Minara 
Resources, 2005b). 
4.3.2.7 Sulphur dust 
Sulphur is a non-metallic dust known to cause irritation and inflammation to the nose 
and throat, and with long-term exposure it may cause chronic bronchitis (NIOSH, 
2000). A large quantity of sulphur was stored as a large, open stockpile and used to 
produce sulphuric acid in the acid plant and hydrogen sulphide gas in the hydrogen 
sulphide plant. Operators unloading sulphur on delivery and loader operators removing 
sulphur from the stockpile for the process were at most risk of exposure to sulphur dust; 
however, respiratory protection was required in this area.  
The sulphur stockpile was located at a safe distance from the main processing areas 
due mainly to the potential fire risk and to prevent exposure to sulphur dust on windy 
days. Eye and respiratory protection was mandatory in the vicinity of the sulphur 
stockpile. 
4.3.2.8 Lime dust 
Hydrated lime was identified through a formal risk assessment process as a potential 
health hazard in the utilities area 4100/5100, particularly for the operator and the 
delivery driver who unloaded the lime. Lime has the potential to irritate the nose, throat 
and respiratory system (International Program on Chemical Safety, 2001). However, 
occupational hygiene monitoring showed levels to be below the occupational exposure 
standard and were therefore deemed acceptable (Wing, 2005). 
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4.3.2.9 Caustic soda 
Inhalation of low levels of caustic soda (sodium hydroxide) as a dust, mist or aerosol 
has the potential to cause irritation of the upper and lower respiratory system (Agency 
for Toxic Substances and Disease Registry, 2002). High-level, short-term exposures of 
sodium hydroxide via inhalation may be corrosive to the respiratory system and cause 
oedema of the lung (obstructive lung disease) often with a delayed onset (International 
Program on Chemical Safety, 2000; Hansen & Isager, 1991; Rubin, Bentur, & Bentur, 
1992; California Office of Environmental Health Hazard Assessment, 1999). The risk 
associated with caustic soda when tipping bags of the material into the process was 
determined to be low through occupational monitoring (Wing, 2005).  
4.3.2.10 Ammonium sulphate 
Visible ammonium sulphate dust was generated during loading and unloading in the 
ammonium sulphate shed. However, it did not exceed the occupational exposure levels 
(Wing, 2005). 
Ammonium sulphate dust is known to cause irritation of the respiratory tract and 
impair respiratory function, especially in asthmatics (Scorecard Organisation, n.d.) and 
the lung function in healthy adult volunteers was affected after a two- to four-hour 
exposure to 1 mg/m3 (Organization for Economic Co-Operation and Development 
Screening Information Data Sets, 2004) 
4.3.3 Toxic effects of metals 
4.3.3.1 Nickel dust 
Certain species of nickel have been shown to be carcinogenic (IARC, 1990; 
International Programme on Chemical Safety, 1991) and following the European Union 
Risk Assessment (2008) conducted by the Danish Government, more stringent 
occupational exposure standards for nickel and its compounds have been implemented 
(Safe Work Australia, 2010b). The carcinogenicity appears to be uniquely associated 
with occupational exposures during the smelting and refining of nickel (Nickel Institute, 
2007). The Agency for Toxic Substances and Disease Registry (2005) state that: 
The most serious harmful health effects from exposure to nickel, such as 
chronic bronchitis, reduced lung function, and cancer of the lung and nasal 
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sinus, have occurred in people who have breathed dust containing certain 
nickel compounds while working in nickel refineries or nickel-processing 
plants. (Agency for Toxic Substances and Disease Registry, 2005, p. 5) 
To date, a number of epidemiological studies have established a link with nasal and 
lung cancer at high exposures to a mixture of nickel compounds found during the 
refining of sulphidic ores (Bates, 2008). Andersen, Berge, Engeland, and Norseth 
(1996) identified the synergistic effect of smoking and nickel exposure in the causation 
of lung and nasal cancer among nickel refinery workers. However, it has been argued 
that such cancers have not been observed in the extraction and processing of lateritic 
ore, which is the ore body mined and processed at the Murrin Murrin Operation (Doll, 
1990; Goldberg et al., 1992). 
Histologically, the early acute respiratory effect of inhalation of nickel dust is an 
inflammatory response, with effects on the epithelial and endothelial cells and an influx 
of alveolar macrophages (Klein & Costa, 2008). This may result in asthma, resolve if 
the insult ceases, or this may lead to fibrosis, (Bates, 2008; Agency for Toxic 
Substances and Disease Registry, 2005). In a study conducted by Cirla, Bernabeo, 
Ottoboni, and Ratti (1985) a significant decrease in lung function (FEV1) was observed 
with six out of the seven asthmatics exposed to 0.3 mg/m3 nickel sulphate for 30 
minutes, whilst similar exposures to other metal salts did not affect lung function. 
Safe Work Australia (2010b) Hazardous Substances Information System (HSIS) 
defines nickel and compounds as hazardous. The current relevant occupational exposure 
standards TWA (eight-hour, time-weighted average) exposure limit in the workplace for 
nickel metal is 1mg/m3. Soluble inorganic and insoluble inorganic nickel compounds 
have TWA’s of 0.1 and 0.2mg/m3 respectively (American Conference of Industrial 
Hygienists, 2010) 
On occasion, there have been exceedances of this standard at the Murrin Murrin 
Operation, most notably for the refinery 3700 area furnace operators, as indicated in 
precursor occupational hygiene studies conducted by Wing (2005) and Cross (2005). 
However, respiratory protection is mandatory for workers in this area. 
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4.3.3.2 Cobalt dust 
The National Toxicology Programme concluded that there was clear evidence of 
carcinogenic activity via inhalation in mice and rats exposed to cobalt dust (National 
Toxicology Program, 1998; Bucher et al., 1999). IARC has determined that, with 
chronic exposure, cobalt and cobalt compounds are possibly carcinogenic to humans 
(IARC, 2006).   
Acute inhalation effects of low doses of cobalt dust include respiratory irritation and 
asthma. Occupational exposure to various forms of cobalt can cause bronchial asthma 
(Swennen, Buchet, Stanescu, Lison, & Lauwerys, 1993; Linna et al., 2003) and effects 
on lung function (Nemery, Casier, Roosels, Lahaye, & Demedts, 1992). 
At higher doses, cobalt may cause a progressive interstitial fibrosis (Liu, Goyer, & 
Waalkes, 2008). Respiratory symptoms may appear anywhere from a few months to 
several years from exposure; symptoms may be reversible if removed from the dust 
exposure, or there may be a delayed progression resulting in progressive interstitial 
fibrosis (Mapel & Coultas, 2002). 
Morgan (1995) describes three respiratory effects produced by exposure to cobalt as: 
reversible airways obstruction, hypersensitive pneumonitis or alveolitis, and pulmonary 
fibrosis. The fibrosis is said to be reversible if exposure to cobalt dust is terminated 
early enough (Cugell, Morgan, Perkins, & Rubin, 1990). Swennen et al. (1993) 
established a dose-effect relationship with decrements in forced expiratory volume in 
one second/vital capacity (FEV1/FVC) and the levels of cobalt exposure. After 
implementing effective exposure controls, a follow-up study was conducted after 13 
years among the same workforce and cobalt exposure in this study was only influenced 
negatively by smoking (Verougstraete, Mallants, Buchet, Swennen, & Lison, 2004). 
The current Australian occupational exposure standard for cobalt metal dust is 0.05 
mg/m3 for an eight-hour workday and 40-hour work week (Safe Work Australia, 
2010b). 
Monitoring results from regular occupational hygiene studies within the refinery at 
the Murrrin Murrin Operation showed that certain operator groups, particularly area 
3800 (cobalt area) were being exposed to concentrations of cobalt exceeding this 
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exposure standard. However, it was common practice to wear respiratory protection 
whilst working in these areas (Oosthuizen & Cross, 2004; Wing, 2005). 
4.3.3.3 Mixed sulphides (nickel/cobalt sulphides) 
As the exact speciation of the nickel and cobalt compounds of the mixed sulphides in 
the process in area 3500 of the refinery remain essentially unknown, it is considered that 
the mixed sulphides material could pose a possible health risk. It has been argued that 
water-soluble nickel presents the greatest carcinogenic risk (Dunnick et al., 1995; 
Grimsrud, Berge, Haldorsen, & Andersen, 2002) although Heller, Thornhill and Conrad 
(2009) and Bates (2008) refute this. Cobalt sulphate is carcinogenic in rodents via 
inhalation (Bucher et al., 1999). Because such chemical species are likely to be in the 
mixed sulphides process material, the precautionary principle has been adopted. When 
there is a process stoppage and material has to be emptied into a bunded area, the 
product is maintained wet and the area hosed down to prevent any airborne dust until it 
can be reintroduced into the process. Full protective clothing is used in such instances. 
Dust levels in this area were invariably well below the occupational exposure standard 
due to the wetting procedure (Wing, 2005; Cross, 2005). 
4.3.4 Toxic effect of gases, solvents and vapours 
4.3.4.1 Gases/fumes from blasting 
According to the Department of Minerals and Energy (1999) during the mining 
process workers could potentially be exposed to fumes from blasting. Such fumes 
consist of carbon monoxide, sulphur dioxide and oxides of nitrogen which, in high 
enough concentrations, may pose health effects, particularly for the respiratory system 
(Mainiero, Harris, & Rowland, 2007). The risk in open pit mining is considered 
negligible as the blasters move away from the area before detonation and fumes 
generally disperse with the wind prior to workers entering the blasting zone. 
4.3.4.2 Diesel emissions 
Diesel exhaust fumes may cause respiratory disorders such as bronchitis, 
emphysema, and lung cancer.  According to NIOSH (2010) diesel exhaust is a potential 
human carcinogen, presumed to be due mainly to polycyclic aromatic hydrocarbons 
(Kelly, 2002).  
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Diesel fumes contain a cocktail of hazardous substances including carbon monoxide, 
nitrogen oxides, benzene, polycyclic aromatic hydrocarbons, sulphur dioxides, and 
particulate matter. Short-term exposure of healthy human subjects to diesel exhaust at 
high concentrations of diesel fumes induces airway inflammatory responses and affects 
lung function (Rudell et al., 1996). Moreover decreased lung function has been 
observed among garage workers, and bus drivers and conductors for a state transport 
corporation (Chattopadhyay, Alam, & Roychowdhury, 2003). 
Various studies have shown associations between increased respiratory symptoms, 
including asthma, exacerbation of asthma, and exposure to diesel fume (Kagawa, 2002; 
Stenfors et al., 2004; Gluck, Schutz, & Gebbers, 2003; Riedl & Diaz-Sanchez, 2005). 
Respiratory effects – for example, goblet cell hyperplasia – were observed in a group of 
Swiss custom officers who worked clearing diesel trucks for 40 hours a week over 5 
years, whilst a control group of office workers experienced no such effect.  
Diesel exhaust fumes are considered to be a significant hazard in underground 
mining. The New South Wales Mines Safety Performance Branch (Driscoll, 2007) 
considers diesel exhaust fumes a high priority exposure needing to be urgently 
addressed.  
The hazard of diesel fumes has been determined to be less significant for open pit 
mining as exhaust fumes are not restricted to a confined-space environment and dilution 
and dispersion of the emissions occurs readily. Nonetheless, drivers and mechanics of 
diesel plant and machinery may be exposed to diesel fumes during their daily routine. 
At the time of the study there was no established occupational exposure standard or 
firmly established monitoring protocol for diesel fumes, therefore no atmospheric 
monitoring was conducted (Adeeb, 2010). 
4.3.4.3 Ammonia 
Some people are more sensitive than others to ammonia. The odour threshold for 
ammonia is reported to be between 5 and 50 ppm (parts per million) and upper 
respiratory irritation occurs at between 30 and 50 ppm (World Health Organization, 
1986). Upon inhalation, highly water-soluble gases such as ammonia may cause 
immediate upper respiratory tract irritation (Schwartz, 2002). However, it has been 
reported that there is a human physiological response and adaption to ammonia 
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(Ferguson, Koch, Webster, & Gould, 1977). Ferguson et al. reported that workers could 
be acclimatised to 100 ppm with occasional excursions to 200 ppm and that after 
acclimatisation; exposures to ammonia at up to 100 ppm produced no discernable health 
effects. Despite this, others have reported an intense irritation to the eyes, nose, and 
throat that occurs at 100 ppm (Agency for Toxic Substances and Disease Registry, n.d.) 
and that ammonia may also cause chemical bronchitis, oedema, and cough often with 
blood-stained sputum (Tranter, 2004).  
When exposure to ammonia is high or prolonged the odour is no longer detected by 
the sense of smell (olfactory fatigue) which creates a high health risk. At extremely high 
doses, greater than the immediately dangerous to life and health (IDLH) standard of 300 
ppm (NIOSH , 1996a) death from asphyxiation is possible (Ross, Seaton, & Morgan, 
1995).  
Chronic irritation of the respiratory tract, chronic cough, asthma, and lung fibrosis 
are the result of long-term repeated exposure to ammonia (Agency for Toxic Substances 
and Disease Registry, n.d.). Decreases in lung function have been reported for fertiliser 
workers exposed to ammonia (Ali, Ahmed, Ballal, & Albar, 2001; Rahman, Bråtveit, & 
Moen, 2007). In contrast, Sundblad et al., (2007) reported ammonia levels at 25 ppm for 
three hours did not significantly affect lung function. Ammonia was considered one of 
the main components of a mixed exposure that caused a decrease in FEV1 among 
livestock farmers. The mixed exposure consisted of ammonia, hydrogen sulphide, and 
inorganic dust (Eduard, Pearce, & Douwes, 2009). Similarly, Preller, Heederik, Boleij, 
Vogelzang, and Tielen (1995) and Reynolds et al., (1996) have suggest a causal link 
between lung function decrements and exposure to a mixture of endotoxins and 
ammonia among swine production workers. 
4.3.4.4 Hydrogen sulphide 
The odour threshold of hydrogen sulphide is approximately 0.5 parts per billion 
(ppb) (Agency for Toxic Substances and Disease Registry, 2009). Hence, hydrogen 
sulphide can be detected at very low levels, much lower than levels acknowledged to 
cause health effects (Government of Western Australia, Department of Health, 2009) 
because the odour of hydrogen sulphide may be detected at such low levels, there was a 
perception on site that the emissions in the processing plant were likely to cause ill 
health. However, the lowest concentration for adverse health effects is at least 500 times 
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the odour detection limit (Government of Western Australia, Department of Health, 
2009). 
Hydrogen sulphide is a mucous membrane irritant, causing skin, eye and respiratory 
irritation. At low concentrations (≤50 ppm) it can quickly cause irritation of the nose, 
throat, and lower respiratory tract (Agency for Toxic Substances and Disease Registry, 
2009). Richardson (1995) demonstrated a significant FEV1/FVC decrease among sewer 
workers who were exposed to hydrogen sulphide as compared to a non-exposed cohort. 
Airborne hydrogen sulphide levels above 100 ppm are considered immediately 
dangerous to life and health (IDLH) (NIOSH, 1996b) via inhalation, causing 
asphyxiation and possible unconsciousness. Delayed pulmonary effects such as oedema 
and pneumonia may occur up to 72 hours after exposure (Nemery, 2002). At high 
concentrations, inhalation of a small volume may lead to immediate loss of 
consciousness, respiratory paralysis, and death (Agency for Toxic Substances and 
Disease Registry, 2009). 
4.3.4.5 Sulphur dioxide, sulphur trioxide and sulphuric acid mist 
Sulphur dioxide, sulphur trioxide and acid mist are direct-acting respiratory irritants 
that cause mild bronchoconstriction (Costa, 2008) and affect the mucus membranes of 
the eyes nose and upper respiratory system. All have a pungent odour which can 
overwhelm the respiratory system at high concentrations. The odour threshold for 
sulphur dioxide is between 0.5 and 0.8 ppm (Tranter, 2004). There is a continuum of 
effects from slight irritation at low exposure levels, to death from acute over-exposure, 
and chronic respiratory disease due to long-term exposures (NIOSH, n.d.). 
Bronchoconstriction has been demonstrated in exercising asymptomatic asthmatics at 
sulphur dioxide levels as low as 1 ppm (Horstman, Seal, Folinsbee, Ives, & Roger, 
1988). Although not as sensitive as asthmatics, males aged 55 or more are more 
sensitive to the effects of sulphur dioxide than adolescents (Rondinelli, Koenig, & 
Marshall, 1987). Co-exposures of low levels of sulphur dioxide with other air pollutants 
have been shown to cause additive (Kagawa, 1983) and synergistic effects, as well as 
decrements in lung function (Kleinman et al., 1981). One of the aims of this study was 
to determine whether there may be an additive or synergistic effect of exposure to low 
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concentrations of air contaminants at the Murrin Murrin mine site. Conversely, it has 
been suggested that there is possible adaption to mixed pollutant exposures (Bell, 1977). 
Winder (2004, p. 408) quotes the exposure-response to oxides of sulphur as: 
 1-5 ppm – mild bronchoconstriction; 
 5 ppm – alteration in lung function; and 
 5-10 ppm – some cases of bronchospasm. 
IARC (1992, 5.5 Evaluation) has determined that “there is sufficient evidence that 
occupational exposure to strong inorganic acid mists containing sulphuric acid is 
carcinogenic to humans”. Epidemiological studies have shown lung cancer and 
laryngeal cancer to be a risk in specific industries where there is exposure to sulphuric 
acid aerosols, although often in these studies there are co-exposures or other 
confounders such as cigarette smoking (National Industrial Chemicals Notification 
Assessment Scheme, 2003). The National Toxicology Program (2000) stated that 
sulphuric acid most often exists as a mist because of its low volatility and high affinity 
for water, and that proximity to the source of the acid mist is the main determinant of 
exposure to workers.  
Proximity to the source is what Wing (2005, p. 119) was alluding to in relation to the 
Murrin Murrin processing plant. He stated that: 
All measured exposures to sulphuric acid mist were found to be below the 
limit of detection, and therefore well below the exposure standard .… It can 
be inferred that the exposures of [the area] 4100/5100 [sulphuric acid plant 
and hydrogen sulphide plant respectively] operators to sulphuric acid mist 
are acceptable under normal production conditions. 
Process leaks may occur, and emissions are inevitable during start-up of the acid 
plant (Dames & Moore, 1997). However, under these circumstances the area is 
restricted to maintenance workers wearing the appropriate personal protective 
equipment. 
4.3.4.6 Hydrogen peroxide mist 
Hydrogen peroxide mist may be generated during unloading of vehicles or when 
hydrogen peroxide is introduced into the refinery process. Hydrogen peroxide is highly 
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corrosive and if inhaled may cause severe irritation and inflammation of the respiratory 
tract. Therefore full personal protective clothing was worn on delivery of consignments 
of hydrogen peroxide by the supplier (Plog, 2002; Degussa, 2011). 
4.3.4.7 Organic solvent 
Organic solvents (volatile organic compounds [VOCs]) via inhalation have been 
shown to cause respiratory symptoms (Koren, Graham, & Devlin, 1992). All organic 
solvents have the ability to irritate the respiratory tract to some degree (Queensland 
Health, 2002) and may affect the nose, throat and lungs and cause asthma-like 
symptoms (New Zealand Department of Labour, 2009). Jaakkola and Jaakkola (2002, p. 
246) state that the commonly used measure of total VOC “is an ambiguous concept” 
and therefore may be misleading in determining adverse effects. Similarly (Rumchev, 
Spickett, Bulsara, Phillips, & Stick, 2004) state that measuring total VOC’s has the 
potential to underestimate the risk. Hence it is better to monitor for the individual 
components of the solvent where possible as the respiratory effects are dependent on the 
type of solvent. Asthmatics appear to be more susceptible to effects of solvents on the 
airways. Often the solvent per se may not affect the lung; however, it may be a vehicle 
for other chemicals dissolved within it that causes effects on the respiratory system 
(Nemery, 2002). An organic solvent (“Shellsol 2046”, White Spirits) was used in the 
process of extraction of nickel and cobalt in area 3900 of the refinery. Personal 
monitoring for volatile organic compounds (Total VOCs) and individual constituents 
was conducted in this area. Total VOCs were in the range of <0.1 to 20 (occupational 
exposure standard 175 ppm, Safe Work Australia, 2011b) and extremely small 
concentrations of toluene and naphthalene were also detected. Wing (2005, p. 110) 
concluded that “these concentrations were found to be so far below the exposure 
standards as to be insignificant”. 
4.3.4.8 Welding fume 
Welding occurred regularly during maintenance activities across the Murrin Murrin 
Operation. Welding in confined spaces was highlighted as a hazard. Welding fume is a 
mixture of particles and gases, the constituents of which depend on the materials being 
welded, materials in the filler, electric parameters and shield gases, and surface 
contaminants. The acute effect of welding fume is considered to be irritation of nasal 
passages, throat and lungs (McMillan, 2002). 
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Inhalation of welding fumes has been shown to cause bronchitis and pneumonitis and 
the severity of symptoms appears to be dependent on the process or metals used. 
Occupational asthma is more prevalent among welders than the general working 
population and exposure to welding fume has resulted in short-term changes in 
pulmonary function. Obstructive changes were observed more frequently among older, 
smoking welders than controls; however, a restrictive pattern was observed more 
frequently among non-smoking welders. Significant decrements in certain pulmonary 
function parameters have been observed in some studies (Liss, 1996). Smoking appears 
to potentiate the effects from welding fume (Occupational Safety and Health 
Administration [OSHA], n.d.)  
Studies of the long-term effects of welding fume indicate that lung cancer among 
welders is 30 to 40 % greater than among the general population; however, other co-
exposures have also been implicated (NOHSC, 1990). However, IARC (1990) 
concluded that there is inadequate evidence for the carcinogenicity of welding fumes 
and gases in animals and limited evidence in humans, as there were confounding factors 
such as smoking and concomitant asbestos exposure. 
4.4 Effects of Co-Exposures (Mixtures of Hazardous 
Substances) on the Respiratory System 
Occupational hygiene monitoring at the Murrin Murrin Operation determined that 
exposure to single hazardous substances were invariably well below the occupational 
exposure standards (Oosthuizen & Cross, 2004; Wing, 2005). The concern of 
employees that a ‘chemical cocktail’ from the mining activities and the refinery process 
could result in adverse health effects was a major driver for this study.  
Exposures to mixtures of hazardous substances have been shown to be more harmful 
than single substance exposures. In reality, occupational exposures are usually to low 
doses of a complex range of chemicals (Interdepartmental Group on Health Risks from 
Chemicals, (2009). Exposure may be concurrent or sequential, and their effects may be 
additive, antagonistic, potentiated or even synergistic (Zeliger, 2008).  
It was recognised through a review of the toxicity of the majority of the occupational 
hygiene hazards at Murrin Murrin that most of the substances have the potential to 
affect the respiratory system and the main target organ is the lung (Hendrick, 2002). It is 
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thus possible that additive, antagonistic, potentiated or even synergistic biological 
effects could occur due to exposure to these combinations of atmospheric contaminants 
(Zeliger, 2008). Furthermore, chemical interactions of substances in the process or when 
released to the atmosphere could occur and secondary particles may be produced by 
intermediate reactions of gases and particulate matter in the atmosphere from gaseous 
emissions (World Health Organization, 2000). Some of the emissions at Murrin Murrin 
included: 
 sulphur dioxide from the sulphuric acid plant and hydrogen sulphide 
circuit flares; 
 oxides of nitrogen from the steam boilers and sintering plants; 
 carbon dioxide from the neutralisation circuits, power production and 
 hydrogen plant; 
 carbon dioxide from the hydrogen plant; 
 particulate emissions from the mining activities, stockpiles, 
conveyors, exposed areas and vehicular movement; 
 process steam; and  
 increased sulphur dioxide emissions during acid plant start-up.  
(Dames & Moore, 1997) 
It has also been recognised that lifestyle factors, particularly cigarette smoking 
(International Programme on Chemical Safety, 1999) may have an additive or 
synergistic effect with other agents particularly on the respiratory system. Such 
examples include: 
 asbestos and smoking (Leigh, Berry, de Klerk, & Henderson, 1996); 
 cobalt and smoking (Verougstraete, Mallants, Buchet, Swennen, & 
Lison, 2004); 
 nickel and smoking (Heller, Thornhill & Conrad, 2009). 
Like many other researchers, Mustajbegovic et al. (2000, p. 439) noted that “in a 
population of workers exposed to low levels of pollutants respiratory symptoms were 
primarily associated with smoking”. Hence cigarette smoking has not only been shown 
to exacerbate respiratory symptoms, diseases, and disorders, but has camouflaged such 
symptoms, and conversely has led to occupational exposures being wrongly blamed for 
respiratory illness. 
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Human variability in susceptibility and sensitivity to toxic chemicals may also 
complicate the overall response to these exposures (Hattis, Erdreich, & Ballew, 1987). 
4.5 Conclusion 
Excessive exposures above the occupational exposure standards of NOHSC: 3008 
(NOHSC, 1995b) and NOHSC: 1003 (NOHSC, 1995a) (Safe Work Australia 2010a) of 
all the aforementioned gases and dusts are known to cause a range of respiratory 
symptoms including: 
 decrease in lung function; 
 Asthma;  
 upper respiratory tract symptoms; 
 lower respiratory tract symptoms, and ultimately; 
 chronic pulmonary diseases, and  
 nasal or pulmonary cancer. 
(Morgan & Seaton, 1995; Hendrick et al., 2002). 
Exposures to any of these hazardous substances singly, or in combination, have the 
potential to cause significant health issues. However, at the generally low levels 
identified during the occupational hygiene monitoring, it is unlikely that any serious 
untoward effects would occur. It is considered that health effects at the cellular level of 
low-level exposure of each of these hazardous substances would be reversible, 
providing a threshold level is not exceeded, although this remains contentious for 
carcinogens (Stacey, 2004). The question of what these hazardous substances, in 
combination at low concentrations, do requires investigation. In the industrial situation, 
employees may be exposed to chemical mixtures at low concentrations (Carpenter, 
Arcaro, & Spink, 2002). There is evidence of occupational respiratory diseases from 
chronic low-level exposures to irritants below their occupational exposure standards 
(Balmes, 2002; Mustajbegovic et al., 2000). 
This current study provides a direct respiratory health assessment of the low-level 
chemical mixtures that the employees in the various work areas were exposed to over 
their length of service at the Murrin Murrin Operation. The main aim was to determine 
whether there was any discernable effect on the respiratory system, and, if so, whether 
further intervention, on top of the control systems already in place, may be required. 
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The Senate Inquiry into Workplace Exposure to Toxic Dust highlighted the fact that 
in Australia, “we do not have research into early detection” (Parliament of Australia, 
2004, p. 43) and there is a “need for health surveillance of employees exposed to toxic 
dust” and that “There is no point waiting until exposure has occurred and deleterious 
changes have occurred” (Parliament of Australia Senate Committee, 2006, p. 44). This 
study was based on this very sentiment. The methodology for early detection of 
respiratory health effects at Minara Resources, Murrin Murrin Mine Site is provided in 
the next chapter.  
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5. RESEARCH METHODOLOGY 
This chapter describes the methods and procedures used to conduct this study. 
5.1 Introduction 
The main purpose of this study was to conduct respiratory health surveillance of the 
Murrin Murrin workforce to detect possible adverse respiratory health effects at an early 
stage, in order to prevent potential long-term occupational respiratory disease. This 
meant evaluating whether working at the Murrin Murrin Operation, or areas within the 
Operation, affected the respiratory health of mine and process workers. 
To do this, an initial study was conducted using a questionnaire to determine the 
respiratory health of each member of the Murrin Murrin workforce, followed by a lung 
function test. These data were then compared with a local control group. The lung 
function of each individual, in the study and control groups, was also compared with 
their predicted normal lung function values (Zapletal et al, 1977). This was followed up 
by a repeat study of a sample (72) of the initial study group members approximately two 
years later.  
The study took place at the Murrin Murrin Operation between 17 February 2004 and 
21 June 2006. The protocols for the methodology used in this study were derived from 
the most current references available in 2004.  
 
5.2 Application to Undertake Research Involving Human 
Subjects 
The research proposal was submitted and accepted by the Edith Cowan University 
Human Research Ethics Committee. The confidentiality of the questionnaires and 
spirometry data was guaranteed by maintaining records for a minimum of five years in 
locked filing cabinets, and codifying the data for statistical analysis. The written consent 
of all employees participating in the study was obtained prior to commencement of the 
study.   
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5.3 Study Group 
5.3.1 Inclusion criteria 
The study group consisted of all Murrin Murrin Operation mine and process workers. 
For a population of 420 with a confidence interval of .99, the sample size required was 
410, therefore the entire population was studied. Only two refused to participate 
therefore the final study group was 418 (99.5%). 
5.3.2 Exclusion criteria 
Excluded from the study were any contract workers on short-term contracts such as 
shut-down workers. Those temporarily occupying full-time positions were included.  
5.4 Control Groups  
5.4.1 Catering staff 
A local group consisting of 40 catering staff who resided at the accommodation camp 
approximately 8 km from the mine site constituted the control group. Only a few 
members of the control group rarely, if ever, visited the mine site or processing plant. 
These few were limited to those transporting employees to and from site and were on 
site for a brief period away from the process areas. This control group was chosen for its 
close proximity to the Murrin Murrrin Operation with the aim of eliminating any 
location/environmental/climatic/geographical variables. They were chosen primarily for 
their absence of exposure to hazardous substances.  
An occupational hygiene survey identified pool chlorine as the only hazardous 
substance at the accommodation camp. However, the controls were considered 
adequate. The cleaning agents used were selected as they were non-hazardous. Both the 
study group and control group worked a 12-hour shift; however, their work periods 
(swings) varied. 
5.4.2 Predicted normal values 
To remove some of this variability, lung function data were also compared to predicted 
normal values extracted from a European reference population of normal lung function, 
who were non-smokers and free from respiratory disease (Zapletal, Paul, & Samánek, 
1977). These data were computed into the spirometer readings by the supplier 
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(NicheMedical, Leederville, WA). The manufacturers of the spirometer considered this 
reference population the best reference population for an Australian population. 
Predicted normal values were used to effectively remove confounding factors such has 
height, weight (BMI) and gender differences. 
5.5 Study Design: Initial Study 
5.5.1 Comparison of the respiratory symptoms and lung function of the Murrin 
Murrin study group with a control group.  
 Data derived through respiratory questionnaire and spirometry for the entire 
workforce (418 study group members) were compared with data from a control group of 
(40) catering staff residing close to the Murrin Murrin Operation. 
5.5.2 Descriptive statistics of the study group compared with the control group 
The parameters from the respiratory questionnaire for the study group were 
compared with the control group, and descriptive statistics for respiratory symptoms, 
smoking history and asthma status were determined. 
5.5.3 Prevalence of lung disorders 
The prevalence of lung disorders for the study group and control group were 
calculated by dividing the number of persons with respiratory disorders by the total 
number of individuals for that group and expressed as a percentage. 
5.5.4 Linear regression analysis 
The lung function parameters FEV1 and FVC, corrected for age, gender and height, 
were compared using linear regression analysis with both the control group and the 
predicted normal values (Zapletal et al., 1977). The linear model of height, plotted 
against the lung function indices FEV1 and FVC (Cotes, 1993) was employed to 
visualise the relationship between the study group, their predicted normal values 
(Zapletal et al., 1977) and the control group data. A series of scatter plots with 
regression lines (IBM® SPSS® PASW Statistics 18) were produced with sequential 
removal of the confounding factors in order to observe their effect on lung function. 
Regression analysis enabled the sequential removal of confounding factors, to 
determine the goodness of fit (R2) value, and the Pearson’s correlation coefficient (r). 
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5.5.5 Comparison of lung function with predicted normal values 
 The lung function of both the study group and the control group was compared with 
their predicted normal values extracted from a reference population of 173 subjects with 
normal lung function, who were non-smokers and free from respiratory disease 
(Zapletal, Paul, & Samánek, 1977). This reference population was considered the most 
appropriate reference population for an Australian population and was computed into 
the spirometer readings by the supplier (NicheMedical, Leederville, WA).  
  
Comparison with the predicted normal values removes the issue of confounding for 
factors such as age, gender, height and weight. 
5.5.6  Work area/department 
The lung function data for populations from each work area/department were 
analysed to determine if there were any statistically significant effects on lung function 
due to working in any specific work area. Both the production and the maintenance 
workers in each area/department were included in the initial and repeat study. 
 
A dependent (paired samples) t-test was conducted to compare the lung function 
parameters (FEV1 and FVC) for the never-smoker sub-group with their equivalent 
predicted normal values (Zapletal et al, 2007) for individuals in each work area. 
5.6 Study Design: Repeat Study 
5.6.1 Longitudinal study of lung function 
Any changes in respiratory symptoms since the initial questionnaire were requested 
and noted. 
Repeat spirometry measurements were conducted to establish rates of change in lung 
function over time, to provide an identifiable picture of lung function of the repeat study 
group. The advantage of utilising a longitudinal study is that it enables observations to 
be made on the same individuals to focus on changes occurring within subjects and to 
make population extrapolations that are not as prone to between subject variation (Yee 
& Niemeier, 1996).  
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Therefore repeat lung function tests were conducted on a sample of 72 of the original 
418 members of the study group (i.e. 17%), approximately two years after the initial 
study. As the attrition rate was 51%, the 72 employees from the remaining 213 study 
population represented 34%.  The time interval from initial spirometry test to the 
follow-up ranged from 173 to 845 days. 
The change in lung function over time from the initial study to the repeat study was 
determined for the 72 employees. The mean change, range of change and overall mean 
change per year in lung function parameters (FEV1 and FVC) was calculated. These 
calculations were made with the sequential removal of confounding factors (smoking, 
asthma and pre-existing respiratory disorders).  
A dependent t-test was conducted to determine whether there was any significant 
difference from the initial lung function tests to the repeat tests. 
5.6.2 Length of service at the Murrin Murrrin Operation 
A disadvantage of longitudinal studies is the loss of study group members (or 
attrition, 51% occurred during this investigation). Therefore an addition statistical 
analysis of the effect of length of service (or period of employment) at the Murrin 
Murrin Operation on lung function was conducted for the original 418 members of the 
study group. The length of service for the 418 study group members ranged from one 
month to six years. 
A multivariate analysis (MANOVA) was conducted to determine whether there was 
a significant difference in lung function with length of service. 
5.7 Pre-Swing and Post-Swing Lung Function in a Cohort of 
Refinery Workers 
Lung function tests for a cohort of refinery workers were conducted as they arrived 
for work on site prior to commencing work in the refinery, and on completion of their 
work period on site before returning home for their rest break. This was done in order to 
detect if there were any statistically significant decrements in lung function over a work 
period (colloquially known as a swing). 
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A dependent t-test was used to determine whether there was a significant difference 
for the pre-swing lung function when compared with the post-swing lung function of 
this group of refinery workers. 
5.8 Study Instruments 
5.8.1 Respiratory questionnaire 
The prevalence of respiratory symptoms in the study and control groups was 
determined using the Government of Western Australia, Mining and Petroleum 
Resources (2004) respiratory questionnaire component of their health assessment form 
(modified British Medical Research Council questionnaire, 1986) (Appendix A). This 
was an internationally accepted standardised respiratory questionnaire. 
The respiratory questionnaire was administered to each individual of the study and 
control groups prior to lung function testing by a competent approved person, approved 
by Resources Safety to carry out MineHealth Assessments on completion of 
compulsory training in spirometry (i.e., lung function testing) to standards required by 
Resources Safety and WorkCover WA. Data regarding each individual’s work history, 
respiratory symptoms, smoking status and history, and asthma status was collected. 
5.8.2 Measurement of lung function 
5.8.2.1 Equipment 
A portable handheld spirometer (EasyOne Model 2001 diagnostic spirometer, ndd 
Medizintechnik AG, Zurich) was used to determine various lung function parameters 
most notably forced expiratory volume in the first second (FEV1) and forced vital 
capacity (FVC). These data were computed automatically by the spirometer and were 
also expressed as predicted values (Zapletal et al., 1977).  
5.8.2.2 Technique 
Prior to commencing spirometry, it was necessary to measure accurately each 
participant’s height (measured without shoes) and weight. These data were entered into 
the instrument along with date of birth, ethnicity, gender, smoker status, and asthma 
status. 
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To gain the best possible lung function measurements it was necessary to explain and 
demonstrate the test procedure and coach each participant during the procedure. To gain 
optimum measurement of lung function the subjects were standing during the 
procedure. All subjects were warned of possible dizziness due to the procedure and all 
elected to stand, although precautions were taken for the possibility of a subject 
fainting.  
As a noseclip is not mandatory for forced expiratory maneuvers, no nose clip was 
worn by any subject, although it is often recommended to prevent air escaping via the 
nose at the end of the manoeuvre. However, this did not pose a problem in any of the 
subjects (Spirxpert, n.d.; Lange, Mulholland, & Kreider, 2009). The participants were 
observed to ensure maximal effort was expended and a true result obtained, in addition 
to any liquid crystal display (LCD) message on the instrument (ndd Medizintechnik 
AG, 2001) which indicates such an event. The participants progressed through the series 
of lung function tests with a minimum of three manoeuvres until repeatability was 
obtained. Any suboptimal efforts were excluded from the study in accordance with the 
manufacturer’s EasyGuide (ndd Medizintechnik AG, 2002, and the ATS/ERS 
guidelines (ATS, 1995; Miller, 2005; Johns & Pierce, 2003). 
Records of all lung function data were maintained on the DMP respiratory health 
assessment form as a backup to the computerised spirometer data. Confidentiality of 
these documents was maintained by securing them in locked filing cabinets. The 
computer records were password protected and codified so that individuals were not 
identifiable. 
5.8.2.3 Calibration and quality control 
The spirometer accuracy was checked regularly during each batch of testing by a 
lung function specialist using a certified 3.00 litre syringe, despite the fact that the 
EasyOne spirometer maintains its calibration during routine use, has an in-built 
calibration system, and does not require daily calibration as specified in international 
spirometry guidelines (Walters, Wood-Baker, Walls, & Johns, 2006; Perez-Padilla et 
al., 2006). 
No deterioration over time was detected. 
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The approved person’s lung function was also monitored during each batch of testing 
to act as a biological control, and to check internal validity. 
The manufacturer’s EasyGuide (ndd Medizintechnik AG, 2002) instruction booklet 
was used to ensure the instrument was used correctly and to ensure quality of results. 
For example, the height above sea level of the Murrin Murrin Operation was pre-entered 
into the spirometer database to allow adjustment for barometric pressure (Spirxpert, 
n.d.). The EasyOne Model 2001 automatically adjusts for the standardization of gas 
volumes and environmental factors such as temperature, pressure and water vapour 
(Lange, Mulholland, & Kreider, 2009). 
5.8.2.4 Protocol 
Lung function was measured following the American Thoracic Society/European 
Respiratory Society protocol (American Thoracic Society, 1995; Miller et al., 2005). 
5.8.2.5 Approved person 
The study was conducted by a DMP competent approved person, approved by 
Resources Safety to carry out MineHealth Assessments on completion of compulsory 
training in spirometry (lung function testing) to standards required by Resources Safety 
and WorkCover WA (Department of Mines and Petroleum 2010a). 
5.9 Exposure Assessment 
Personal atmospheric monitoring of the workplace hazardous substances was 
conducted in each area of the site in a separate but associated study, and a detailed 
occupational exposure history was compiled for each work group. A qualitative review 
of the respiratory health effects presented by the hazardous substances associated with 
the mining and process plant were discussed in Chapter 4. 
5.10 Statistical Analysis 
The Statistical Package for the Social Sciences (SPSS) (IBM SPSS Statistics 18, 
2010) was used for all data analysis. 
 The results using this methodology are outlined in the following chapter. 
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6. RESULTS 
6.1 Initial Lung Function Study 
6.1.1 Study group 
The study population consisted of 384 male and 34 female (a total of 418) mining, 
processing and administrative employees working at the Minara, Murrin Murrin mine 
site.  
6.1.2 Control group 
The control group consisted of 27 male and 13 female (a total of 40) catering 
personnel at the Murrin Murrin accommodation village 8 km from the mine site.  
6.1.3 Predicted normal values 
Lung function data of the study and control groups were compared with predicted 
normal values (Zapletal et al., 1977) which were programmed into the spirometer. 
Predicted normal lung function values are derived from a population asymptomatic of 
lung function disorders and lifelong non-smokers. These values are computed into the 
spirometer and the results for each test subject compared with the predicted values 
relative to their gender, height and age. Both the study and control group test subjects 
were therefore compared to their respective predicted normal value for each lung 
function parameter (e.g., FEV1 and FVC). 
6.2 Profile of the Study Group Compared With the Control 
Group 
The descriptive statistics for the study and control groups are compared in Table 6.1, 
below. 
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Table 6.1 Descriptive Statistics of the Study Group Compared with the Control Group 
 Study Group (n=418) 
 
Control Group (n=40) 
Male 92% (n=385) 68% (n=27) 
Female 8% (n=33) 32% (n=13) 
Mean Height (cm) & 
Standard Deviation 
177 ±7.99 173 ±8.86 
Height Range (cm) 155-200 155-195 
Mean Age (years) & 
Standard Deviation 
39 ±9.1 39 ± 12.7 
Age Range (years) 19-67 19-63  
Current Smokers  34% (n = 144) 39% (n = 16) 
Ex-smokers 25% (n = 104) 28% (n = 11) 
Non-smokers 41% (n = 170) 33% (n = 13) 
 
6.3 Prevalence of Respiratory Symptoms in the Study Group 
Compared With the Control Group 
The prevalence of respiratory symptoms in the study and control group was 
determined using the Government of Western Australia, Mining and Petroleum 
Resources (MPR) questionnaire (2004) (modified British Medical Research Council 
questionnaire). Thirteen participants of the study group (3%) and one participant in the 
control group (3%) did not complete the questionnaire although all performed the lung 
function test. Thus there were 405 study group and 39 control group participants who 
completed the questionnaire. Any missing data was taken into account for the following 
calculations and statistical analysis. Table 6.2 below provides the prevalence of 
respiratory symptoms in the study and control groups. 
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Table 6.2 Prevalence of Respiratory Symptoms in the Study Group vs. Control Group 
  
 
Cough 
Study 
Group 
n(%) 
Control 
Group 
n(%) 
 
1 
Do you usually cough first thing in the morning? 19 (5%) 3 (8%) 
2 Do you usually cough during the day or night? 31 (77%) 4 (10%) 
3 Do you have a cough like this on most days for as much as three 
months each year? 
12 (3%) 0 (0%) 
 Phlegm   
4 Do you usually bring up phlegm from your chest first thing in the 
morning? 
24 (6%) 3 (8%) 
5 Do you usually bring up phlegm from your chest at any other time of 
the day? 
26 (6%) 2 (5%) 
6 Do you bring up phlegm like this on most days for as much as three 
months each year? 
13 (3%) 1 (3%) 
7 In the past three years have you had a period of increased cough and 
phlegm lasting for three weeks or more? 
3 (1%) 2 (5%) 
8 Have you had more than one such period? 4 (1%) 0 (0%) 
 Breathlessness on Activity   
9 Do you get short of breath when hurrying on level ground or walking 
up a slight hill? 
12 (3%) 2 (5%) 
10 Do you get short of breath when walking with other people of your age 
on level ground? 
3 (1%) 2 (5%) 
11 Do you have to stop for breath when walking at your own pace on 
level ground? 
0 (0%) 0 (0%) 
 Breathlessness at Rest   
12 Do you ever get short of breath at rest? 5 (1%) 0 (0%) 
13 Do you ever wake up in your sleep short of breath? 7 (2%) 1 (3%) 
 Wheezing   
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14 Does your chest ever sound wheezy or whistling? 46 (11%) 8 (20%) 
15 Do you get this on most days or nights? 9 (2%) 1 (3%) 
16 Have you ever had attacks of shortness of breath with wheezing? 11 (3%) 2 (5%) 
17 Was your breathing absolutely normal between attacks? 7 (2%) 2 (5%) 
 Therefore – converse of question 17 – not normal between attacks =  4 (1%) 0 (0%) 
 Breathing Difficulty   
18 Does your chest ever feel tight or your breathing become difficult? 21 (5%) 3 (8%) 
 Smoking History   
19 Do you, or did you, smoke more than 1 cigarette/day; a cigar/week; or 
2 oz (50 g) pipe tobacco/month for at least one year?  
Smokers and ex-smokers 
248 (61%) 
 
Used to 
calculate 
Pack Years 
 
104 (25%) 
26 (67%) 
 
Used to 
calculate 
Pack 
Years 
 
11(28%) 
20 How much do you (or did you) smoke each day? (no. of cigarettes). 
Roll owns or pipes (number of grams/week)?  
21 How old were you when you started smoking? 
 
22 
If you are an ex-smoker, how old were you when you gave up smoking 
permanently?  
 Smokers = (Q19-Q22 ) = 144 (34%) 15 (39%) 
 Therefore Non-Smokers =  154 (38%) 13 (33%) 
 Past Chest Illness   
23 During the past three years have you had any chest illness which has 
kept you from usual activities for a week or more? 
24 (6%) 1 (3%) 
24 Did you bring up more phlegm than usual during this illness? 7 (2%) 0 (0%) 
25 Have you had more than one illness like this in the past three years? 4 (1%) 0 (0%) 
 Asthma   
26 Have you ever had asthma? 35 (9%) 4 (10%) 
 Other respiratory illness   
27 Have you ever had any other respiratory illness? 37 (9%) 4 (10%) 
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Questions 20, 21 and 22 from the MPR (2004) questionnaire were used to determine 
pack years (Connolly & Alpert, 2008; National Cancer Institute, n.d.) to assess the 
effect of smoking on the FEV1 for the Ever Smokers of the study and the control 
groups. The scatter plots showing these data are presented in the two figures below. The 
R2 values and r values are given for each graph. The R2 value i.e. goodness of fit of the 
regression line, and Pearson’s correlation coefficient (r) which measures the strength of 
the relationship between two variables FEV1 and Pack Years. 
 
Figure 6.1 The Effect of Smoking (Pack Years) on FEV1 (litres) for the Study Group Ever 
Smokers (n=242) (R2 0.14) (r minus 0.46). 
 
 
Figure 6.2 The Effect of Smoking (Pack Years) on FEV1 (litres) for the Control Group 
Ever Smokers (n=24) (R2 0.21) (r minus 0.37). 
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6.4 Prevalence of Respiratory Disorders 
6.4.1 Control population 
There were a total of five individuals in the control population (5/40 = 12.5%) with 
abnormal spirometry results (ndd Medizintechnik AG, 2002; Johns & Pierce, 2003); 
three with mild obstruction, one with mild obstruction and low vital capacity possibly 
due to restriction, and one with low vital capacity possibly due to restriction of lung 
volumes. 
6.4.2 Study population 
There were 26 individuals in the study population (26/418 = 6.2%) with abnormal 
spirometry results (ndd Medizintechnik AG, 2002; Johns & Pierce, 2003); 18 with mild 
obstruction, five with mild obstruction and low vital capacity possibly due to restriction, 
and three with moderate obstruction and low vital capacity possibly due to restriction. 
All were non-work-related, each with a history of respiratory illness and/or smoking. 
The conditions for these 26 individuals were: 
 history of pneumothorax, former smoker; 
 triple by-pass/sleep apnoea/10% lung removed due to thrombosis, 
BMI >35; 
 smoker 30 cigarettes/day, BMI >40; 
 smoker15 cigarettes/day, BMI >30; 
 smoker 25 cigarettes/day and asthmatic, BMI >30; 
 history of bronchitis, diabetic, asthmatic, BMI >30; 
 known poor lung function (reason not provided) BMI >35; 
 former smoker 20 cigarettes/day, BMI >30; 
 former smoker, possible asthmatic, BMI >35; 
 smoker 40 cigarettes/day; 
 asthmatic, former smoker; 
 asthmatic, occasional smoker; 
 former smoker, 12 cigarettes/day; 
 history of pneumonia, heart valve replacement, former smoker 30 
cigarettes/day; 
 former smoker 30 cigarettes/day; 
 asthmatic, former smoker 20 cigarettes/day; 
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 known poor lung function (reason not given); 
 smoker 15 cigarettes/day; 
 smoker of a pack of hand-rolled cigarettes (“rollies”) per week BMI 
>35; 
 asthmatic, occasional smoker; 
 two asthmatics, former smokers; 
 former smoker 50 cigarettes/day; 
 former smoker 30 cigarettes/day, asthma, history of pleurisy; 
 bronchitis, smoker 25+ per day, asthmatic (died of lung cancer shortly 
after completion of the study); 
 history of pneumonia, possible asthma. 
BMI classification according to the World Health Organization (n.d.). 
 
These were pre-existing respiratory disorders (non-work related) as determined 
through questionnaire.  
6.5 Comparison of the Lung Function of the Study Group, 
with Their Predicted Values, and the Control Group - With 
Sequential Removal of Confounders 
6.5.1 Lung function versus height 
The linear model of height, plotted against the lung function indices FEV1 and FVC 
(Cotes, 1993) was employed to visualise the relationship between the study group, their 
predicted normal values (Zapletal et al., 1977) and the control group data. A series of 
scatter plots with regression lines (IBM® SPSS® PASW Statistics 18) were produced 
with sequential removal of the confounding factors in order to observe their effect on 
lung function. 
6.5.2 Sequential removal of confounders 
A series of graphs are presented below to compare the FEV1 and FVC of the study 
group, their predicted values, and the control group, initially looking at all subjects of 
the study group (n=418) and the control group (n=40) followed by sequential removal 
of confounding of smoking, smoking and asthma, then smoking, asthma and non-work-
related respiratory disorders, ultimately ending up with comparison of the presumed 
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healthy non-smokers sub-population of the study group (i.e., with all confounders 
removed). 
These are presented in a series of three figures, firstly comparing the FEV1 for all 
subjects of the study group, their predicted values and control group; followed by FVC 
for all subjects of the study group, predicted values and control group; and then with the 
sequential removal of confounding as described above. 
The R2 values and r values are given for each graph. The R2 value is the goodness of 
fit of the regression line, and Pearson’s correlation coefficient (r) measures the strength 
of the relationship between two variables; which for this series of graphs are FEV1 and 
height, and FVC and height. 
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6.5.2.1 All subjects study and control groups: FEV1 plotted against height 
 
Figure 6.3 Scatter Plot Showing the Relationship of FEV1 (litres) and Height (cm) for All 
Subjects (n= 418) of the Study Group. (R2 0.42) (r 0.65).  
 
Figure 6.4 Scatter Plot Showing the Relationship of FEV1 (litres) and Height (cm) for All 
Subjects (n=40) of the Control Group. (R2 0.38) (r 0.62). 
 
Figure 6.5 Scatter Plot Showing the Relationship of the Predicted Values of FEV1 (litres) 
and Height (cm) for All Subjects of the Study Group (n=418) (R2 0.77) (r 0.88). 
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6.5.2.2 All subjects study and control groups: FVC plotted against height 
 
Figure 6.6 Scatter Plot Showing the Relationship of FVC (litres) and Height (cm) for All 
Subjects (n = 418) of the Study Group. (R2 0.49) (r 0.70). 
 
Figure 6.7 Scatter Plot Showing the Relationship of FVC (litres) and Height (cm) for All 
Subjects of the Control Group (n = 40) (R2 0.56) (r 0.75). 
 
Figure 6.8 Scatter Plot Showing the Relationship of the Predicted Values of FVC (litres) 
and Height (cm) for All Subjects for the Study Group (n = 418) (R2 0.84) (r 0.92). 
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6.5.2.3 Removal of confounding of smoking: FEV1 plotted against height 
 
Figure 6.9 Scatter Plot Showing the Relationship of FEV1 (litres) and Height (cm) for the 
Study Group Never Smokers (n = 153) (R2 0.54) (r 0.74). 
 
Figure 6.10 Scatter Plot Showing the Relationship of FEV1 (litres) and Height (cm) for the 
Control Group Never Smokers (n = 13) (R2 0.60) (r 0.78). 
 
Figure 6.11 Scatter Plot Showing the Relationship of the Predicted Values of FEV1 (litres) 
and Height (cm) for the Study Group Never Smokers (n = 153) (R2 0.78) (r 0.88). 
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6.5.2.4 Removal of confounding of smoking: FVC plotted against height 
 
Figure 6.12 Scatter Plot Showing the Relationship of FVC (litres) and Height (cm) for the 
Study Group Never Smokers (n = 153) (R2 0.57) (r 0.93). 
 
Figure 6.13 Scatter Plot Showing the Relationship of FVC (litres) and Height (cm) for the 
Control Group Never Smokers (n = 13) (R2 0.74) (r 0.94). 
 
Figure 6.14 Scatter Plot Showing the Relationship of the Predicted Values of FVC (litres) 
and Height (cm) for the Study Group Never Smokers (n = 153) (R2 0.86) (r 0.94). 
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6.5.2.5 Removal of confounding of smoking and asthma: FEV1 plotted against 
height 
 
Figure 6.15 Scatter Plot Showing the Relationship of FEV1 (litres) and Height (cm) for the 
Study Group Never Smokers/Non-Asthmatics (n = 136) (R2 0.55) (r 0.75). 
 
Figure 6.16 Scatter Plot Showing the Relationship of FEV1 (litres) and Height (cm) for the 
Control Group Never Smokers/Non-Asthmatics (n = 13) (R2 0.60) (r 0.78). 
 
Figure 6.17 Scatter Plot Showing the Relationship of the Predicted Values of FEV1 (litres) 
and Height (cm) for the Study Group Never Smokers/Non-Asthmatics (n = 136) (R2 0.78) 
(r 0.89) 
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6.5.2.6 Removal of confounding of smoking and asthma: FVC plotted against 
height 
 
Figure 6.18 Scatter Plot Showing the Relationship of FVC (litres) and Height (cm) for the 
Study Group Never Smokers/Non-Asthmatics (n = 136) (R2 0.56) (r 0.75). 
 
Figure 6.19 Scatter Plot Showing the Relationship of FVC (litres) and Height (cm) for the 
Control Group Never Smokers/Non-Asthmatics (n = 13) (R2 0.74) (r 0.88). 
 
Figure 6.20 Scatter Plot Showing the Relationship of the Predicted Values of FVC (litres) 
and Height (cm) for the Study Group Never Smokers/Non-Asthmatics (n = 136) (R2 0.86) 
(r 0.93). 
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6.5.2.7 Removal of non-work-related respiratory symptoms: FEV1 plotted against 
height 
 
Figure 6.21 Scatter Plot Showing the Relationship of FEV1 (litres) and Height (cm) for the 
Study Group on Removal of Individuals with Non-Work-Related Respiratory Symptoms (n 
= 392) (R2 0.47) (r 0.69). 
 
Figure 6.22 Scatter Plot Showing the Relationship of FEV1 (litres) and Height (cm) for the 
Control Group on Removal of Individuals with Non-Work-Related Respiratory Symptoms 
(n = 35) (R2 0.60) (r 0.77). 
 
Figure 6.23 Scatter Plot Showing the Relationship of FEV1 (litres) and Height (cm) for the 
Predicted Values of the Study Group on Removal of Individuals with Non-Work-Related 
Respiratory Symptoms (n = 392) (R2 0.77) (r 0.69). 
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6.5.2.8 Removal of non-work-related respiratory symptoms: FVC plotted against 
height 
 
Figure 6.24 Scatter Plot Showing the Relationship of FVC (litres) and Height (cm) for the 
Study Group on Removal of Individuals with Non-Work-Related Respiratory Symptoms (n 
= 392) (R2 0.51) (r 0.71). 
 
Figure 6.25 Scatter Plot Showing the Relationship of FVC (litres) and Height (cm) for the 
Control Group on Removal of Individuals with Non-Work-Related Respiratory Symptoms 
(n = 35) (R2 0.70) (r 0.84). 
 
Figure 6.26 Scatter Plot Showing the Relationship of FVC (litres) and Height (cm) for the 
Predicted Values of the Study Group on Removal of Individuals with Non-Work-Related 
Respiratory Symptoms (n = 392) (R2 0.84) (r 0.92). 
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6.5.2.9 Removal of confounding of smoking, asthma, and non-work-related 
symptoms: FEV1 plotted against height 
 
Figure 6.27 Scatter Plot Showing the Relationship of FEV1 (litres) and Height (cm) for the 
Study Group on Removal of Smokers, Asthmatics, and Individuals with Non-Work-
Related Respiratory Symptoms (n = 134) (R2 0.53) (r 0.73). 
 
Figure 6.28 Scatter Plot Showing the Relationship of FEV1 (litres) and Height (cm) for the 
Control Group on Removal of Smokers, Asthmatics, and Individuals with Non-Work-
Related Respiratory Symptoms (n = 12) (R2 0.69) (r 0.83). 
 
Figure 6.29 Scatter Plot Showing the Relationship of FEV1 (litres) and Height (cm) for the 
Predicted Values of the Study Group on Removal of Smokers, Asthmatics and Individuals 
with Non-Work-Related Respiratory Symptoms (n = 134) (R2 0.77) (r 0.88). 
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6.5.2.10 Removal of confounding of smoking, asthma and non-work-related 
symptoms: FVC plotted against height 
 
Figure 6.30 Scatter Plot Showing the Relationship of FVC (litres) and Height (cm) for the 
Study Group on Removal of Smokers, Asthmatics and Individuals with Non-Work-Related 
Respiratory Symptoms (n = 134) (R2 0.54) (r 0.73). 
 
Figure 6.31 Scatter Plot Showing the Relationship of FVC (litres) and Height (cm) for the 
Control Group on Removal of Smokers, Asthmatics and Individuals with Non-Work-
Related Respiratory Symptoms (n = 12) (R2 0.77) (r 0.88). 
 
Figure 6.32 Scatter Plot Showing the Relationship of FVC (litres) and Height (cm) for the 
Predicted Values of the Study Group on Removal of Smokers, Asthmatics and Individuals 
with Non-Work-Related Respiratory Symptoms (n = 134) (R2 0.85) (r 0.92). 
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6.5.3 Analysis of sequential removal of confounders 
6.5.3.1 Goodness of fit (R2) values of FEV1 and FVC versus height as the 
confounders are removed 
Table 6.3 Goodness of Fit (R2) for the Regression Plots for FEV1 and FVC for the Study Group, 
as the Confounders are Removed, Compared with Their Predicted Values 
Linear 
Regression 
 
All 
Subjects 
 
Minus 
Non-Work-
Related 
Respiratory 
Disorders 
 
Never 
Smokers 
 
Never 
Smokers/ 
Non-
Asthmatic 
 
Never 
Smokers/ 
Non-
Asthmatic 
No Non-
work-related 
Respiratory 
Disorders 
Predicted 
Value 
 
n = 418 392 154 137 134  
FEV1 v 
Height 
 
R2 = 0.42 
 
R2 = 0.47 
 
R2 = 0.54 
 
R2 = 0.55 
 
R2 = 0.53 
 
R2 = 0.77 
FVC v 
Height 
 
R2 = 0.49 
 
R2 = 0.51 
 
R2 = 0.57 
 
R2 = 0.56 
 
R2 = 0.54 
 
R2 = 0.85 
It can be seen that there was an improvement in goodness of fit (R2) for the 
regression plots of the study group relative to the predicted values as confounders were 
removed. The confounders were smoking, asthma and non-work related (pre-existing) 
respiratory disorders, and therefore the converse descriptions – never smokers, non-
asthmatic, no non-work related respiratory disorders – are headings in the table above. 
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6.5.3.2 r values of FEV1 and FVC versus height as the confounders are removed 
Table 6.4 Pearson’s Correlation (r) for the Regression Plots for FEV1 and FVC Plotted Against 
Height for the Study Group, as the Confounders are Removed, Compared with their Predicted 
Values 
Linear 
Regression 
 
All 
Subjects 
 
Minus 
Non-Work-
Related 
Respiratory 
Disorders 
 
Never 
Smokers 
 
Never 
Smokers/ 
Non-
Asthmatic 
 
Never 
Smokers/ 
Non-
Asthmatic 
No Non-work-
related 
Respiratory 
Disorders 
Predicted 
Value 
 
n = 418 392 154 137 134  
FEV1 v 
Height 
 
r = 0.65* 
 
r = 0.69* 
 
r = 0.74* 
 
r = 0.75* 
 
r = 0.73* 
 
r = 0.88* 
FVC v 
Height 
 
r = 0.70* 
 
r = 0.71* 
 
r = 0.93* 
 
r = 0.75* 
 
r = 0.73* 
 
r = 0.92* 
Note. * Correlation is significant at the 0.01 level. 
It can be seen that there is an improvement in the Pearson’s correlation (r) for the 
regression plots of the study group relative to the predicted values as confounders were 
removed. 
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6.5.3.3 Independent t-test of FEV1 for the study and control groups as the 
confounders are removed 
Table 6.5 Independent t-test – Comparison of FEV1 Between the Study and Control Groups 
 All Subjects 
 
Never Smokers 
 
Never Smokers / Non-
asthmatics 
 
 Study Control Study Control Study Control 
n= 418 40 154 13 137 13 
mean 3.9L 3.6L 4.1L 3.7L 4.1L 3.7L 
S.D. 0.74L 0.77L 0.71L 0.8L 0.69L 0.80L 
p <0.05 >0.05 >0.05 
Initially the FEV1 for the study and control groups appear to be significantly 
different, but as the confounding was removed there appeared to be no significant 
difference for FEV1 for these populations. 
6.5.3.4 Independent t-test of FVC for the study and control groups as the 
confounders are removed 
Table 6.6 Independent t-test – Comparison of FVC Between the Study and Control Groups 
 All Subjects 
 
Never Smokers 
 
Never Smokers / Non-
asthmatics 
 
 Study Control Study Control Study Control 
n= 418 40 154 13 137 13 
mean 5.1L 4.6L 5.2L 4.6L 5.2L 4.6L 
S.D. 0.93L 1.01L 0.93L 0.99L 0.91L 0.99L 
p <0.05 <0.05 <0.05 
Overall, there appeared to be a significant difference in FVC between the study and 
control group, even after the confounders were removed. 
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6.5.3.5 Dependent t-test of FEV1 for the study group and their predicted values as 
the confounders are removed 
Table 6.7 Dependent t-test – Comparison of FEV1 for the Study Group and their Predicted 
Values as the Confounders are Removed. 
 All Subjects 
n=418 
Minus Non-work-
related 
Respiratory 
Disorders 
n=392 
Never Smokers 
n=154 
Never 
Smokers/Non-
asthmatics 
n=137 
Never 
Smokers, Non-
Asthmatic 
No Non-work-
related 
Respiratory 
Disorders 
n=134 
 Study Predict
ed 
Study Predict
ed 
Study Predict
ed 
Study Predict
ed 
Study Predict
ed 
Mean 3.94L 3.96L 4.0L 4.0L 4.1L 4.0L 4.1L 4.0L 4.2L 4.1L 
S.D. 0.74L 0.52L 0.67L 0.51L 0.71L 0.51L 0.69L 0.50L 0.62L 0.49L 
p >0.05 <0.05 >0.05 <0.05 <0.05 
There were mixed results on comparison of the FEV1 for the study group and 
predicted values. There was no significant differences (p >0.05) between the study and 
predicted values for FEV1 without removal of any confounders and for removal of ever 
smokers; whilst there was a significant difference (p <0.05) when ever smokers and 
asthmatics, and ever smokers and asthmatics plus those with respiratory disorders were 
removed.  
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6.5.3.6 Dependent t-test of FVC for the study group and their predicted values as 
the confounders are removed 
Table 6.8 Dependent t-test – Comparison of FVC for the Study Group and their Predicted 
Values as the Confounders are Removed. 
 All Subjects 
n=418 
Minus Non-
work-related 
Respiratory 
Disorders 
n=392 
Never 
Smokers 
n=154 
Never 
Smokers/Non-
asthmatics 
n=137 
Never 
Smokers, 
Non-
Asthmatic 
No Non-work-
related 
Respiratory 
Disorders 
n=134 
 Study Predict
ed 
Study Predict
ed 
Study Predict
ed 
Study Predict
ed 
Study Predict
ed 
Mean 5.1L 4.8L 5.1L 4.8L 5.2L 4.9L 5.2L 4.9L 5.3L 4.9L 
S.D. 0.93L 0.64L 0.88L 0.63L 0.93L 0.63L 0.91L 0.62L 0.86L 0.60L 
p <0.05 <0.05 <0.05 <0.05 <0.05 
There were significant differences (p <0.05) between the study and predicted values 
for FVC even on removal of confounding factors. 
6.6 The Effect of Length of Service and Lung Function 
6.6.1 Effect of length of service on the lung function for the presumed healthy 
sub-group of the study group 
The effect of length of service (DateDiff) on lung function for the presumed healthy 
non-smokers of the study group (32%) is represented in the two regression plots below: 
 111 
 
Figure 6.33 Scatter Plot Showing the Relationship of FEV1 (litres) and Length of Service 
(DateDiff – days) for the Presumed Healthy Sub-Group of the Study Group (n = 134) (R2 
0.002) (r 0.04) 
 
 
Figure 6.34 Scatter Plot Showing the Relationship of FVC (litres) and Length of Service 
(DateDiff – days) for the Presumed Healthy Non-Smokers of the Study Group (n =134) 
(R2 0.004) (r 0.07). 
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6.6.2 Comparison of the effect of length of service on the FEV1 for the non-
smoker and smoker sub-groups of the study group 
The effect of length of service and FEV1 for the study group non-smokers was 
compared with the study group smokers in the two plots below: 
 
Figure 6.35 Scatter Plot Showing the Relationship of FEV1 (litres) and Length of Service 
(DateDiff – days) for the Non-Smoker Sub-Population of the Study Group (n = 174) (R2 
3.262E-5) (r 0.01). 
 
Figure 6.36 Scatter Plot Showing the Relationship of FEV1 (litres) and Length of Service 
(DateDiff – days) for the Smoker Sub-Population of the Study Group (n = 143) (R20.037) 
(r minus 0.19). 
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6.6.2.1 MANOVA for the comparison of the effect of length of service on the FEV1 
for the non-smoker and smoker sub-groups of the study group 
A multivariate analysis (MANOVA) showed there was no significant difference (p 
>0.05) with length of service between the study group non-smokers and the study group 
smokers. However, this analysis showed a significant difference (p <0.05) in FEV1 
between the non-smoker and smoker sub-groups of the study population. There was no 
similar effect for the FVC between the non-smoker and smoker sub-groups of the study 
population.  
6.7 The Effect of the Area Worked and Lung Function 
6.7.1 Comparison of the FEV1 with the FEV1 predicted values for individuals in 
each work area 
A dependent (paired samples) t-test conducted to compare the FEV1 and FEV1 
predicted values for the never-smoker sub-group in each work area is shown in the 
following table.  
Table 6.9 Dependent t-test Comparing the FEV1 with the FEV1 Predicted Values for Individuals 
in Each Work Area. 
Work Area Mean Standard 
Deviation 
95% Confidence 
Limits 
 
df 
Sig. 
(2 –tailed) 
Lower Upper 
Administration -.060 .527 -.300 .180 20 .608 
Mining 
Production 
.102 .506 -.129 .332 20 .368 
Mining 
Geologists 
-.205 .393 -.830 .421 3 .374 
Mining 
Maintenance 
-.037 .386 -.650 .577 3 .862 
Ore Leach 
Production 
.140 .360 -.089 .369 11 .206 
Ore Leach 
Maintenance 
.012 .404 -.259 .283 10 .923 
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Refinery 
Production 
-.063 .413 -.268 .142 17 .526 
Refinery 
Maintenance 
-.046 .421 -.279 .187 14 .679 
Utilities 
Production 
-.227 .623 -.748 .293 7 .336 
Utilities 
Maintenance 
.007 .572 -.522 .536 6 .974 
Laboratory .255 .508 -.135 .646 8 .170 
Warehouse .644 .479 -.118 1.405 3 .075 
General 
Maintenance 
.208 .369 -.040 .456 10 .092 
Electrical 
Maintenance 
.202 .208 .028 .377 7 .029* 
Note. *p <0.05 
The mean, standard deviation, degrees of freedom, and lower and upper confidence 
limits for all individuals in each specific work area are provided.  A significant 
difference (p <0.05) was observed for the electrical maintenance work area. No other 
differences were observed for any other work groups (p >0.05). 
6.7.2 Comparison of the FVC with the FVC predicted values for individuals in 
each work area 
A dependent (paired samples) t-test was conducted to compare the FVC and FVC 
never-smoker sub-group in each work area is shown in table 6.10.  
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Table 6.10 Dependent t-test Comparing the FVC with the FVC Predicted Values for Individuals 
in Each Work Area 
Work Area Mean Standard 
Deviation 
95% Confidence 
Limits 
 
df 
Sig. 
(2 –tailed) 
Lower Upper 
Administration .198 .526 -.041 .438 20 .099 
Mining 
Production 
.376 .695 .060 .693 20 .022* 
Mining 
Geologists 
-.400 .708 -1.526 .727 3 .341 
Mining 
Maintenance 
.473 .791 -.786 1.731 3 .318 
Ore Leach 
Production 
.322 .518 -.007 .651 11 .054 
Ore Leach 
Maintenance 
.105 .409 -.170 .380 10 .415 
Refinery 
Production 
.327 .587 .035 .618 17 .030* 
Refinery 
Maintenance 
.235 .471 -.026 .495 14 .074 
Utilities 
Production 
-.128 .610 -.638 .381 7 .570 
Utilities 
Maintenance 
.395 .817 -.361 1.150 6 .248 
Laboratory .493 .705 -.049 1.034 8 .069 
Warehouse .829 .801 -.446 2.103 3 .130 
General 
Maintenance 
.512 .510 .170 .855 10 .008* 
Electrical 
Maintenance 
.512 .421 .160 .864 7 .011* 
*p <0.05 
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A significant difference (p <0.05) was observed for the following work areas: 
 mining production; 
 refinery production; 
 general maintenance; 
 electrical maintenance. 
No significant difference was observed for the other work groups (p >0.05). 
6.8 Repeat Spirometry of 72 Mine Site Workers Involved in 
the Initial Study 
Repeat lung function tests were conducted on a sample of 72 individuals from the 
initial 418 mine site workers. This population consisted of 25 non-smokers/non-
asthmatics, 43 smokers and four asthmatics from the original study group. Five of the 
72 individuals had known non-work-related respiratory disorders. Not all repeat testing 
was conducted at the same time interval. The time intervals from the initial spirometry 
test to the follow-up ranged from 173 days to 845 days. 
The following table shows the 
 mean change; 
 range of change; 
 overall mean change per year; of 
FEV1 and FVC as the confounders are sequentially removed. 
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Table 6.11 The Change in Lung Function Over Time for the Repeat Study Group with 
Sequential Removal of Confounders 
 Number of 
Individuals 
(n) 
Lung 
Function 
Parameter 
Mean ± 
Standard 
Deviation 
(litres) 
Range 
(litres) 
Mean Time 
Period± 
Standard 
Deviation 
(days) 
Overall 
Mean 
Change 
(ml/year) 
All 
Subjects 
72 FEV1 -0.036±0.21 -0.54 
to 0.39 
623±198 -21 
 72 FVC -0.007±0.33 -0.74 
to 0.79 
623±198 -4 
Smokers/ 
Asthmatics 
47 FEV1 -0.068±0.22 -0.54 
to 0.39 
616±192 -40 
 47 FVC -0.003±0.35 -0.74 
to 0.79 
616±192 -2 
Non-
Smokers/ 
Non-
Asthmatics 
25 FEV1 0.024±0.17 -0.33 
to 0.39 
637±211 +14 
 25 FVC -0.013±0.29 -0.60 
to 0.40 
637±211 -7 
Presumed 
Healthy, 
Non-
Smokers 
24 FEV1 0.033±0.17 -0.33 
to 0.39 
633±215 +19 
 24 FVC <0.001±0.29 -0.60 
to 0.40 
633±215 0 
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6.8.1 Comparison of the change in FEV1 over time for the presumed healthy, 
non-smoker and the smokers/asthmatics sub-groups from the repeat study 
The comparison of the change in FEV1 for the study group presumed healthy 
subjects, and the smoker/asthmatic sub-group, over the period from the initial to the 
repeat study is shown in Figures 6.37 and 6.38. 
 
 
Figure 6.37 Scatter Plot Showing the Change in FEV1 (FEV1diff) in Litres, with the Period 
of Time Between Initial and Repeat Spirometry for the Presumed Healthy, Non-Smoker 
Sub-Group (n = 26) (R2 0.003) (r 0.058) (p >0.05). 
 
 
Figure 6.38 Scatter Plot Showing the Change in FEV1 (FEV1diff) in Litres, with the Period 
of Time Between Initial and Repeat Spirometry for the Smokers/Asthmatic Sub-Group (n = 
47) (R2 0.031) (r minus 0.18) (p <0.05). 
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In a dependent t-test there was no significant difference in FEV1 from the first 
spirometry test compared with the repeat spirometry test for presumed healthy, non-
smoker sub-group (p >0.05). However, there was a significant difference (p <0.05) in 
FEV1 from first spirometry test compared with the repeat spirometry test for the 
smokers/asthmatics sub-group. 
6.9 Cross-Swing Lung Function of a Cohort of Refinery 
Workers 
Lung function tests for a cohort of refinery workers were conducted as they arrived 
for work on site prior to commencing work in the refinery, and on completion of their 
work period on site before returning home on their rest break. There was a mixture of 
dayshift and nightshift workers. There were 32 workers in total; however, five workers 
were repeated on a second swing. This equated to seven production workers and five 
maintenance workers from Crew A; 12 production workers from Crew B, three 
production workers from Crew C, and 10 maintenance workers from Crew D; giving a 
total of 37 pre-swing/post-swing observations.  
6.9.1 Cross-swing change in lung function (FEV1 and FVC) all 37 observations 
Table 6.12 Cross-Swing Change in Lung Function (FEV1 and FVC) 
 Range 
(Litres) 
Mean 
(Litres) 
Standard 
Deviation 
p 
FEV1 -0.58 to +0.52 -0.03 0.25 >0.05 
FVC -0.72 to + 0.95 +0.01 0.35 >0.05 
There was no significant difference (p >0.05) between the FEV1 and FVC values for 
the 35 individuals (with 37 observations) from the start of a swing to the end of the 
swing. 
6.9.2 Repeat cross-swing change in lung function (FEV1 and FVC) for five 
individuals 
There was no significant difference (p >0.05) between the FEV1 and FVC values for 
the five individuals from this cohort for their combined initial and repeat cross-swing 
lung function data.  
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6.10 Internal Reliability – Biological Control 
As well as calibrating regularly during each batch of testing using a certified three 
litre syringe as per the ATS/ERS recommended standard; the lung function of the 
trained researcher was measured 41 times throughout the investigation to act as a 
biological control, for calibration purposes and to demonstrate internal  reliability. The 
figures below (Figures 6.39 and 6.40) are scatter plots, and the table of descriptive 
statistics (Table 6.13) of the FEV1 and FVC of the trained researcher over the study 
period. 
 
Figure 6.39 Scatter Plot Showing the FEV1 (litres) Measured at Various Time Intervals 
[Diff] (days) Over the Study Period. (R2 0.056) (r minus 0.237) (p >0.05). 
 
Figure 6.40 Scatter Plot Showing the FVC (litres) Measured at Various Time Intervals 
[Diff] (days) Over the Study Period. (R2 0.066) (r minus 0.237) (p >0.05).  
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Table 6.13 The Range, Mean and Standard Deviation of the Lung Function of the Biological 
Control over the Study Period 
 Minimum Maximum Mean Standard Deviation 
FEV1 (litres) 3.73 4.46 4.13 0.166 
FVC (litres) 4.40 5.96 5.29 0.307 
 
The outcome of these results for the: 
 Initial study of the respiratory health surveillance of 418 employees at the 
Murrin Murrin Operation, compared with two control populations;  
 Repeat study of 72 of these subjects; as well as the;  
 Cross-swing study of a cohort of refinery workers; 
is discussed in the following Discussion chapter. 
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7. DISCUSSION 
7.1 Profile of the Study Group Compared With the Control 
Group 
A total of 418 mining, processing and administrative employees based at the Murrin 
Murrin mine site constituted the study group. This group was compared with the control 
group of 40 catering personnel at the Murrin Murrin accommodation village some 8 
kilometres from the mine site. The caterers were chosen for their geographic proximity 
to the mine site. The caterers rarely if ever visited the mine site or processing plant; the 
only exceptions were perhaps the bus drivers or delivery personnel where their time on 
site was limited. The control group were chosen for their proximity to the mine site to 
minimise any respiratory effect due to geographical location (Hendrick, 2002; National 
Institute for Occupational Safety and Health, 2009a).  
7.1.1 Potential confounding due to the differences in the study and control 
populations 
The potential confounding due to differences in the profiles of the study and control 
groups were: 
 the male to female employee ratio in the study group was 92% to 8%; 
and for the control group it was 68% to 32%; 
 the height range and mean height was different, with the study group 
range 155-200 cm, mean = 177 cm, and the control group range 155-
195 cm, mean = 173 cm; and  
 the smoking status was different in the study group compared with the 
control group (i.e., 38% non-smokers and 33% respectively). 
7.1.2 Factors influencing lung function 
There are positive and negative factors that affect lung function. It is well recognised 
that gender and height are the most important predictors of lung function with a linear 
correlation, whilst the relationship between age is more complex with a non-linear 
correlation (Pellegrino et al., 2005). It is known that excess BMI can impair lung 
function (Cotes, 1993). Genetic factors indeed influence lung function, as does a healthy 
lifestyle, body composition and respiratory muscle strength. Asthma is caused by both 
genetic and environmental factors and has a pronounced effect on lung function (Ryon 
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& Rom, 1998). Subjects with asthma or other respiratory disorders may well exclude 
themselves from such a mining operation (healthy worker effect). However, the most 
obvious negative factor is cigarette smoking, which has been determined to be the 
single most preventable risk factor for COPD (Blanc et al., 2009). Diabetes mellitus and 
obesity are amongst the disease states that have an indirect affect on lung function 
(Ostrowski & Barud, 2006).  
To overcome the effects of confounding, the study design included predicted normal 
values (Zapletal et al., 1977) for gender, age, and height, computed into the software of 
the spirometer, against which to compare each individual’s data. Potential confounding 
due to smoking status, being an asthmatic and pre-existing respiratory disorders were 
identified through the respiratory questionnaire and addressed during statistical analysis. 
As to be expected, on statistical analysis (Simple Linear Regression, IBM® SPSS® 
PASW Statistics 18) there was a positive correlation between lung function and height 
and conversely a negative correlation with lung function and age (data not shown) for 
both the study and control groups. 
The lung function of the study group was considered significantly different from 
both the control group and the predicted norm group (Zapletal, et al., 1977) as there was 
almost a consistent significant difference (p <0.05) on comparison of their respective 
FEV1s and FVCs. However, the R2 values (goodness of fit) for the regression analysis 
appeared to become closer as the confounders related to poor lung function were 
removed (logistic regression). The difference of 5% more smokers in the control group 
was likely to account to some degree for the difference in prevalence of the non-work 
related respiratory disorders, which was 12.5% for the controls compared with 6.2% for 
the study group. There was a significant difference in both FEV1 and FVC between the 
study group and their predicted values as all the obvious confounders (smokers, 
asthmatics and those with non-work related respiratory disorders) were removed. This 
may indicate the difference between a West Australian cohort (circa 2006) (i.e. the 
study group) and a European cohort (circa 1977) (i.e. the predicted normal values).  
7.2 Initial Study 
Data from the initial study consisted of the responses to the respiratory symptoms 
questionnaire and data from the lung function tests for both the study and control 
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groups. The questionnaires and measurements required for spirometry were initially 
conducted at the medical centre by appointment; however, as this proved impractical for 
most employees, the investigator conducted the study in the various work-area offices, 
and the accommodation office at the camp was used for the control group assessments. 
The procedures and instruments for measuring height, weight and lung function 
remained consistent and according to the ATS/ERS Guidelines (American Thoracic 
Society, 1995; Miller et al., 2005) and the Thoracic Society of Australia and New 
Zealand (Pierce and Johns, 1996). 
7.2.1 Prevalence of respiratory symptoms in the study group compared with the 
control group 
A comparison of the prevalence of respiratory symptoms in the study and control 
groups is given in Table 6.2 of the results chapter. These symptoms were determined by 
administration of a respiratory questionnaire.  
7.2.1.1 Summary of the comparison of the study and control group respiratory 
symptoms 
The pattern of respiratory symptoms determined from the questionnaire for the study 
group differed only slightly from that of the control group, differing predominantly at 
sub-question level where more detail was requested. The following contrasting 
responses to the respiratory questionnaire where the responses were greater for the study 
group are reported by exception. 
 Although a slightly larger proportion of the control group reported 
they had a cough, proportionally more individuals in the study group 
reported that they usually coughed during the day and night (77% vs 
10%). Also, 12 of the study group versus none in the control group 
reported it as a persistent cough; 
 Five of the study group reported that they had experienced being short 
of breath at rest, in contrast to none in the control group; 
 Proportionally more of the study group (6%) compared with the 
control group (3%) reported that during the past 3 years they had a 
chest illness which kept them from their usual activities for a week or 
more; and 2% of the study group reported that they brought up more 
phlegm than usual during this illness. 
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All these symptoms could be related back to individuals who were ever smokers or 
had known non-work related respiratory disorders. Cigarette smoking is known to cause 
coughing and particularly a persistent chronic cough that last longer than two to three 
weeks (Kerstjens, Rijcken, Schouten, & Postma, 1997) and to result in cough and 
phlegm (Heijdra, Pinto-Plata, Kenney, Rassulo, & Celli, 2002). Dyspnea, or shortness 
of breath, may be due to asthma or other respiratory or cardiovascular disorders 
(American Thoracic Society, 2003). The respiratory questionnaire was able to determine 
that none of these symptoms were work related. 
7.2.2 Prevalence of respiratory disorders 
The prevalence of respiratory disorders was determined by administration of a 
respiratory questionnaire and confirmed by spirometry (Section 6.4). In the control 
population there were five individuals (5/40 = 12.5%) with poor spirometry results (ndd 
Medizintechnik AG, 2002); three with mild obstruction, one with mild obstruction and 
low vital capacity, possibly due to restriction, and one with low vital capacity possibly 
due to restriction of lung volumes. In the study population there were 26 individuals 
(26/418 = 6.2%) with poor spirometry results: 18 with mild obstruction, five with mild 
obstruction and low vital capacity possibly due to restriction, and three with moderate 
obstruction and low vital capacity possibly due to restriction. All were pre-existing non-
work-related (prior to working at Murrin Murrin) each with a history of respiratory 
illness and/or smoking. 
Subjects with interpretations on the spirometry report with mild obstructive 
respiratory disorders included subjects with known asthma, bronchitis, and emphysema; 
these disorders were also determined prior to spirometry through interview using the 
respiratory questionnaire. Those diagnoses with low vital capacity possibly due to 
restriction were mainly smokers however there were three cases where other respiratory 
disorders that had been identified and medically treated. These interpretations provided 
on the report from the EasyOne spirometer not only correspond with the detail provided 
by the study group subjects but also to the pathophysiological profile of these 
respiratory disorders (Johns Hopkins School of Medicine's Interactive Respiratory 
Physiology, 1995). 
A detailed analysis for the study group determined that there were 26 cases of non-
work-related respiratory disorders each either with a history of respiratory illness, or 
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smoking, and elevated BMI, or a combination of these. These are listed in section 6.4.2 
of the results section. 
7.2.3 Comparison of the lung function of the study group, with their predicted 
values, and the control group – with sequential removal of confounders 
The lung function of the study group (Figure 6.3) was compared, with the: 
 control group (Figure 6.4); and 
 predicted values for the study group individuals (Figure 6.5). 
This was followed by a series of evaluations after sequential removal of the obvious 
confounding factors such as smoking, asthma and known non-work-related respiratory 
symptoms. The confounding of age and gender was addressed by comparison with their 
predicted values (Zapletal et al., 1977). 
The series of analysis began with all subjects with no data removed from the study 
group (418 individuals on site) or control group (40 caterers off-site). Next, the ever 
smokers data were removed, followed by ever smokers and asthmatics, and finally the 
ever smokers, asthmatics and the 26 individuals with known non-work-related 
respiratory symptoms (Figures 6.3 – 6.32). 
Two analyses were employed. Firstly, the FEV1 and FVC were plotted against height 
to visualise the relationship of the study group versus the control group, and the 
predicted normal values, and a simple linear regression employed. Secondly, 
comparison of the means of the study group data versus the control group data 
(independent t-test) and the predicted normal values (dependent t-test) was also 
conducted (IBM® SPSS® PASW Statistics 18). 
It can be seen from the first in the series of regression plots (Figures 6.3 – 6.5)  that 
the lung function data (FEV1 and FVC) for all subjects in the study group (418) and 
control group (40) were more disperse than the predicted normal values (i.e., many 
outliers). This was considered mainly due to confounding factors such as smoking and 
individuals with known non-work-related respiratory disorders; whereas the predicted 
values (Zapletal et al., 1977) were derived from a representative sample of a healthy, 
non-smoking population.  
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On more detailed examination of the respiratory questionnaire, the factors 
contributing to this disperse nature (scatter) for the study group data compared with the 
predicted values for these group individuals were outliers: those with poor lung 
function, including the 26 cases determined to have non-work-related respiratory 
disorders, a history of smoking, elevated BMI, or a combination of these; and those with 
excellent lung function who reported a high level of physical activity, such as scuba 
diving – known for ‘large lungs’ (Tetzlaff et al., 2006) – which were associated with the 
best lung functions. The increased diversity in spirometry results for both the study and 
control groups, as compared with the predicted values for the study group data, was 
reflected in the R2 (linear regression goodness of fit) values for the FEV1 or FVC versus 
height linear model as shown in Figures 6.3 – 6.5. 
There was an improvement in the (goodness of fit) R2 values and the Pearson’s 
correlation (r) values for the series of regression plots depicted in Figures 6.3 through to 
6.32, for the study group relative to the predicted values, as the confounders of 
 individuals with known non-work-related respiratory disorders; 
 ever smokers; and 
 asthmatics, 
were sequentially removed, and they more closely resembled the predicted values. 
These data are summarised in Tables 6.3 and 6.4. It can be seen that the study group 
lung function data never fully resembles the predicted value data, that could be due to 
the fact that the study group was from an Australian population whereas the Zapletal et 
al. (1977) lung function data was derived from a cross-section of healthy children, 
adolescents and adults from a European population. These predicted values were the 
manufacturer’s recommendation as best reflecting the Australian population and were 
programmed into the spirometer, as there are no similar Australian predicted values. 
This population difference in lung function between the study group and their predicted 
values was also demonstrated through a series of t-tests summarised in Tables 6.7 and 
6.8. The results demonstrate that overall there was a consistent significant difference in 
FVC even as the confounders were removed (p <0.05) and a significant difference in 
FEV1 when the confounding of smoking, asthma and other non-work-related respiratory 
symptoms were removed from the data (p <0.05) thus demonstrating that overall there 
was a significant difference in FEV1 and FVC between the study group and the 
predicted values. This is consistent with the linear regression where there was more 
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scatter of data around the line of best fit for the study group data compared with the 
predicted values for these data (comparison of Figures 6.27 with 6.29 for FEV1, and 
Figures 6.30 and 6.32 for FVC). 
7.2.4 Length of service 
7.2.4.1 Study group 
The effect of length of employment at the Murrin Murrin site (length of service) on 
lung function was investigated using linear regression plots, and by Multivariate 
Analysis of Variance for the main study group presumed healthy workers (i.e., non-
smokers, non-asthmatics, and no non-work-related respiratory symptoms) (IBM® 
SPSS® PASW Statistics 18). 
The regression plots for FEV1 and FVC for the presumed healthy workers were 
relatively flat indicating no decrease or increase in FEV1 or FVC with length of service 
(Figures 6.33 and 6.34). In addition, the Pearson’s Correlations were not significant (p 
>0.01) also indicating there was no effect of length of service on the lung function for 
the study group. 
7.2.4.2 Contrast between the non-smoker and smoker sub-groups of the study 
group 
On analysis, a contrast was shown between the non-smoker (Figure 6.35) and smoker 
(Figure 6.36) sub-groups. There was an evident decrease in FEV1 with length of service 
for the smoker sub-group whilst there was no decrease for the non-smoker sub-group 
with length of service (IBM® SPSS® PASW Statistics 18). Again, the dispersion of the 
data was evident as the R2 values were small (R2 3.262E-5 and R2 0.037 respectively). 
However, the Pearson’s correlation for length of service for the smoker sub-population 
was significant at the 0.01 level indicating a decrement in FEV1 over time for the 
smokers. In addition, the Multivariate Analysis of Variance (MANOVA) (Section 
6.6.2.1) showed no significant difference in FEV1 with length of service between the 
non-smokers and smokers (p >0.05). However, there was a significant difference in 
FEV1 between non-smokers and smokers (p <0.05). 
Therefore there was no decrease in FEV1 for the study group presumed healthy 
workers with length of service at the Murrin Murrin mine site and processing plant. In 
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contrast there was a decrement in FEV1 due to smoking associated with time (length of 
service) indicating that there was no work-related effect using this study protocol for 
this study period. 
7.2.5 Effect of area worked and lung function 
A dependent t-test (IBM® SPSS® PASW Statistics 18) was conducted to determine 
if there were any statistically significant changes in FEV1 and FVC (Tables 6.9 and 6.10 
respectively) compared with their predicted values for the never-smoker populations in 
the 16 work areas studied. There appeared to be a degree of variation in the mean values 
of FEV1 (Table 6.9) and FVC (Table 6.10) across the workgroups; however, this was 
considered to be within the between-subject variation in lung function (Spirxpert, n.d.). 
There were insufficient observations to conduct statistical analysis for two of these 
work areas, calcrete and pastoral, when the ever smokers were removed from the data. 
Statistical analysis revealed that there was no significant difference in lung function for 
most work areas. There were significant findings which indicated a slightly positive 
increase in lung function. There was a significant difference (p <0.05) in FEV1 for the 
electrical maintenance group; and a significant difference (p <0.05) in FVC for the 
mining production, refinery production, general maintenance and electrical maintenance 
workers. 
These increases were considered to be slight increases as the various regression plots 
relating to lung function over time for the non-smokers and presumed healthy worker 
groups were essentially flat (horizontal) indicating no decrease in lung function. 
Therefore there was no decrease in lung function for the never-smoker populations in 14 
work areas studied at the Murrin Murrin mine site and processing plant. 
7.3 Repeat Study 
The initial aim was to conduct the repeat spirometry study at a 1-year interval. 
However, due to work commitments this was not possible; therefore this was extended 
to a 2-year interval. Ultimately the mean time period for the repeat spirometry tests was 
1.7 years (range 173-845days) because the Murrin Murrin workforce had a high attrition 
rate at the time (i.e., workers leaving employment) of approximately 51% (Minara 
Resources, Human Resources, personal communication). Hence repeat lung function 
tests were conducted on a sample of 72 of the initial 418 mine site workers to include a 
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cross-section of workers known to have been employed for approximately six months or 
longer, purposely including those known to have poor lung function (five of the 72). 
This sample consisted of 29 non-smokers (four of these were asthmatic) and 43 
smokers, from the original study group. Best attempts were made to gather a cross-
section of workers from all work areas. A comparison of their initial and repeat lung 
function tests were statistically analysed to determine if there was a decrement in lung 
function over time from initial to repeat test. It has to be noted that the difference in 
time interval (173-845days) has the potential to create bias as there may be a dilution of 
a possible effect on lung function associated with the shorter exposure time on site.  
7.3.1 Difference in lung function over time 
Table 6.11 shows the change in lung function over time for the repeat study group, 
plus the change in lung function with time on sequential removal of the confounding 
factors of smoking, asthma, and other non-work-related respiratory symptoms. The data 
indicate that there was a decrease in both FEV1 (21 ml/year) and FVC (4 ml/year) for all 
72 cases of the repeat study group. The decreases were most marked for the smokers 
and asthmatic sub-group (with FEV1 a decrease of 41 ml/year and FVC 2 ml/year). 
However, as the confounders were removed, ultimately resulting in the presumed 
healthy sub-group, there was no decrease in FEV1 and FVC. In fact, there was a slight 
increase in FEV1 of 19 ml/year. This slight increase was possibly due to a learning 
effect; that is, improved spirometry technique due to an individual’s ability to do better 
on a repeat spirometry test as they have mastered and improved their technique (Nield 
& Burmas, n.d.). 
The range of change in FEV1 and FVC was narrower for the non-smokers/non-
asthmatics than for the smokers/asthmatics, which matched the range for all subjects 
(72) individuals, indicating that smokers, asthmatics and those with known non-work-
related respiratory symptoms were mostly responsible for the largest decreases and 
increases (outliers) in lung function. This was confirmed by reviewing the respiratory 
questionnaires of these individual outliers. These were for individuals with either 
known non-work-related respiratory disorders or heavy smokers. This was reflected in 
the standard deviation for all subjects which were comparatively large (Table 6.11). The 
greatest decrement in FEV1 was observed for an individual with known non-work-
related respiratory symptoms (recent pneumothorax, and a smoker). The greatest 
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decrement in FVC was observed in an asthmatic diabetic individual. The outliers in 
FEV1 and FVC for the presumed healthy sub-group were for one individual whose 
questionnaire indicated nothing abnormal, and the spirometry reports were normal on 
both occasions. The only distinguishing difference was that one spirometry session was 
quality B and the repeat spirometry C, both considered to be acceptable (ndd 
Medizintechnik AG, 2002). There were also improvements in FEV1 and FVC for the 
presumed healthy sub-group for two different individuals. The reasons for these 
improvements were not determined, but may be due to increased physical activity, 
improved spirometry technique, or a recovery from a respiratory illness which was not 
ascertained during interview for the respiratory questionnaire. 
As demonstrated in Table 6.11, the mean change for FEV1 of minus 40 ml/year for 
the smokers/asthmatic sub-group was statistically significant (p <0.05). This decrement 
was also considered biologically significant, significant beyond the natural decrease in 
FEV1 with age (Kerstjens, Rijcken, Schouten, & Postma, 1997; Oasys, 2006). This 
significant decrement over time appeared to be associated with the smokers and 
asthmatics because on analysis when these confounders were removed (i.e., the non-
smokers/non-asthmatics sub-group) there was no significant difference in the means for 
FEV1 from the initial to the repeat study (p >0.05) (IBM® SPSS® PASW Statistics 18). 
To remove further confounding, the data from five individuals with known non-
work-related respiratory symptoms were removed. One of these individuals had a 
decrement of 330 ml over a 732-day period (equivalent to 165 ml/year). On removal of 
all known confounding data, the resulting presumed healthy sub-group had a mean 
change of plus (an increment of) 19 ml/year and no change in FVC (neither a positive or 
negative change). 
In contrast, for the smokers/asthmatics sub-group there was a decrease in FEV1 
(minus 40 ml/year) and a relatively small decrease in FVC (minus 2 ml/year) (Table 
6.11) which appears to be the typical profile of the early effects of mild smoking 
(Kerstjens et al., 1997; Heijdra, Pinto-Plata, Kenney, Rassulo, & Celli, 2002). 
Overall, there was no decrease in lung function for the presumed healthy sub-group, 
over the time from initial spirometry to the repeat spirometry, for the Murrin Murrin 
Operation personnel, whereas there was a decrease in lung function for the 
smoker/asthmatic sub-group in this repeat study. 
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7.4 Cross-Swing Lung Function in a Cohort of Refinery 
Workers 
Lung function tests for a cohort of refinery workers were conducted as they arrived 
for work on site prior to commencing work in the refinery, and on completion of their 
work period on site before returning home on their rest break (known as a swing) 
(Section 6.9 of the results chapter). All but three of these were smokers. Despite this, 
there was no significant change in lung function from the start of swing to the end of 
swing for this cohort of refinery workers. 
Twenty-nine of the 32 refinery workers were smokers. Three members of this cohort 
had mild obstruction as diagnosed by spirometry, one had a history of pneumothorax 
and was a current smoker, and one was an asthmatic and a smoker. Another with normal 
spirometry had a history of non-work-related pneumonia and smoked 20 cigarettes per 
day. 
7.4.1 Cross-swing FEV1 
The cross-swing FEV1 results in Table 6.12 in the results chapter show that the 
maximum decrease in FEV1 was minus 0.58 L, with a maximum increase in FEV1 of 
0.52 L. The maximum decrease in FEV1 was observed for a smoker with a history of 
(non-work-related) pneumonia. The maximum increase (improved) FEV1 was observed 
in a heavy smoker with a history of (non-work-related) bronchitis. 
There was a mean decrease for the cohort of minus 0.03 L, from the start to 
completion of the work period, for the cross-swing refinery worker cohort. This 30 ml 
decrease was not significant (p >0.05). 
7.4.2 Cross-swing FVC 
The maximum decrease in FVC for this cohort was minus 0.72 L, with a maximum 
increase in FVC of 0.95 L. The 0.72 L decrease was observed for a mild smoker, and 
the improvement in FVC of 0.95 L was observed for a heavy smoker with a history of 
non-work-related bronchitis. Despite these large volume changes, both were recorded as 
normal spirometry (ndd Medizintechnik AG, 2002) on the spirometer records.  
The maximum negative change (minus 0.72 L) was a 12% change over a period of 
14 days. Although it was recorded as normal spirometry (ndd Medizintechnik AG, 
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2002) a follow-up of this individual was requested on the grounds that such a decrease 
is considered of clinical significance even in normal subjects (American Thoracic 
Society, 1995; Wang & Petsonk, 2004; Mason, Broaddus, Murray, & Nadel, 2005). The 
spirometry from this individual has since been consistently classified as normal 
spirometry (Mary Morrissey, Minara Resources, personal communication, March, 
2011).  
Despite the large standard deviation, with some individuals showing changes of up to 
17% in their lung function, there was no statistical significant difference (p >0.05) in 
lung function for this cohort from the beginning of the swing to the end of the swing for 
either FEV1 or FVC for these 37 observations (Table 6.12). Nor was there a statistical 
significant difference (n= 10, p >0.05) in the repeat cross-swing lung function for five 
of these refinery workers. 
7.5 Limitations 
No matter how well a study is conducted there will always be limitations, such as 
study design, attrition, missing data, unknown confounding factors, instrumentation, 
and data analysis (Checkoway et al., 2004). 
7.5.1 Main study 
It was considered that there was no selective failure to participate as all the control 
group members agreed to participate and only two of the 420 study-group members 
refused to participate. However, there was attrition during collection of the initial study-
group data as workers were joining and leaving employment at the Murrin Murrin 
Operation. Work rosters were used to capture all employees in each work area until the 
final number of 418 was reached. This may have produced a ‘healthy worker effect’ 
(Checkoway et al., 2004) whereby individuals with work-related respiratory disorders 
left the Murrin Murrin workforce, which was considered unlikely. 
7.5.2 Repeat study 
Follow-up of workers leaving the workforce was purposefully not included in the 
study design and in the ethics protocol hence there was loss of follow-up in the repeat 
study. However, best attempts were made to gather a cross-section of workers from all 
work areas hence there may have been some selection bias, as well as a potential 
‘healthy worker effect’ due to the possibility of individuals with work-related 
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respiratory disorders leaving the workforce. Attrition is reported to be a major limitation 
of longitudinal studies (Checkoway et al., 2004). Attrition was an issue with this study. 
The attrition rate of approximately 51% over this period would have introduced new 
workers with less time on site (causing a dilution of the effect) therefore attempts were 
made to focus on the longer-serving members of the workforce and limiting it to those 
with service of greater than six months; in the event, the range of length of service was 
from 0.47 years to 2.3 years, with a mean of 1.7 years. Smokers and those with known 
non-work-related respiratory symptoms were included with the intention of seeking any 
potential synergistic effect. 
Due to the attrition rate impeding the repeat study, the length of service (time worked 
on site, [minimum 1 month, maximum 8 years with a mean of 2.5 years]) in the initial 
study was also analysed.  
7.5.3 Missing data 
Missing data can seriously affect the outcome of a study, and can distort or miss-
represent the sample (IBM SPSS Statistics 18, 2010).  
Every attempt was made to acquire all data. It was very rare for individuals not to 
divulge information and, since anonymity was assured, it is likely that the 
questionnaires completed by interview by an ‘approved person’ were answered 
truthfully. For example, Patrick et al. (1994) states that reporting of smoking is usually 
accurate. 
Two sets of data were excluded as the quality rating for the spirometry tests did not 
meet the quality criteria; one person rushed the test and did not complete it, and the 
other was disqualified due to inadequate effort, which was also indicated as a 
substandard quality rating on the spirometer read-out (ndd Medizintechnik AG, 2002). 
The remaining spirometry data met the strict protocol requirements. 
Therefore most data was missing at random and the IBM® SPSS® PASW Statistics 
18 excluded these cases for that particular value during statistical analysis. 
7.5.4 Variability 
Variability may occur due to misclassification of the spirometry results due to the 
difference in the outcome between sessions, where in one session the data for an 
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individual are within the normal range, but at another session they are outside that 
range. This is likely to create within- and between-subject variability. The intra-
individual standard deviation of repeated measurements of FEV1 and FVC in a healthy 
adult is considered to be about 200 ml and about 340 ml respectively (Rozas & 
Goldman, 1982). To reduce within-session variability the ATS/ERS criteria (American 
Thoracic Society, 1995; Miller et al., 2005) and the manufacturers (ndd Medizintechnik, 
2002) guidelines were rigorously applied. Moreover a single competent person collected 
all data using the same instrument to conduct the spirometry tests. 
7.5.4.1 Intra-individual variation 
Intra-individual variation is mainly due to physiological issues, environmental issues, 
the instrumentation and the conduct of the lung function tests. Physiologically lung 
function is known to vary mainly due to stature and age (Chinn, Cotes, & Martin, 2006). 
However, the largest variability in this study was due to confounding factors: non-work-
related factors such as smoking, non-work-related respiratory diseases such as asthma, 
effects of overweight and cardiovascular diseases such as diabetes, which are known to 
have a pronounced effect on lung function (Poirier et al., 2006). The standard deviation 
of results on occasions was considered high (for example, in the cross-swing study of 
the refinery workers) but observed to be caused by the confounders introduced by 
individuals with known non-work-related respiratory disorders, and smoking. The study 
protocol was strictly adhered to in order to limit all but the physiological issues. 
7.5.4.1 .1 Internal validity – biological control 
A biological control with known normal lung function was incorporated into the 
study protocol to monitor intra-individual variation in lung function. The lung function 
of the trained researcher was repeatedly measured throughout the investigation to act as 
a biological control to demonstrate internal validity. There was no significant (p >0.05) 
decrease in lung function for this individual over the study period, and although there 
was an apparent decrease normally attributed to age this was not significant (r - 0.24 for 
both FEV1 and FVC) (Figures 6.39 and 6.40). This was consistent with the study 
findings. The standard deviation in FEV1 was 166 ml, and for FVC was 307 ml, which 
is consistent with the intra-individual standard deviation, quoted by Rozas & Goldman 
(1982). 
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7.5.4.2 Between-subjects variation in FEV1 
Between-subjects variation in lung function is largely affected by subjects with 
respiratory disorders, although there have been shown to be diurnal variation (Spirxpert, 
n.d.). 
As demonstrated in Tables 6.5 and 6.7: 
 The mean ± SD for FEV1 for all subjects in the study group was 3.94 
± 0.74; 
 The mean ± SD for FEV1 for cases with no known non-work-related 
respiratory symptoms in the study group was 4.0±0.67; 
 The mean ± SD for FEV1 for all subjects in the control group was 
3.6±0.77. 
7.5.4.3 Between-subjects variation in FVC 
As demonstrated in Tables 6.6 and 6.8: 
 The mean FVC for all subjects in the study group was 5.1±0.93; 
 The mean ± SD for FVC for cases with no known non-work-related 
respiratory symptoms in the study group was 5.1±0.88; 
 The mean ± SD for FVC for all subjects in the control group was 
4.6±1.01. 
7.5.4.4 Effect of learning 
It has been suggested that the effect of learning the spirometry technique may 
improve the lung function results of a repeat test (Nield & Burmas, n.d.). Such variation 
is more likely to be due to the difference in equipment used and the variety of people 
conducting the spirometry test. However, if spirometry is conducted to the ATS/ERS 
criteria this variation should be eliminated. 
7.5.4.5  Climate or other factors 
It is possible that climate or other factors may have confounded the results. To 
eliminate the possible effect of climate a control population close to the Murrin Murrin 
operation was chosen.  
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To reduce possible bias of atmospheric pressure during lung function testing, the 
spirometer was pre-programmed with the altitude of the Murrin Murrin operation.  The 
model of spirometer used for this study was pre-programmed to remove any effects of 
temperature and relative humidity at the time each lung function test was performed.   
7.5.5 Internal validity 
Internal validity is the assurance that can be given to a cause and response 
relationship in a study (Checkoway, et al., 2004). In this study the lung function data of 
smokers acted effectively as a positive control, whilst the lung function of a healthy 
non-smoking person (biological control) effectively acted as a negative control for 
internal validity. 
7.5.5.1 Smokers decrease in lung function 
A consistent negative effect on FEV1 among smokers was demonstrated throughout 
this study. This was seen on analysis of the ever smokers for both the study and control 
groups with FEV1 plotted against pack years. Here, a significant decrement in FEV1 was 
observed (Figures 6.1 and 6.2). Both of these gave a negative correlation significant at 
the 0.01 level. Similarly, there was a decrement in FEV1 for smokers with length of 
service (time worked on site) (Figure 6.36) significant at the 0.05 level. Again, a 
decrement in FEV1 was observed in the repeat study. Here, there was a significant 
difference (p <0.05) in FEV1 from the first spirometry test compared with the repeat 
spirometry test for the smokers/asthmatics sub-group (Figure 6.38). 
As the confounder of smoking was removed from most data an improvement 
appeared with lung function data, specifically FEV1, as smoking appeared to affect FVC 
to a lesser extent.  
7.5.5.2 Biological control (lung function of the approved person) 
The lung function of the approved person conducting the lung function tests was 
taken on 41 occasions during each batch of testing for calibration purposes and for 
internal validity. The linear regression plots of both FEV1 and FVC versus time 
difference between spirometry were effectively horizontal indicating that there was little 
to no change in FEV1 and FVC with time (Figure 6.39 and 6.40). The dispersion of the 
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data was evident as the goodness of fit R2 values were small (R2 = 0.056 and R2 = 0.066 
respectively).  
On further analysis, the Pearson’s correlation for: 
 FEV1 with time was r = minus 0.237; p >0.05; and  
 FVC with time was r = minus 0.258; p >0.05. 
This indicates that there was no significant difference in both lung function measures 
and that there was a negative relationship, perhaps starting to indicate the effect of age 
(Sharma & Goodwin, 2006).  
It is considered that this study protocol was sensitive enough to detect a decrement in 
lung function due to smoking over the study period, and that there was no significant 
difference in FEV1 and FVC with time for the biological control. 
7.6 Correlation with the Known Work-Area Exposure Levels 
Because there was no overall decrement in lung function for the Murrin Murrin 
Operation employees for this study period, the correlation with the known occupational 
exposure levels in each work area became redundant. The absence of an effect on lung 
function is considered to be reflective of the actual work-area exposure levels which 
were invariably well below the regulatory occupational exposure standards.  
7.7 Reasons for the Absence of an Effect on Lung Function for 
the Main Study and Repeat Study and the Cohort of Refinery 
Workers 
The outcome of this study was that there was no overall decrement in lung function 
for the Murrin Murrin Operation employees for the period each individual worked on 
site, or when working in specific work areas at the mine site or the processing plant for 
this study period. This result was consistent in all phases of the study. Statistical 
analysis showed that with length of service on site, in the repeat study, and the 
biological control over the study period, there was no overall decrease in lung function. 
In contrast, the effect of smoking was detected across all phases, acting as internal 
validity (positive control) that an effect could be detected by these research tools. 
The results of the study provide evidence that primary preventive measures aimed at 
protecting workers are effective. Point source emissions are contained within the 
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environmental operating licence limit and the workplace exposures are generally 
maintained to levels below their respective occupational exposure standards. In 
instances where exceedances were likely, adequate personal protective controls were 
implemented. The data therefore suggest that the mine and process plant safety and 
environmental programs were effective. These primary preventive measures include: 
 plant and process design; 
 plant integrity and maintenance;  
 controlled process chemistry; 
 plant and process controls; 
 process operation and control, including instrumentation, 
training/competency, and operating procedures. 
Secondary preventative measures (backup controls) were also in place to detect 
process upsets and equipment failure, for example, control-room instrumentation and 
control-room operators. Tertiary preventative measures included strategically placed 
emission monitoring alarms around the processing plant, emergency response planning 
and training, and finally emergency evacuation and respiratory protection as a last resort 
in their hierarchy of control. Improvements to their program have been implemented 
such as dust reduction projects in the nickel and cobalt buildings. 
It is essential, however, that Minara Resources continuously monitor and review 
these controls to ensure their effectiveness and to make further improvements where 
possible. 
7.8 Addressing the Smoking Issue 
It is important not to ignore the effect of smoking – although this is a lifestyle choice, 
not strictly a workplace issue – by providing the opportunity for employees to enter a 
smoking cessation program, as Australian workplaces will ultimately benefit in the long 
term. 
DMP (2010b) recognises that smoking is a contributory risk factor to worker health, 
and promotes the health of people engaged in mining operations. Implementing a Health 
Ownership Model (Cameron, 2010) by addressing both workplace health needs and 
individuals’ health needs, in this case by encouraging and supporting employees to quit 
smoking, will be beneficial to both the company and the individual. 
 140 
7.9 Summary 
This research set out to determine if there was a possible adverse respiratory effect of 
concurrent and repeat exposures to complex mixtures of low-level airborne chemicals at 
the Murrin Murrin operation. The overall outcome of this study was that there was no 
overall decrement in lung function for the Murrin Murrin Operation employees for the 
period each individual worked on site, or when working in specific work areas at the 
mine site or the processing plant for this study period. It could be argued that this time 
period may be too short to pick up a long-term effect, however, since commissioning 
the processing plant had been open for more than 5 years, and mining activity prior, 
with the maximum length of service in this study of 8 years. The length of service of 
participants ranged from 1 month to 8 years, (mean of 2.5 years). Also, this result was 
consistent in all phases of the study. Statistical analysis showed that length of service on 
site, in the repeat study, and the biological control over the study period, was not related 
to a decrease in lung function. In contrast, the effect of smoking was detected across all 
phases, acting as internal validity (positive control) that an effect could be detected by 
these research tools. 
The conclusions and recommendations arising from this study are provided in the 
next and final chapter.  
 141 
8. CONCLUSION AND RECOMMENDATIONS 
The concern shown by the employees at the Murrin Murrin Operation that workplace 
emissions may be harming their respiratory health appears to be dispelled by this study.  
The purpose of this study was to detect possible adverse respiratory health effects at 
an early stage in order to prevent potential long-term occupational respiratory disease in 
the Murrin Murrin workforce, and then, if necessary, to recommend interventions to 
prevent untoward health effects, and enable management to have a proactive approach 
to the protection of the workforce. No work-related respiratory health effects were 
detected for this workforce relative to the workforce’s length of service and over the 
study period. There are, of course, limitations to this study as it really only addresses 
some of the more acute respiratory health issues and insufficient time elapsed to 
examine any long-term effects.  
8.1 Initial Study 
8.1.1 Prevalence of respiratory symptoms in the study group compared with the 
control group 
In combination, the respiratory symptoms established from the questionnaire and 
from spirometry determined that in the control group population there were 12.5% 
individuals with non-work-related respiratory disorders compared with 6.2% in the 
study group. All these symptoms were related back to individuals who were Ever 
Smokers or had known non-work-related respiratory disorders. A detailed analysis of 
the data from the 418 participants in the study group discovered that there were 26 cases 
of non-work-related respiratory disorders.  
8.1.2 Length of service 
On statistical analysis, with these 26 individuals and the smokers’ data removed (i.e., 
the presumed healthy workers sub-group) there was no overall decrement in lung 
function for the Murrin Murrin Operation employees with length of service (p <0.01).  
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8.1.3 Effect of area worked 
In addition, there was no decrease in FEV1 associated with the Never Smokers in the 
14 work areas studied at the mine site or processing plant when compared with their 
predicted FEV1 values. 
8.2 Repeat Study 
Similarly, in the repeat study, there was no significant difference in FEV1 from the 
first spirometry test compared with the repeat spirometry test for the presumed healthy 
sub-group (p >0.05).  
8.3 Cross-Swing Study of a Cohort of Refinery Workers 
The cross-swing study of a cohort of 35 refinery workers indicated there was no 
(before and after) decrement in lung function from the start of a swing to the end of a 
swing (p >0.05). In addition, for a repeat cross-swing study for five of these individuals, 
again, there was no significant difference (p >0.05) between the FEV1 and FVC values.  
8.4 Effect of Smoking 
A constant theme throughout the findings of this study was the negative effect due to 
cigarette smoking. There were decrements in lung function measured for the smokers in 
the study and control groups. There was a significant difference in FEV1 between non-
smokers and smokers with length of service (p <0.05) and a significant difference (p 
<0.05) in FEV1 from first spirometry test compared with the repeat spirometry test for 
the smokers/asthmatics sub-group in the repeat study. This in effect acted as internal 
validity indicating that spirometry was sensitive enough to detect a decrease in lung 
function due to smoking in the initial and repeat studies (Kerstjens, Rijcken, Schouten, 
& Postma, 1997). 
8.5 Summary 
It has been demonstrated in this research that, when used in conjunction with a 
respiratory questionnaire, spirometry testing provides an effective diagnostic tool with 
adequate sensitivity to detect effects on lung function. It must be noted that this study 
was not about validation of spirometry, but the detection of possible adverse respiratory 
health effects at an early stage using the respiratory questionnaire in conjunction with 
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lung function testing, which it appears to do well. Asthmatics (non-work related) were 
identified both through the questionnaire and by spirometry. In this study, an effect due 
to smoking was observed while there was no obvious effect on lung function for the 
presumed healthy sub-group, for the study period. This combination (spirometry plus 
questionnaire) was able to identify individuals with non-work-related respiratory 
symptoms. Furthermore it was determined that there was no overall decrement in lung 
function for the presumed healthy workers with length of service or any specific work 
area. That there was no significant difference in FEV1 from the first spirometry test 
compared with the repeat spirometry, and there was no cross-swing decrement in lung 
function for this cohort of refinery workers. 
Thus it can be concluded that spirometry in combination with a respiratory 
questionnaire is sensitive enough to detect an effect on lung function, however, no 
workplace effect was noted, using this study protocol. 
8.6 Recommendations 
The reasons for the absence of a work-related effect on lung function at the Murrin 
Murrin Operation using this study protocol, over this study period, would appear to be 
due to the primary, secondary and tertiary preventative measures implemented at the 
mining and process areas. These preventative measures included a hierarchy of controls 
including isolation, engineering, administrative and personal protective equipment, as 
well as occupational hygiene monitoring, and health surveillance. However, it cannot be 
assumed that these preventative measures will remain adequate over the longer term. 
The aim of occupational hygiene is to ensure exposure to hazardous substances does not 
affect employee health. Therefore it is recommended that, through continuous 
improvement, this level of protection is maintained, and even improved upon where 
possible by proactively reviewing workplace health risk assessments and conducting 
health monitoring. 
As asthma and other pre-existing respiratory disorders may be exacerbated by 
occupational exposures, these  subjects should be monitored more closely than other 
employees for possible respiratory health effects. It is equally important not to ignore 
the effect of cigarette smoking, although this is a lifestyle issue rather than a workplace 
issue. Individual health ownership to protect those with asthma and, to help smokers 
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quit smoking should be encouraged within the workplace this will be beneficial to both 
the company and the individual. 
Suggestions for further research; 
 extend this longitudinal study to identify long term trends at the Murrin Murrin 
operation;  
 expand this study to review the respiratory health of people who have worked in 
the WA mining industry for periods in excess of 15 years; 
 examine the respiratory health of shutdown workers such as the boilermakers, 
welders, and confined space workers who carry out the majority of the ‘dirtier’ 
maintenance work and are more likely to be exposed to higher levels of 
respiratory health risks.  
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TABLE OF ABBREVIATIONS 
 
AED aerodynamic equivalent diameter 
ANZSRS Australian and New Zealand Society of Respiratory Science 
ATS American Thoracic Society 
BIMS Brambles Industrial Maintenance Services 
BMI body mass index 
CCD counter current decantation 
CCH Commerce Clearing House (a Wolters Kluwer business) 
CI confidence interval 
CIC 33 census industry code (primary metal industries) 
cm centimetre = one hundredth of a metre 
Co Cobalt 
CO carbon monoxide 
COPD chronic obstructive pulmonary disease 
DALYs disability adjusted life years 
DMP Department of Mines and Petroleum 
DMPR Department of Mineral and Petroleum Resources 
EC endothelial cells 
eNO exhaled nitric oxide 
ERS European Respiratory Society 
FeNO fractional exhaled nitric oxide 
FEV1 forced expiratory volume in one second 
FEV1/FVC the ratio of forced expiratory volume in one second to forced 
vital capacity 
FEV1/FVC% the ratio of forced expiratory volume in one second to forced 
vital capacity – as a percentage 
FOT forced oscillation technique 
FVC forced vital capacity 
FZ ferruginous zone 
HPAL high pressure acid leach 
HSIS hazardous substances information system 
H2S hydrogen sulphide 
IARC International Agency for Research on Cancer 
IBM International Business Machines – a company that 
manufactures and sells computers and computer software 
IDLH immediately dangerous to life and health 
ILO International Labour Organization 
IL-8 interleukin 8 
km kilometres 
L litre(s) 
LCD liquid crystal display 
MANOVA multivariate analysis of variance 
m3 cubic metre 
mg milligram = one thousandth of a gram 
mg/m3 milligram per cubic metre 
ml millilitre = a thousandth of a litre 
MPR Mining and Petroleum Resources 
MSHA Mine Safety and Health Administration 
n sample size 
Ni nickel 
NIOSH National Institute for Occupational Safety and Health 
NOHSC National Occupational Health and Safety Commission 
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NO2 nitrogen dioxide 
oC degrees centigrade 
OSHA Occupational Safety and Health Administration 
O3 Ozone 
p (or p-value) a measure of how likely the sample results are, 
assuming the null hypothesis is true; the smaller the p-value, 
the less likely the sample results 
PAL pressure acid leach 
PAPA public health and air pollution in Asia 
PAR% population attributable risk – as a percentage 
PEL permissible exposure limit 
PFT pulmonary function test 
pH a measure of the acidity or alkalinity of a solution 
PM2.5 fine particles in the (ambient) air 2.5 micrometres or less in 
size 
PM10 fine particles in the (ambient) air 10 micrometres or less in 
size 
ppb parts per billion 
ppm parts per million 
RADS reactive airways dysfunction syndrome 
RCS respirable crystalline silica 
ROM run of mine 
r Pearson’s correlation coefficient – a standardised measure of 
the strength of relationship between two variables 
R2 coefficient of determination. The goodness of fit of a statistical 
model describes how well it fits a set of observations 
SABRE surveillance of Australian workplace based respiratory events 
SAG semi-autogenous grinding 
SAP saprolite zone 
SD standard deviation 
SO2 sulphur dioxide 
SM smectite zone 
SPSS Statistical Package for the Social Sciences 
SWORD surveillance of work-related and occupational respiratory 
disease 
TLC total lung capacity 
TWA time-weighted average 
UK United Kingdom 
μm micrometre(s) = one millionth of a metre 
US United States 
VOC volatile organic compounds 
VC vital capacity 
vs versus 
WoRLD work-related lung disease 
≤ equal to or less than 
> more than 
< less than 
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GLOSSARY OF TERMS 
Allergy 
 
All subjects 
A reaction of the immune system to something that does not 
bother most  people. 
All individuals in the study (and control) group. 
Approved Person 
 
 
 
Asthmagen 
 
A person approved by the Department of Mines and 
Petroleum, Resources Safety, Western Australia, to carry out 
MineHealth Assessments on completion of compulsory 
training in spirometry (lung function testing). 
Any substance that is causally related to the development of 
asthma symptoms. 
Biological Control The lung function of a subject with stable respiratory function 
recorded regularly as part of an ongoing quality control 
program. 
BOC Plant The production and supply of compressed and bulk gases. 
Bulka Bags Large lightweight bags, usually made of woven 
polypropylene, with four cross corner loops, capable of 
holding 1m3 or 1 tonne, can be handled by crane, Hyab, 
forklift. 
Crew A group of workers operating and maintaining (in this 
instance) the refinery. 
Cross-Swing Lung function tests for a cohort of refinery workers were 
conducted as they arrived for work on site prior to 
commencing work in the refinery, and on completion of their 
work period on site before returning home on their rest break. 
Dependent t-test A test using the t-statistic that establishes whether two 
means collected from the same sample (or related 
observations) differ significantly. 
Ever Smokers A person who has ever been a cigarette smoker or cigar 
smoker. 
FEV1diff Change in FEV1 from the initial to the repeat lung function 
test. 
Independent t-test A test using the t-statistic that establishes whether two 
means collected from independent samples differ 
significantly. 
Length of Service The duration of service in the company (at Minara 
Resources, Murrin Murrin mine site). 
Never Smokers A person who has never been a cigarette smoker or cigar 
smoker. 
Non-work-related 
respiratory 
symptoms 
Respiratory symptoms determined to be other than work 
related. 
Pack Years A way to measure the amount a person has smoked over a 
long period of time. 
Predicted (normal) 
Values 
Spirometry reference values from groups of relatively healthy 
persons (non-smokers, with no known respiratory disorders). 
Presumed Healthy The sub-group of the study (and control) group on removal of 
those subjects who were ever-smokers, and those with 
known non-work related respiratory disorders. Therefore the 
never-smokers, with no known non-work related respiratory 
symptoms (I.E., The known confounders removed). 
Rollies Hand-rolled cigarettes. 
Sig 
 
Statistical significance. 
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Spirometry A test that can help diagnose various lung conditions. 
Swing A work pattern – from arrival for work on site, to completion 
of work period on site, before returning home for a rest break. 
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APPENDIX A: HEALTH ASSESSMENT FORM, DMP, WA 
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